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1.1 DNA under attack
Our genetic information is stored in our DNA. From the color of our eyes to the
proteins involved in the energy production in our cells, all these things are coded
for in this huge macromolecule in a language consisting of only 4 letters (bases):
adenine (A), cytosine (C), guanine (G) and thymine (T). This information is faith-
fully copied by DNA polymerase to a new DNA molecule upon cell division, and
in a process called transcription, this information is read by RNA polymerase to
form a RNA molecule that can then be translated by the ribosome into proteins,
the workhorses in our cells. For both these processes, a characteristic of nucleic
acids (such as DNA and RNA) called base pairing is used: an A is complementary
to a T (and to an uracil, U, in RNA) and a G to a C. In the double helix of the DNA,
an A is hence always found opposite to a T and a C to a G. This conveys an ele-
gant read-out mechanism for the DNA and RNA polymerase: if they encounter a
A in the template, they put a T (or U in RNA) opposite to it in the nascent DNA or
RNA, and a C opposite to a G and vice versa. As can be expected for such an impor-
tant information holder as DNA, it is a relatively stable macromolecule, helping to
preserve our genetic information.
However, there are influences from both outside and inside that cause damage
in this stable macromolecule: UV-irradiation, for example. Staying in the bright
sun can cause DNA damage, especially due to the UV-B component of sunlight,
which ranges from 280-320 nm. The major lesions that this radiation causes are
crosslinks between adjacent pyrimidines (C and T bases): cyclobutane pyrimidine
dimers (CPDs) and 6-4 photoproducts (6-4PPs) (Yoon et al., 2000). Such lesions in-
terfere with the correct reading of the genetic information, since they, for example,
block the transcription of the DNA into RNA, they block replication of the DNA











Other types of radiation also cause damage in the DNA, with ionizing radiation
such as γ-radiation being the most dangerous. This type of radiation can cause
double-strand breaks in the DNA, which is of course detrimental to the information
encoded in the molecule (Rich et al., 2000). Besides radiation there are also other
DNA damaging agents in our surroundings. Smoking, for example, causes the
intake of polycyclic aromatic hydrocarbons, which lead to the formation of diol
epoxide - DNA adducts that are highly tumorigenic (Zhong et al., 2011).
Not only influences from the outside cause damage in our DNA, but metabolic
processes also contribute to DNA lesions, since they produce free oxygen radicals
and other reactive compounds that can cause oxidative damage to the bases that
can lead to the loss of the correct coding information at that spot.
As stated above, DNA is a relatively stable macromolecule, so the percentage
of lesions resulting from the above mentioned causes is low. However, the sheer
amount of DNA in a cell (approximately 6 billion base pairs in a human cell) makes
this low percentage accumulate to form for example about 10.000 base losses per
cell per day (Nouspikel, 2009a). This forms a serious problem for a cell, because an
unrepaired lesion can give rise to a mutation. For example, if a guanine is methy-
lated at the O6 position, it looks more like an adenine, hence upon DNA replication
a thymine will be erroneously incorporated in the new DNA molecule leading to
GC to AT mutations (Warren et al., 2006). In many regions of the DNA a single-
base substitution might not represent a major problem, but if the error occurs at
the wrong spot in a gene, the information encoded by the gene might be changed
in a detrimental way, since even a single base substitution can lead to a severe dis-
ease. Cystic fibrosis is just one of the many examples (Lommatzsch et al., 2009).
Another possible consequence of DNA lesions is cell death. The block in replica-
tion or transcription caused by unrepaired lesions is a strong signal for apoptosis.
In other words, the cell will commit organized suicide. This is actually a safety
mechanism for the cell to prevent it from continuing to divide after its genetic in-
formation has been changed, but it is also a process that contributes to aging.
To prevent mutation and cell death it is thus crucial that damage in the DNA
is repaired. Therefore, several DNA repair pathways have evolved, each with their
own specificity for particular lesions. Below, the major DNA repair pathways will
be discussed. Most of these pathways are conserved from bacteria to humans, but
in this chapter an emphasis will be given on the system in humans. Examples will
be shown to demonstrate the contribution to the understanding of these systems
that structural biology on macromolecules in the pathways has made.
1.2 Direct reversal
The conceptually simplest pathway for DNA repair is the pathway of direct reversal
(DR). As the name suggests, this pathway is responsible for directly reversing a
DNA lesion. There are two main types of direct DNA damage reversal systems:












Figure 1.1: Direct reversal
(a) Mechanism of direct reversal as performed by the O6-meG-DNA methyl transferase
(MGMT), based on Eker et al., 2009. See text for detailed explanation.
(b) Crystal structure of MGMT (red-yellow) bound to damaged DNA (green) showing nu-
cleotide flipping with the damaged base shown in blue and the arginine intruding into the helix
is shown in magenta. Structure 1t38 was used for this figure.
A representative example of the first type is formed by the enzyme O6-meG-
DNA methyl transferase (MGMT), also referred to as alkylguanine transferase
(AGT). This protein repairs an O6-methylguanine lesion by irreversibly transferring
the methyl group of O6-methylguanine to an active site cysteine, which restores the
guanine base to its original form (see Figure 1.1(a)). Methylated MGMT cannot be
reused and is rapidly degraded (Eker et al., 2009).
The crystal structure of human MGMT in complex with damaged DNA gives
insight into the details of this mechanism (Daniels et al., 2004). In the structure it
can be seen that the damaged base is flipped out of the helix into the active site of
the enzyme while an arginine of the protein takes the place of the damaged base
into the DNA duplex thus stabilizing the extrahelical conformation of the lesion
(Figure 1.1(b)). Widening of the minor groove and bending of the DNA upon bind-
ing of MGMT’s helix-turn-helix motif to the DNA’s minor groove facilitates this
nucleotide flipping. Also a conserved tyrosine aids in the flipping by stimulating
phosphate rotation. The specificity of this enzyme for O6-alkyl guanines can be
explained by the interactions of the protein with the damaged base in the active
site.
Another example of direct repair is the repair of pyrimidine dimers by pho-
tolyases. These proteins reverse the photolesions CPD and 6-4PP that are caused
by the UV-component of sunlight using the visible component of the very same
source. A certain photolyase is specific for either a CPD or for a 6-4PP, but either
type of photolyase works via a similar mechanism. From crystal structures of pho-
tolyases (reviewed in Müller & Carell, 2009) it was found that they first bind to a











dinucleotide lesion out of the duplex into the active site close to a FAD cofactor. The
reaction is then predicted to continue as follows (Brettel & Byrdin, 2010): absorp-
tion of a photon in the FAD reaction center or in the second cofactor that functions
as auxiliary light-harvesting antenna (8-HDF or MTHF) leads to the transfer of an
electron to the lesion that destabilizes the damage. The formation of this lesion radi-
cal leads to the breaking of the bond between the two pyrimidines and the electron
is then transferred back to the cofactor, yielding a repaired DNA substrate and a
photolyase that is back in its ground state. Photolyases have been found in bacte-
rial systems, fungi and animals, but not in placental mammals such as humans.
1.3 Base excision repair
Base excision repair (BER) is the main pathway that repairs lesions due to oxidation,
alkylation, deamination and depurination/ depyrimidation of bases in the DNA.
It functions in three steps (Figure 1.2(a); reviewed in Robertson et al., 2009). First
a specialized glycosylase recognizes the damaged base and removes it by cutting
the N-glycosidic bond, creating an apurinic/ apyrimidinic (AP) site. One glycosy-
lase typically recognizes only one type of lesion. In mammals up to now eleven
different glycosylases have been identified. The second step involves recognition
of the newly generated AP site by an AP endonuclease and this enzyme cuts the
DNA backbone 5’ to the lesion. Sometimes the first two steps are carried out by a
single enzyme, since some glycosylases have an AP-lyase activity. After the 5’ inci-
sion, single strand break repair is initiated. There are two possibilities for this third
step of BER: a short patch and a long patch option. In the short patch option, DNA
polymerase displaces the AP site and adds a nucleotide in the DNA to fill in the
gap, and then it catalyzes the removal of the displaced AP site. Finally, a ligase cat-
alyzes the closing of the gap. In the long patch option, DNA polymerase displaces
and polymerizes stretches of DNA longer than one base. This produces a flapped
substrate, and this flap is removed by FEN1, after which the repair can be finished
by DNA ligase (Robertson et al., 2009).
A detailed atomic description of the first step of BER can be seen in the crystal
structure of human uracil-DNA glycosylase (UDG) in complex with its DNA sub-
strate before and after cleavage (Parikh et al., 2000). This enzyme recognizes uracil
bases that erroneously enter DNA via misincorporation or cytosine deamination
and subsequently excises the erroneous base, leaving behind an AP site. In the
structure it can be seen that the uracil is flipped out of the helix into the enzyme’s
active center (Figure 1.2(b)). UDG closes around the substrate and enforces a large
distortion in the uracil and the deoxyribose that promotes cleavage of the glycosylic
bond, since the distortion is relieved upon cleavage.
Endonuclease IV from E.coli forms a nice example for the second step of BER:
5’ incision of the AP site. Its crystal structure in complex with DNA containing an
AP site gives insight into its mechanism (Hosfield et al., 1999). The enzyme is seen
to bind DNA in a positively charged, crescent shaped groove. At the bottom of this
groove, most of the conserved residues are found as well as three Zn2+ atoms in











Figure 1.2: Base excision repair
(a) Mechanism of base excision repair based on Robertson et al., 2009 showing UDG as
glycosylase and APEX as AP endonuclease. See text for detailed explanation.
(b) Crystal structure of uracil-DNA glycosylase (UDG; red to yellow) bound to DNA (green)
showing uracil flipping with the flipped damaged base in blue. Structure 1emh was used for
this figure.
(c) Crystal structure of T4 endonuclease (red to yellow) bound to DNA (green) showing the
flipping of the abasic site (in blue), the three Zn atoms (in magenta) and the Tyr and Leu
sticking into the helix in magenta. The structure 1qum was used for this figure.
insertion of three residues (a tyrosine, a leucine and an arginine) into the double
helix assists in this bending of the DNA and helps in flipping both the damage as
well as the opposite base out of the duplex. The damage is flipped into a pocket that
sterically excludes undamaged bases, hence providing specificity to the enzyme.
The target phosphate binds to the active site Zn2+ ions and is hence positioned
correctly for a nucleophilic attack on the scissile P-O bond by a hydroxide ion that
is activated by the Zn2+ ions, leading to incision 5’ to the abasic site.
1.4 Mismatch repair
Replication of DNA is done by DNA polymerase. This is a highly accurate enzyme
that has a very low error rate (one error per 107 bases). A major factor contributing
to this accuracy is the proofreading of the enzyme: it checks itself whether it has
made a mistake, and it corrects the mistake when it has occurred. However, this low
error rate still corresponds to quite some errors, given that in one cell division in a
human cell, the polymerase has to copy around six billion bases. Other sources of











Figure 1.3: Mismatch repair
(a) Mechanism of mismatch repair based on Kunz et al., 2009. Detailed explanation can be
found in the text.
(b) Crystal structure of MutSα in complex with DNA (green) with MSH2 in red and MSH6 in
yellow, the conserved Glu434 in magenta, ADP in magenta, DNA in green and the mismatch
in blue. The structure 2o8b was used for this figure.
to a cytosine followed by deamination, which yields a thymine and hence a G-T
mismatch.
To correct errors made in DNA replication, the mismatch repair system (MMR)
has evolved (see Figure 1.3(a)). In this pathway, first the mismatch is recognized. In
humans this is done by the heterodimeric complex MutSα, which consists of MSH2
and MSH6. After mismatch recognition, the MLH1-PMS2 dimer called MutLα is
recruited. Cycles of ATP binding, hydrolysis and ADP-ATP exchange in MutSα
then leads to a sequence of conformational changes in MutSα that enables it to
slide along the DNA away from the mismatch. It has been proposed that it looks
for the discontinuous strand, which is the newly synthesized strand and hence the
strand containing the erroneous base. Latent endonuclease activity in the PMS2
subunit of MutLα is activated and a nick is introduced in the strand containing the
discontinuity. Subsequently, a stretch of DNA in the nicked strand is degraded by
EXO1, after which the gap is filled by DNA polymerase δ and then sealed by DNA
Ligase I (Kunz et al., 2009). Mismatches that arise from DNA damage, such as the
above-mentioned G-T mismatch, are corrected by BER (section 1.3), which has a
special glycosylase for excision of T from G-T mismatches.










1.5. DOUBLE-STRAND BREAK REPAIR
from the crystal structure of MutSα in complex with G-T mismatch containing DNA
(Warren et al., 2007). This structure shows that MutSα forms an asymmetric oval
disc with two channels in the center. The ATPase sites are found at one end of
the oval and the DNA containing the mismatch in the channel at the other end.
The DNA is bent about 45◦ (Figure 1.3(b)). Only MSH6 interacts with the mis-
match and a glutamate of a conserved Phe-X-Glu motif of MSH6 hydrogen bonds
to the mispaired thymine, which is also sandwiched between two hydrophobic
residues, while a backbone carbonyl interacts with the mispaired G. Many non-
specific protein-DNA interactions are also seen that by itself are probably sufficient
for binding to deformable DNA substrates, since MutSα can also bind C-C mis-
matches that cannot make all the above interactions. Besides this, co-crystal struc-
tures with a number of very different DNA substrates show virtually identical com-
plexes, suggesting that MutSα recognizes a global feature such as helix instability
(Warren et al., 2007).
1.5 Double-strand break repair
Probably the most detrimental lesion for a cell is a double-strand break (DSB): the
DNA has been broken in both the strands of the double helix. Even a single un-
repaired double strand break can lead to cell death (Rich et al., 2000). At least two
repair pathways have evolved to deal with this deleterious lesion (see Figure 1.4(a)):
Non-Homologous End-Joining (NHEJ) and Homologous Recombination (HR) (re-
viewed in Pardo et al., 2009). The choice between these two pathways depends on,
amongst others, the stage of the cell cycle.
NHEJ is the most general applicable pathway of the two, because it can re-
ligate any two ends together without the requirement of a homologous sequence
(Pardo et al., 2009). In this pathway, the MRN (Mre11-Rad50-Nbs1) and the DNA-
PK/Ku (DNA-dependent protein kinase/ Ku) complexes bind to the ends of the
double strand break shortly after formation of the break. These protein complexes
bridge together the ends of the break and prevent their degradation. Different
alignments of the ends are attempted. Subsequently, DNA ligase IV is recruited
to perform the ligation. If ligation is not immediately possible, the ligase and the
DNA-Pk/Ku complexes recruit DNA-processing enzymes that for example correct
for non-ligatable ends of the DNA molecules (missing the 5’ phosphate etc.) or
fill in missing parts of complementary strands and then the two ends are ligated
together.
The second pathway for repair of DSBs is the Homologous Recombination (HR)
pathway in which an intact homologous DNA molecule is used as a template for
repair. Also in this pathway the ends are stabilized by MRN and DNA-Pk/Ku, but
then nucleolytic degradation of the 5’ ends takes place to generate a long 3’ single-
stranded end, to which the ssDNA binding protein RPA binds. RPA is then dis-
placed by a filament of Rad51 (also involving Rad52, Rad54 and Rad55-57), which
is responsible for the homology search (to find a template for the repair, such as
the sister chromatid during the S and G2 stages of the cell cycle), and for invasion











Figure 1.4: Double-strand break repair
(a) Mechanism of double strand break repair based on Pardo et al., 2009. Details can be found
in the text.
(b) Crystal structure of the Ku heterodimer (in red to yellow) bound to DNA (green). Structure
1jey was used to make this figure.
D-loop, in which DNA polymerase fills in the missing DNA stretches. After this,
the ends are ligated and the D-loop is resolved, giving a repaired DNA molecule.
Protein crystallography gives some insights into the mechanism of DSB repair,
in particular, on the function of the Ku70-Ku80 dimer (Ku). This complex binds
double strand breaks shortly after their formation and protects them, but it still
allows end-processing to occur, so apparently it does not hide the entire DNA end.
The crystal structure of the Ku heterodimer bound to DNA (Walker et al., 2001)
provides an explanation: it was shown that Ku forms a positively charged cradle
into which DNA lies and also bridges around the DNA (Figure 1.4(b)). One part of
the DNA is covered with Ku (the bottom part in Figure 1.4(b)), but the rest of the
DNA is accessible for end-processing and end-joining reactions. The observation
that the Ku heterodimer forms a ring around the DNA immediately explains why
it only can bind to DSBs and not to a DNA molecule without end.
1.6 Nucleotide excision repair
The array of DNA lesions is very large and diverse. The pathway of Nucleotide
Excision Repair (NER) solves this problem (reviewed in Nouspikel, 2009b): this
pathway can recognize a large range of lesions and excise the stretch of DNA con-
taining the damage. The main feature of the damage to be recognized seems to
be that it has to disturb the double helix to a certain extent (e.g. by disrupted base-
pairing and/ or stacking): it is more this distortion that is recognized than the exact










1.6. NUCLEOTIDE EXCISION REPAIR
Figure 1.5: Nucleotide excision repair
(a) Mechanism of nucleotide excision repair, showing both the global genome repair branch and
the transcription-coupled repair branch based on Nouspikel et al., 2009b (see text for details).
(b) Crystal structure of DDB1 (red; the domains are indicated as BPA, BPB and BPC) and
DDB2 (yellow) bound to DNA (green) containing a 6-4PP lesion (blue). The DDB2 hairpin
inserting into the helix is shown in magenta. For this figure structure 3ei1 was used.
In humans it is the XPC-HR23B-Cen2 complex that most often does the initial
recognition (see Figure 1.5(a)). It flips out the damaged bases and the bases op-
posite to it and it then binds to the bases opposite to the lesion in a non-sequence
dependent manner (Min et al., 2007), showing that it recognizes the helix-distorting
properties of the damage and not the damage itself. Not all lesions distort the helix
to the same extent and therefore, there is the DDB1-DDB2 complex for the recog-
nition of smaller lesions (such as UV-photoproducts). DDB1-DDB2 is part of an
E3-ubiquitin ligase complex. For such smaller damages, it is the DDB1-DDB2 com-
plex that first recognizes the lesion and binds to it, with the lesion being flipped
into a shallow pocket that determines DDB2’s specificity (Scrima et al, 2009; Figure
1.5(b)). After this, it recruits XPC-HR23B-Cen2 to the damage. Then both XPC and
DDB2 get ubiquitinated. This leads to the degradation of DDB2, while XPC binds
stronger to the DNA after ubiquitination and thus the lesion is transferred to XPC
(Sugasawa et al., 2005).
Subsequently, Transcription Factor II H (TFIIH) is recruited to the site of dam-
age, which opens up a bubble of around 30 nucleotides using the ATPase activity
of its subunit XPB to anchor TFIIH to the DNA and the 5’ to 3’ helicase activity
of its subunit XPD to open up the DNA (Egly & Coin, 2011). The blockage of this
translocation of XPD by a genuine damage has been proposed to be involved in











XPC and might be involved in additional damage verification by probing for ap-
propriately distorted DNA (Gillet et al., 2006). RPA is recruited to the site as well
and binds the single stranded DNA in the repair bubble. XPF-ERCC1 then incises
the DNA strand containing the lesion 5’ to the damage (Matsunaga et al., 1995) and
XPG 3’ to the damage (O’Donovan et al., 1994). A stretch of DNA of around 25-30
nucleotides is then taken out and is later filled in by DNA polymerase δ, ǫ or κ and
ligated, yielding a corrected DNA (Nouspikel, 2009b).
How the DDB1-DDB2 complex recognizes photolesions (CPD and 6-4PP) is
shown from its crystal structure in complex with DNA containing a 6-4PP (Scrima et
al., 2008). DDB1’s three WD40 domains fold into three β-propeller domains (BPA,
BPB and BPC). DDB2 also has a β-propeller fold and binds to DDB1 using a N-
terminal helix-loop-helix motif inserted between the BPA and BPC domains and a
large hydrophobic surface patch on the bottom face of DDB2. In the crystal struc-
ture it can be seen that the lesion is held exclusively by the WD40 domain of DDB2,
and more precisely its top face (Figure 1.5(b)), which has extensive positive charges.
A small hairpin of DDB2 intrudes in the DNA’s minor groove and flips the damage
into a shallow pocket on the protein’s surface, which would exclude larger lesions,
hence explaining DDB1-DDB2’s specificity. The DNA duplex is kinked by about
40◦ upon DDB2 binding.
1.7 Transcription-coupled repair
1.7.1 Discovery and mechanism of transcription-coupled repair
In 1985 it was noted that some lesions in the transcribed regions of the genome are
repaired faster than those in the overall genome (Bohr et al., 1985). Two years later
it was reported that the lesions in the transcribed strand of the transcribed genes
are repaired preferentially (Mellon et al., 1987). This led to the establishment of the
pathway of Transcription-Coupled Nucleotide Excision Repair (TC-NER), which
was found to be a subpathway of NER.
This subpathway is thought to act in mammalians as in Figure 1.6 (reviewed in
Fousteri & Mullenders, 2008). When RNA polymerase is transcribing the genome,
it is dynamically interacting with Cockayne Syndrome protein B (CSB). Upon en-
countering a lesion past which it cannot transcribe, this interaction is stabilized
and CSB recruits chromatin remodelers and Cockayne Syndrome protein A (CSA)
in complex with DNA Damage Binding protein 1 (DDB1) as part of an E3 ubiq-
uitin ligase complex inactive at the time of recruitment. Also the NER factors are
recruited that repair the lesion by excising a short stretch of DNA containing the
lesion (as described in section 1.6). Once the lesion is repaired, RNA polymerase
can resume transcription (Fousteri et al., 2006).
In bacteria such as E. coli, it is the product of the mfd gene, transcription-repair
coupling factor (TRCF), that starts repair upon stalling of RNA polymerase (Selby
et al., 1991). This protein detects stalled RNA polymerase and then recruits NER
factors (UvrA and UvrB in E. coli). In contrast to the mammalian system, TRCF











Figure 1.6: Transcription-coupled repair
Mechanism of transcription-coupled repair showing the roles of CSA and CSB (figure based on
Fousteri et al., 2008). Details can be found in the text.
allow room for repair (Selby & Sancar, 1993). As in mammalians, Nucleotide Exci-
sion Repair then finishes the repair by excision and filling up the stretch of DNA
containing the lesion. No factor equivalent to CSA in humans has been found in
bacteria.
TC-NER repairs lesions that stall transcription such as UV-induced lesions and
bulky chemical adducts such as polycyclic aromatic hydrocarbons. Most studies on
TC-NER are conducted using UV-lesions. Cellular studies have shown that CSA-
or CSB-deficient cells are not only sensitive to UV-irradiation, but are also hyper-
sensitive to oxidative stress (D’Errico et al., 2007; Tuo et al., 2003). However, it is
generally thought that RNA polymerase does not stall at oxidative lesions (Kathe et
al., 2004). Normally oxidative lesions are repaired by BER (section 1.3). It has been
hypothesized that either the CS proteins are also involved in BER or that oxidative
lesions are nonetheless repaired by TC-NER. However, repair of oxidative lesions
in TC-NER is currently an area filled with controversies due to the retraction of
several key papers in this area (discussed in Stevsner et al., 2008). In bacteria, it has
been reported that TRCF is not involved in the repair of oxidative lesions (Schalow
et al., 2012).
1.7.2 Cockayne syndrome proteins A and B
Most of the pathway of TC-NER is identical to Global Genome Nucleotide Excision
Repair (GG-NER). The major difference is the initial step of damage recognition,
which is done in TC-NER by a stalled RNA polymerase. The two factors unique
to TC-NER, besides RNA polymerase, are CSA and CSB, which will be described











The gene for CSB is located on chromosome 10.q11-21 and encodes a protein of
1493 amino acids (168 kDa)(Troelstra et al., 1992). As shown Figure 1.7(b), several
motifs can be recognized in the CSB sequence such as an acidic region of CSB (with
a currently unknown function), a glycine-rich stretch (presumably needed to yield
conformational flexibility to the N-terminal part of the protein), a bipartite nuclear
localization signal and an ATPase domain (Licht et al., 2003). The latter domain
consists of seven ATPase motifs and places CSB in the SWI2/SNF2 family of DNA-
dependent ATPase. Proteins of this family usually are molecular motors that use
energy of ATP hydrolysis to remodel protein-DNA interfaces (Hauk et al., 2011). In
vitro studies on CSB have shown that CSB indeed has a DNA-stimulated ATPase
activity, but no helicase activity (Citterio et al., 1998). Dephosphorylation of CSB,
which occurs in response to UV-irradiation, leads to increased ATPase activity and
hence provides a regulatory mechanism (Christiansen et al., 2003). Another inter-
esting feature of CSB is that it contains a ubiquitin-binding domain (UBD) that is
crucial for repair: without it, the TC-NER complexes fully assemble, but no repair
is initiated, and the repair can be restored by a heterologous UBD on CSB (Anindya
et al., 2010).
The best-known function of CSB is in TC-NER. CSB has been shown to tran-
siently interact with RNA polymerase during transcription and this interaction
is prolonged when there is transcription arrest (Van den Boom et al., 2004). CSB
then initiates TC-NER by recruiting other TC-NER factors to the site of the stalled
RNA polymerase: histone acetyltransferase p300, NER proteins, and CSA-DDB1
E3-ubiquitin ligase complex with the COP9 signalosome (Fousteri et al., 2006). It
has then been proposed to use its DNA-dependent ATPase activity for modifying
the RNA polymerase - DNA interface to make space for the NER factors to repair
the lesions, especially for the 3’ incision by XPG. This is necessary in TCR because
the large RNA polymerase would otherwise cover the site of the lesion (Licht et al.,
2003).
CSB not only functions in TC-NER, but also in transcription in general. The
above-mentioned transient interaction of CSB and RNA polymerase has been
shown to help elongation by RNA pol I, II and possibly III (Licht et al., 2003), both
in nuclear and mitochondrial transcription (Berquist et al., 2012). CSB stimulates
elongation by RNA polymerase at natural pause sites or by strong RNA secondary
structure and it helps the polymerase to bypass (small) lesions such as thymine
glycol and 8-oxoguanine (Charlet-Berguerand et al., 2006). Moreover, CSB has been
reported to be involved in regulation of transcription after UV or oxidative stress
(Proietti-De-Santis et al., 2006; Kyng et al., 2003 respectively). A function for CSB in
the transcription for some but not all promoters was found. In another study, tran-
scription of genes involved in chromatin maintenance and remodeling was seen to
be influenced by CSB (Newman et al., 2006).
A third function of CSB seems to be in oxidative damage repair, since CSB-
deficient cells are hypersensitive to oxidative stress. CSB has therefore been sug-
gested to have a function in BER, which is the main pathway for repair of these
lesions. CSB-deficient cells were seen to have reduced repair of the oxidative dam-











Figure 1.7: Sequence of CSA and CSB.
Schematic representation of the amino acid sequence of CSA (a) and CSB (b), showing the
most important domains.
deficient repair could be corrected for with the CSB gene. The precise mechanism
via which CSB functions in BER is currently not known; CSB has been reported to
stimulate expression of OGG1, and the two proteins have been observed to reside in
the same complex, but no direct physical interaction between them has been estab-
lished. In vivo CSB also interacts with other BER proteins: poly(ADP-ribose) poly-
merase 1 (PARP-1) and apurinic/apyrimidinic endonuclease 1 (APE1) (Thorslund
et al., 2005, Wong et al., 2007), but exactly how this influences BER is unknown.
The gene for CSA is located on chromosome 5q12-q31 (Henning et al., 1995). It
encodes a 396 amino acid protein (44 kDa) and it has been predicted to fold into a
WD40 domain, since it contains seven WD40 repeats (see Figure 1.7(a)). Proteins
with this fold are often involved in protein-protein interactions (Stirnimann et al.,
2010 and Xu et al., 2011). In the cell CSA is found in an E3 ubiquitin ligase complex
that consists of DDB1, Cul4A and Roc1 (reviewed in Scrima et al., 2011), which is
inactive in initial stages of repair due to binding of COP9 signalosome (Groisman
et al., 2003).
E3 ubiquitin ligases such as the one CSA is involved in, mediate the process of
ubiquitination, which means covalently attaching one ubiquitin - a 76 amino acid,
very conserved protein - or a polyubiquitin chain to a target protein. This is often a
signal for proteasome-mediated destruction, but it can also alter the function of the
the target protein non-proteolytically. The ubiquitination pathway starts with the
ATP-dependent activation of ubiquitin by the E1 ubiquitin-activating enzyme. The
human genome contains only one type of E1 enzyme. Next, the activated ubiquitin
is transferred to the E2 ubiquitin-conjugating enzyme. 25 different E2 enzymes are
present in humans. In the final step, a E3 ubiquitin ligase recognizes the substrate
and promotes the transfer of the ubiquitin from the E2 enzyme to the substrate.











the specificity. There are assumed to be more than 1000 different E3 enzymes in
humans with different specificities so that proteins can be selectively targeted for
ubiquitination. The largest family of E3 ubiqituin ligases are the Cullin-RING ubiq-
uitin ligases (reviewed in amongst others Lee & Zhou, 2007 and Jackson & Xiong,
2009). Seven different Cullin proteins exist in humans. With their C-terminus,
Cullins bind to ROC1 (Regulator Of Cullins), which contains a RING domain (Re-
ally Interesting New Gene) for binding to the E2 enzyme. Binding of (a linker and) a
substrate receptor protein that determines the specificity occurs on the N-terminus
of the Cullin.
One of the linker proteins involved in such a Cullin-RING E3 ubiquitin ligase
complex is DDB1 (reviewed in Iovine et al., 2011). It has three WD40 domains that
form a triple β-propeller (Li et al., 2006). With its second propeller, BPB, it binds to
the N-terminus of Cul4A (Angers et al., 2006). In a cavity between its first and third
β-propeller (BPA and BPC), it binds to one of many different substrate receptors.
These are called DDB1-Cul4 associated factors (DCAFs). Through proteomic stud-
ies, many DCAFs have been identified (amongst others Higa et al., 2006; Jin et al.,
2006; Olma et al., 2009) that function in a variety of biological processes (reviewed
in Scrima et al., 2011). They are thought to usually bind to DDB1 by inserting a
helical motif between the BPA and BPC propeller of DDB1, though not all known
substrate receptors for DDB1 have a sequence for such a motif, so these have either
a different binding mode or the motif has passed unnoticed in their sequence (Li et
al., 2010). The majority of DCAFs have a WD40 propeller domain, but other types
of DCAFs also exist. Most of them are thought to recognize protein epitopes, or
post-translational modifications of proteins, which they are assumed to usually do
with the top face of their WD40 domain. This target protein is not necessarily the
protein that undergoes ubiquitination, since the E3 ubquitin ligase is able to span
up to 100 Å due to the rotational flexibility of the BPB domain of DDB1 versus the
BPA-BPC domain (Scrima et al., 2008).
The most-studied DCAFs besides CSA are DDB2 and CDT2. DDB2 functions in
NER, as described in section 1.6, and in contrast to most DCAFs, it binds to dam-
aged DNA and then promotes ubiquitination of proteins in the surroundings. The
Cul4A-DDB1-CDT2 E3 ligase functions in cell cycle regulation, since it is in con-
trol of S/G2 cell cycle transitions through degradation of the replication licensing
factor CDT1 (Zhong et al., 2003). Other targets of this DCAF include cell cycle regu-
lator p21 (Abbas et al., 2008) and the histone methyltransferase SET8 (Centore et al.,
2010). The variety of cellular processes that are regulated by Cul4-DDB1 E3 ubiqui-
tin ligases make them a nice target for pathogens. These ligases are thus sometimes
hijacked by viruses in order to target specific proteins for degradation to create a
nice host cell environment for virus replication and dissemination (Barry & Früh,
2006). For example, interferon-activated transcription factor STAT1 is ubiquitinated
after infection with simian virus 5 due to V protein of this virus, which functions
as a DCAF in its host cell and redirects the Cul4-DDB1 E3 ubiquitin ligase towards
this target. The STAT family of transcription factors controls the expression of over
a hundred genes with diverse antiviral functions, hence degrading these has a clear











to bind to DDB1 even though the protein does not have a WD40 domain.
Cullin-RING E3 ubiquitin ligases are usually regulated by the COP9 signalo-
some (CSN) (reviewed in Schwechheimer, 2004). The E3 ligase activity is activated
through attachment of NEDD8 (neddylation), a small-ubiquitin-like modifier. Re-
moval of NEDD8 is done by the metallo-isopeptidase activity of the fifth subunit
of the COP9 signalosome (CSN5) and thus the CSN can regulate the E3 ubiqui-
tin ligase. The timing of the regulation of different E3 ubiquitin ligases differs.
For example, for the Cul4A-DDB1-DDB2 E3 ligase, CSN dissociates from the com-
plex upon UV-damage, after which the complex gets neddylated and activated.
However, with the Cul4A-DDB1-CSA complex, CSN stays in the complex after UV-
irradiation and only dissociates much later; this means that the CSA-containing E3
ubiquitin ligase only gets active at later stages of the repair.
As described above, it is clear that CSA is present in the cell in a E3 ubiqui-
tin ligase complex and what this type of complexes does in general. However, the
exact function of CSA has not yet been determined. CSA is known to recruit nu-
cleosomal binding protein HMGN1, the transcription cleavage factor TFIIS and the
pre-mRNA splicing factor XAB2 to the vicinity of damage once there are stalled
RNA polymerase-CSB complexes (Fousteri et al., 2006). In contrast to CSB, CSA
is not required for the assembly of NER pre-incision factors TFIIH, XPA, RPA and
XPF-ERCC1. As other possible functions for CSA it has been proposed that it pro-
tects TC-NER factors from degradation at the initial stages of repair and/ or that
it causes the removal of some of these factors in later stages of repair so that RNA
polymerase can resume transcription.
It has been proposed that CSA is involved in degradation of the stalled RNA
polymerase to make room for repair, since CSA co-localizes with RNA polymerase
upon UV-irradiation (Kamiuchi et al., 2002) and RNA polymerase was reported to
be a target for ubiquitination in UV-irradiated cells depending on CSA and CSB
(Bregman et al., 1996). Cul4A-DDB1-CSA would then be a logical choice for the re-
sponsible E3 ligase. Later, however, it was reported that ubiquitinated RNA poly-
merase was only present in the soluble fraction, but not in the chromatin fraction
and it was noted that RNA polymerase does not need to dissociate for repair to
take place (Fousteri et al., 2006). It was then proposed that CSA perhaps protects
RNA polymerase from degradation and that ubiquitination is only an emergency
strategy in case the cell can’t cope with the damage (Fousteri et al., 2006), though
this has not been proven conclusively.
CSB has also been proposed as a potential substrate of CSA, linking the two
main TC-NER factors together. However, the results on this matter are contro-
versial. CSB-CSA interaction has been found with in vitro translated proteins
and in a yeast two-hybrid assay (Henning et al., 1995). Moreover, translocation
of CSA to the nuclear matrix upon UV-radiation was found to be dependent on
the presence of CSB (Kamiuchi et al., 2002). No interaction was found, though,
in gel filtration experiments of whole-cell extracts (Van Gool et al., 1997) nor in co-
immunoprecipitation and immunofluorescence experiments (Bradsher et al., 2002).
An argument in favor for CSB being the substrate of CSA is that the CSA ubiqui-











has been reported to be ubiquitinated and degraded in a CSA-dependent matter
several hours after UV-irradiation (Groisman et al., 2006). However, this doesn’t fit
with the observation that UV-lesions are removed by TC-NER at an approximately
linear rate during at least 30 hours (Van Hoffen et al., 1995) and other groups were
unable to obtain the same result (Mullenders, personal communication). It is pos-
sible that use of different antibodies by different groups leads to biased protein
detection after post-translational modifications of CSB in the process of TC-NER.
In short, the results concerning the substrate(s) for CSA are contradictory in the lit-
erature and hence the substrate(s) for CSA have not been established conclusively.
Another possible way of linking CSA and CSB together is via the UBD of CSB:
perhaps this domain recognizes ubiquitin on either CSB itself or on another, yet
unidentified, protein ubiquitinated by the CSA complex, after which repair can be
initiated, and hence CSA and CSB might be coupled in this way. This hypothesis
is supported by the observation that the yeast homologue of CSB (Rad26) does not
have a UBD and yeast also does not have the requirement for a homologue of CSA in
TC-NER, since the most likely CSA homologue (Rad28) is not required for TC-NER
in yeast (Bhatia et al., 1996; Anindya et al., 2010).
1.7.3 Cockayne Syndrome
Mutations in the genes for either CSA or CSB (ERCC8 and ERCC6 respectively) lead
to the severe human disorder Cockayne Syndrome (CS). This rare disease, named
after the London physician Edward Alfred Cockayne (1880-1956), is characterized
by UV sensitivity, premature aging, growth failure and progressive neurodevelop-
mental abnormality. The mean age of death is around 12 years (Nance & Berry,
1992). The cellular phenotype of CS is failure of recovery of transcription after UV-
exposure and increased sensitivity to oxidative stress (Mayne & Lehmann, 1982).
The severity of the disease ranges widely amongst patients. In the classical CS type
I the symptoms begin to appear in the first two years of life and the disease pro-
gresses until death in the first or second decade of life. In CS type II the onset of the
disease is earlier, shortly after birth, and death occurs around seven years, while CS
type III has a much milder phenotype with a later onset.
Mutations in either ERCC6 and ERCC8 can cause Cockayne Syndrome, with no
obvious clinical or cellular differences in patients with mutations in the gene cod-
ing for CSA or CSB (Lehmann, 2003). In 62 % of the cases, the mutated gene is the
ERCC6 (Laugel et al., 2010). In total 37 distinct mutations have been identified in
this gene. Missense mutations in this gene are partially clustered in ATPase mo-
tif III (four out of ten) and the six other missense mutations are also found in the
approximate central 1/3 of the protein containing the ATPase motifs. Nonsense
or frame-shift mutations lead to truncations of at least 330 amino acids (> 20 % of
the protein length). Besides mutations in ERCC6, 18 distinct mutations in ERCC8
leading to CS are reported. All disease-causing point mutations ERCC8 are found
in WD40 repeats. All reported truncations take out at least one WD40 repeat and
can be expected to have a detrimental influence on the overall fold and hence the










1.8. UV DAMAGE ENDONUCLEASE REPAIR
It has been attempted to link the type of mutation (truncation, missense muta-
tion) to the severity of the disease. A success in this seemed to be booked in 2004,
when it was reported that the complete absence of CSB in a patient due to a ho-
mozygous null mutation causes a less severe phenotype than other mutations such
as missense mutations: it was seen to cause a very mild form of CS (Hashimoto
et al., 2008) or the much milder disease UV-sensitivity syndrome (UVSS) (Horib-
ata et al., 2004). This latter disease is characterized by cutaneous photosensitivity,
but no neurological impairment and a normal life expectancy. At cellular level, fi-
broblasts from UVSS patients show a defect in recovery of RNA synthesis after UV
exposure, but there is no defect in oxidative damage repair. It was then proposed
that in some patients with CS, CSB forms a block for transcription after repair has
completed due to a defect in removing it (e.g. incapacity for it to be ubiquitinated),
while this problem does not occur in complete absence of CSB and thus the com-
plete absence leads to the milder disease UVSS. This hypothesis was adapted some
years later, when the existence of a fusion protein was reported that consisted of
the first five exons of CSB and of the PGBD3 transposon (Newman et al., 2008).
This PiggyBac fusion protein is just as abundant in normal cells as CSB and it is
conserved in primates since just prior to divergence of marmosets, therefore it is
likely to have some beneficial function. It was hypothesized that perhaps this fu-
sion protein may cause CS in absence of functional CSB. Mutations downstream of
intron 6 hence should cause CS and upstream only UVSS, since in that case both
CSB and the PiggyBac-protein are absent. However, later two other patients with
severe CS were described that have neither CSB nor the PiggyBac fusion protein
due to a homozygous deletion involving non-coding exon 1 and upstream regula-
tory sequences, putting this hypothesis in doubt (Laugel et al., 2008). Therefore, it
can be concluded that up to now, no clear correlation has been found in the type
of mutation and the severity of the disease. It is hence difficult to link the genetic
cause of the disease to its actual pathogenesis.
1.8 UV damage endonuclease repair
Besides the pathways for the repair of UV damages described above, there is also
another DNA repair pathway present in some bacteria and lower eukaryotes. It was
discovered when NER deletion mutants of S. pombe were observed to have some
residual activity for removing pyrimidine dimers (Birnboim & Nasim, 1975 and
McCready et al., 1993). This was later attributed to an ATP-independent incision
activity on CPDs and 6-4PPs that was found in cell extracts of S. pombe. The pro-
tein responsible was initially called S. pombe DNA endonuclease, but later renamed
as UV damage endonuclease (UVDE; Bowman et al., 1994). It was found to incise
the DNA directly 5’ to UV-photoproducts leaving 3’ hydroxyl and 5’ phosphoryl
groups as termini (Bowman et al., 1994). Around the same time, a gene was discov-
ered N. Crassa that could complement for UV-sensitivity in a E.coli repair-deficient
strain (Yajima et al., 1995). Since the resulting protein was seen to cut CPD and 6-
4PP 5’ next to damage and had sequence similarity to S. pombe UVDE (SpUVDE;











Figure 1.8: UVDE repair
(a) Mechanism of UV damage endonuclease repair based on Kisker, 2007. Details described
in the text.
(b) Crystal structure of UV damage endonuclease (red to yellow) with the three metal ions
shown in green and residues Gln104 and Tyr105 shown in magenta. Figure based on structure
2j6v.
double mutants in both NER and UVDE were found to be more sensitive than ei-
ther single mutant, confirming that this pathway was indeed an alternative to NER
(Freyer et al., 1995).
The general mechanism of UVDE is now thought to be as follows. First, UVDE
recognizes a damage in the DNA, presumably because of flexibility of the DNA due
to the damage and/ or loss of hydrogen bonding. It then incises the phosphodi-
ester backbone directly 5’ to the damage, leaving a 5’ phosphate and a 3’ hydroxyl
group. The repair can be terminated via one of two possible pathways (see figure
1.8(a)). One option is that DNA polymerase fills in a stretch of DNA, after which
the overhanging flap is processed by a FLAP-endonuclease such as rad2 and DNA
ligase seals the nick. The other option is that the 5’ end is digested by an exonu-
clease, after which the gap is filled by DNA polymerase and the nick is closed by
DNA ligase (Yoon et al., 1999; Alleva et al., 2000).
To date, UVDE has been found in 4 archaebacteria, 30 eubacteria and a num-
ber of lower eukaryotes such as S. pombe and N. crassa, but not in humans (Goosen
& Moolenaar, 2008). The eukaryotic UVDEs are in general larger than the bac-
terial ones: they have an extra domain on their N-terminus, which is potentially
important for interaction with other proteins. The most-studied UVDE, SpUVDE,
for example, is 68 kDa full-length (599 amino acids), with amino acids 250 to 527
being the most conserved region. Truncations of the N-terminus until the 232th
residue were reported not to influence SpUVDE’s catalytic function, but deletion
till the 273th residue yielded a soluble but inactive protein (Takao et al., 1996), con-
firming the region 250-527 as the catalytic domain. Since full-length SpUVDE is a










1.8. UV DAMAGE ENDONUCLEASE REPAIR
ature, which has been shown to be fully functional (Kaur et al., 1998) and able to
complement repair deficient E.coli (Takao et al., 1996). The bacterial UVDE homo-
logues only span this catalytic region with around 30 % sequence identity with the
C-terminal half of SpUVDE. At the C-terminus, there is more variation amongst
eubacteria. Most eukaryotes, like SpUVDE, have a stretch relatively rich in charged
amino acids at their C-terminus which is indispensable for UVDE’s function, since
already a 35 amino acid C-terminal truncation abrogates SpUVDE’s catalytic func-
tion (Takao et al., 1996). Some bacterial UVDEs also have this region, though many
do not have it and still are active (for example, T. thermophilus UVDE).
With purified (N-terminally truncated) SpUVDE, its substrate specificity has
been explored. SpUVDE was found to have a remarkably broad substrate speci-
ficity. It not only cuts efficiently the UV-photoproducts CPD and 6-4PP, but also
their Dewar isomers and abasic sites and, to a smaller extent, mismatches, small
loops, single-strand nicks and gaps. Very small incision activity has been reported
on uracil, dihydrouracil and platinum-DNA GG diadducts (Kaur et al., 2000; Pas-
paleva et al., 2009). In the case of the platinum-DNA GG diadducts and the small
loops, the incision site was found to be several nucleotides away from the damage
(Avery et al., 1999). The activity on abasic sites was highest if the site was flanked
by a pyrimidine, suggesting that UVDE is actually optimized for incising distorted
dipyrimidines (Paspaleva et al., 2009).
The substrate range for UVDE is quite diverse, including both lesions causing
a strong distortion in the DNA (such as 6-4PP; Kim & Choi, 1995) as well of those
that distort the DNA less (such as CPD), hence it cannot be only the degree of the
kink that determines activity by UVDE. Loss of hydrogen bonding has also been
suggested as factor for recognition, since mismatches are cleaved, but some sub-
strates with distorted hydrogen bonding (such as xanthine opposite T or C) are not
incised by UVDE (Avery et al., 1999). Hence it is probably a combination of factors
that is important for substrate recognition.
The substrate specificity of other characterized UVDEs has been reported to be
slightly less broad: NcUVDE was reported to incise UV-photoproducts, Dewar iso-
mers and abasic sites (Kanno et al., 1999), B. subtilis UVDE (BsUVDE) is known
to incise UV-lesions and abasic sites (Moolenaar, personal communication), while
TthUVDE incises only CPD and 6-4PP efficiently and it incises abasic sites less well
(Paspaleva, Thomassen et al., 2007).
The speed of the repair by UVDE has been measured in S. pombe using anti-
bodies against the lesions (Yonemasu et al., 1997). Removal of CPD and 6-4PP was
found to be still very fast in ∆rad13 cells (only UVDE, no NER), while this removal
is much slower in ∆UVDE cells (no UVDE, only NER) and no repair takes place in
absence of both UVDE and NER. This shows that UVDE repair is faster than NER.
However, ∆rad13 cells are considerably more UV-sensitive than ∆UVDE cells, so
apparently NER removal of UV-lesions is more important for the organism than
UVDE. A potential reason for this is the existence of TC-NER (section 1.7), which
directs NER first towards the most important regions of the genome: the actively
transcribed genes (Yasui et al., 1998).











nism of UVDE (Paspaleva, Thomassen et al., 2007). It was found that TthUVDE has
a TIM-barrel fold, though missing the α8-helix (Figure 1.8(b)). It has a large groove
with positive charges on the ends, which is proposed to be the DNA binding groove
based on structural similarity to endonuclease IV (see section 1.3). At the bottom
of this groove, three metal ions are found, which are postulated to be manganese
based on the requirement of this metal cofactor for the enzyme’s activity. Just like
endonuclease IV there are two residues sticking out into the solvent in the structure
of UVDE (Gln104 and Tyr105; together called the ’probing finger’), which probably
are involved in flipping the damaged base out of the helix and stabilizing the kink
in the DNA. Additional evidence for this flipping comes from biochemical exper-
iments that show that the two bases opposite the damage are flipped out of the
DNA helix (Paspaleva et al., 2009).
The relatively broad substrate specificity is a special feature of UVDE. Usually
in DNA repair, single proteins have a very narrow specificity for only one dam-
age, which is often achieved by flipping this damaged base in a specific pocket.
An example is photolyase: it only recognizes or CPD or 6-4PP (section 1.2). When
there is a broad specificity, like in NER (section 1.6), there are usually many pro-
teins involved that recognize a more global feature of the DNA that indicates that
it is distorted (bendability of the DNA, ease to insert a hairpin between the two
strands). In the case of NER, there are at least 30 proteins involved in eukaryotes
and 6 in bacteria. UVDE, however, is only a single protein that has a relatively broad
substrate specificity, which makes it an interesting model to study DNA repair. It
has been proposed that UVDE first senses bendability of DNA (explaining why it
incises single-strand nicks and gaps) and then it flips the damage into a pocket that
is most suited for a damaged dipyrimidine (Paspaleva et al., 2009). However, in ab-
sence of a co-crystal of UVDE with DNA, it is difficult to give a good explanation
for the broad substrate specificity of UVDE.
1.9 Contents of this thesis
As is clear from this introduction, DNA repair is essential to maintain genome in-
tegrity. Now core proteins in excision repair have been identified, further under-
standing of their mode of action requires high resolution insights in their interac-
tion with damaged DNA, which can be obtained via protein crystallography. This
approach allows one to elucidate structures of macromolecules at atomic resolu-
tion. Such a detailed picture of the molecule of interest clarifies the protein’s mech-
anism and it is therefore widely used. The examples given in this introduction form
just a small excerpt of the wealth of information that has been generated in the last
decades using this technique, but they are representative of the type of information
crystal structures can yield.
The principal focus of this thesis is to get detailed insight into how UV-damage
can be removed from DNA. To reach this goal we focused on two different repair
systems involved in the removal of UV lesions from DNA, namely the human TC-
NER system (section 1.7) and the bacterial UVDE system (section 1.8). In this thesis










1.9. CONTENTS OF THIS THESIS
gained from protein crystallography. In the first part of the thesis (Chapters 2-4)
the question of CSA’s role in TC-NER is addressed, in particular considering the
interaction of CSA with DDB1 and other putative partners and how mutations in
this protein lead to the human disease Cockayne Syndrome. The second part of
this thesis (Chapters 5-6) is about UVDE and addresses the question of how this
enzyme can repair different UV-lesions.
• Chapter 2 describes the first steps necessary to obtain a crystal structure: pro-
tein expression, purification and crystallization, in this case applied to the
human protein CSA (see section 1.7.2).
• Chapters 3 and 4 then continue to describe the crystal structure of CSA and
insights gained from it.
• Chapters 5 and 6 deal with the recognition and incision of damaged DNA
by the enzyme UVDE (section 1.8). First, the identity and role of a post-
translational modification is explored. A study addressing UVDE’s mech-
anism of damage recognition and the basis of its broad substrate specificity
follows.
• Chapter 7 is devoted to the crystal structure of an unrelated protein, potato
serine protease inhibitor, to show the more general applicability and strength
























Cockayne Syndrome protein A is one of the main components in mammalian
Transcription-Coupled Repair. Here the overproduction, purification, and crys-
tallization of human Cockayne Syndrome protein A in complex with its interacting
partner DNA Damage Binding protein 1 are reported. The complex was copro-
duced in insect cells, copurified and crystallized using sitting drops with PEG3350
and sodium citrate as crystallizing agents. The crystals have unit cell parameters
a=b=142.03 Å, c=250.19 Å and diffract to 2.9 Å on beamline ID14-1 at the European
Synchrotron Radiation Facility.
published in: E.M. Meulenbroek, N.S. Pannu, Overproduction, purification, crystalliza-
tion and preliminary X-ray diffraction analysis of Cockayne syndrome protein A in complex










2. PURIFICATION AND CRYSTALLIZATION OF COCKAYNE SYNDROME PROTEIN A
2.1 Introduction
The human genome is constantly subject to damaging agents such as ultra-violet
irradiation. One of the major pathways to remove DNA lesions is Nucleotide Exci-
sion Repair (NER). It is responsible for removing a wide variety of chemically and
structurally diverse lesions. A subpathway of NER is Transcription-Coupled NER
(TC-NER), which removes lesions blocking transcription. Most proteins are shared
between Global Genome NER (GG-NER) and TC-NER, but two proteins are unique
to TC-NER: Cockayne Syndrome Protein A and B (CSA and CSB). As can be read in
Chapter 1, these proteins were proposed to have the following functions (Fousteri
et al., 2006): CSB attracts NER factors and chromatin remodelers to the site of the
lesion and it uses its DNA-dependent ATPase activity to remodel the RNA poly-
merase - DNA interface to prevent RNA polymerase hiding the damaged site from
the NER factors. CSA is found in a CSA-DDB1 E3-ubiquitin-ligase/CSN complex,
which is inactive for E3-ubiquitin-ligase activity upon recruitment, and might pre-
vent degradation of the stalled RNA polymerase and/ or other TCR factors in early
stages of the repair or it might be involved in degradation of CSB at a later stage
of the repair process. The degradation of CSB could be important for recovery of
transcription after TCR is finished (Groisman et al., 2006).
The biological importance of CSA and CSB can be seen since mutations in either
protein can cause the recessive human disorder Cockayne Syndrome. This disease,
named after the London physician Edward Alfred Cockayne (1880-1956), is char-
acterized by neurologic abnormality, growth retardation, abnormal sensitivity to
sunlight and premature aging (Nance & Berry, 1992). Eighteen different mutations
in CSA that can cause Cockayne Syndrome (Laugel et al., 2010) have been reported.
Cockayne Syndrome protein A is found in the cell in complex with DDB1, which
is a multifunctional protein that links several different substrate adaptors like CSA
to the Cul4A-Roc1 complex hence constituting the E3-ubiquitin ligase complex (re-
cently reviewed in Iovine et al., 2011). Several crystal structures of DDB1 have been
reported, the first of which was reported in Li et al., 2006. However, to date no
structural information is available on CSA.
Determination of the structure of Cockayne Syndrome protein A will provide
insight into the important DNA repair mechanism TC-NER and into the molecular
basis by which the disease-causing mutations in CSA cause Cockayne Syndrome.
To this end, we report the overproduction, purification, and crystallization of CSA
in complex with DDB1.
2.2 Materials and Methods
2.2.1 Cloning and overproduction
The open reading frame (ORF; amino acids 1-396) for human CSA (ERCC8; OMIM
609412) was amplified by PCR from a clone in a pFastbac vector kindly made avail-
able by Wim Vermeulen (Erasmus Medical Center, The Netherlands) and cloned










2.2. MATERIALS AND METHODS
gen). Overproduction in E.coli strains BL21 Rosetta, RIL, RP, pLysS and pLysS star
was attempted at 277, 293 and 310 K with 0.1 – 1 mM IPTG.
Overproduction in E.coli was concluded to be unsuccessful, after which over-
production of CSA together with its interaction partner DDB1 was attempted in
Sf9 insect cells. For this, a vector with the ORF (amino acids 1-1140) for human
DDB1 (OMIM 600045) was kindly made available by Andrea Scrima and Nicolas
Thomä (Friedrich Miescher Institute, Switzerland). The sequence of a N-terminal
6x-His-tag and a thrombin cleavage site were inserted in front of the ORF and to-
gether it was placed behind the p10 promoter in a pFastbac Dual vector (Invitrogen)
using XmaI and Acc65I. The resulting DDB1 molecule had the following residues
extra at its N-terminus: MHHHHHHRRLVPRGSGGR.
CSA was amplified from the pET52b construct with a C-terminal 10x His-tag
and thrombin cleavage site using the following primers: 5’-TTT CAC GGT CCG
GGG ATG CTG GGG TTT TTG TCC GCA CG-3’ and 5’-AGT AGT CGA CGT TAA
TTA GTG GTG GTG ATG GTG ATG ATG GTG-3’ and cloned into the same pFastbac
Dual vector as DDB1 behind the PolH promoter using the restriction enzymes RsrII
and SalI. The resulting protein misses its C-terminal glycine and has the following
residues extra at its C-terminus: LALVPRGSSAHHHHHHHHHH. The construct
was verified by sequencing (Baseclear, Netherlands).
The pFastbac Dual with CSA and DDB1 was transformed into the strain
DH10EMBacY (Berger et al., 2004), kindly provided by Imre Berger (EMBL, France).
Recombinant bacmid was isolated and transfected to Sf9 insect cells using Fugene
HD (Roche) following the manufacturer’s instructions. Recombinant baculovirus
was produced and insect cells were infected at a density of 1.5-2 x 106 cells/ml us-
ing 2 ml 4th generation virus per 100 ml cell culture in suspension. The cells were
harvested 66 hours post-infection.
2.2.2 Purification
All purification steps were executed at 277 K. Harvested cells were resuspended
in lysis buffer containing 50 mM Tris pH 8, 20 mM imidazole, 200 mM NaCl, 0,1
% Triton-X-100, 5 mM β-mercaptoethanol and Complete mini EDTA-free protease
inhibitor cocktail (Roche). Cells were lysed by sonification and the lysate was cen-
trifuged in an ultracentrifuge at 30.000 rpm (61.700 g) for 30 min at 277 K in a Beck-
man Coulter 70.1 Ti preparative rotor. The supernatant was loaded on a His-Trap
HP column (GE healthcare) using an Äkta Express (GE healthcare) and washed
with 20 column volumes of Ni buffer A containing 20 mM Tris pH 8, 30 mM imi-
dazole, 200 mM NaCl and 5 mM β-mercaptoethanol. The CSA-DBB1 complex was
eluted with a gradient of 24 column volumes to 30 % Ni buffer B and then 28 col-
umn volumes to 100 % Ni buffer B containing 20 mM Tris pH 8, 330 mM imidazole,
200 mM NaCl and 5 mM β-mercaptoethanol.
The Ni column fractions containing the CSA-DBB1 complex were diluted three
times with 20 mM HEPES pH 7.2 and loaded on a Hitrap Q HP column (GE health-
care). The column was washed with Q buffer A containing 20 mM HEPES pH 7.2,










2. PURIFICATION AND CRYSTALLIZATION OF COCKAYNE SYNDROME PROTEIN A
a gradient of 25 column volumes to 100 % Q column B containing 20 mM HEPES
pH 7.2, 1 M NaCl and 5 mM β-mercaptoethanol. Next, the CSA-DDB1 containing
fractions were loaded on a Superdex 200 gel filtration column (GE healthcare) equi-
librated with 20 mM HEPES pH 7.2, 200 mM NaCl and 5 mM DTT and the column
was run with a flow rate of 0.3 ml/min. Protein purity was assessed with 10 %
SDS PAGE stained with Coomassie Blue (Simply Blue Safe stain, Invitrogen) and
by silver staining (Silver Stain Plus, Biorad).
2.2.3 Crystallization
CSA-DDB1 was concentrated with a 10 kDa MWCO centrifugal filter unit (Milli-
pore) to a concentration of 5-8 mg/ml. Crystallization conditions were screened
using sitting-drop vapour-diffusion using the commercial screens JCSG+ and PACT
(Qiagen) at 293 K with a drop size of 0.8 µl. A Genesis RS200 (Tecan) was used for
pipetting the reservoir solution (75 µl) and an Oryx6 (Douglas Instruments) was
used for pipetting the drops. After two days, small needle-like crystals appeared
in conditions 71, 83, and 95 from PACT, which contain 0.2 M sodium citrate, 20%
(w/v) PEG 3350 and 0.1 M Bis Tris propane 6.5, 7.5 or 8.5. The crystals were verified
to be protein using a fluorescence microscope with filter U-MWU2 (Olympus).
These crystals were optimized at 293 K and the best condition was found to
be 0.2 M sodium citrate, 24% PEG 3350, 0.1 M Bis-Tris propane pH 8.0. Based on
this condition, an additive screen (Hampton Research) was performed following
the manufacturer’s instructions. 3% glycerol was found to cause a significant im-
provement in size and morphology of the crystals. After additional optimization,
addition of 5-7% glycerol turned out to be optimal and drops of size between 2 and
4 µl using a protein solution to crystallant solution volume ratio of 2:1 or 3:1.
2.2.4 X-ray diffraction analysis
Crystals were caught in cryoloops and soaked in a solution containing mother
liquor and 10–12 % glycerol before flash-cooling them in liquid nitrogen. X-ray
diffraction experiments were done on ID14-1 at the European Synchrotron Radia-
tion Facility (ESRF), Grenoble, France. 180 images were collected with an oscillation
angle of 1.0◦ and the exposure time was 13 s per frame on ID14-1 at 0.9334 Å at 100
K. Images were processed with iMosflm (Leslie, 1999). Scaling and merging was
done with SCALA from the CCP4 suite (Winn et al., 2011).
2.3 Results and discussion
Overproduction of CSA in E.coli was attempted with several tags, but only an MBP-
fusion protein was soluble. Purification on amylose resin (New England Biolabs)
gave protein of good purity. Cleavage of the MBP-tag with TEV protease, however,
led to precipitation of CSA. Gel filtration on the MBP-fusion protein showed that











2.3. RESULTS AND DISCUSSION
Figure 2.1: Coomassie-stained SDS PAGE gel showing CSA and DDB1 at the end of the
purification procedure.
Figure 2.2: Crystals of CSA in complex with DDB1. The scale bar is 100 µm in length.
Coproduction of CSA and its interacting partner DDB1 was then attempted in
insect cells, because the structurally and functionally related complex DDB1-DDB2
has been coproduced and purified from insect cells (Scrima et al., 2008). Coproduc-
tion of CSA and DDB1 in Sf9 cells yielded a soluble protein complex and a large
excess of DDB1 (more than three times excess). The large excess of DDB1 could
be removed by using a customized gradient on the Ni column, since DDB1 alone
eluted in the first part of the gradient (0-30 % B), while the CSA-DDB1 complex
eluted in the second part of the gradient (30-100 % B). CSA copurified with DDB1
as a 1:1 complex as judged from SDS PAGE (Figure 2.1) throughout the entire purifi-
cation and no free CSA was obtained. The complex eluted as a single peak from the
gel filtration around 170 kDa. This indeed approximates the size of a 1:1 complex
of CSA with DDB1, whose theoretical sizes are 46 and 129 kDa in our constructs.
Western blotting with antibodies against DDB1 and CSA and mass-spectrometry
on proteolytic fragments confirmed the identity of both proteins.
Crystallization conditions were found in a pH anion cation screen (PACT) and
optimized by a grid screen around the condition varying PEG concentration and
pH. The initial crystals were around 0.09 by 0.01 by 0.01 mm and diffracted to
around 8 Å at the ESRF. An additive screen was performed and 3 % glycerol was










2. PURIFICATION AND CRYSTALLIZATION OF COCKAYNE SYNDROME PROTEIN A
Figure 2.3: A diffraction image of a crystal of the CSA-DDB1 complex, in which the anisotropic
nature of the diffraction can be seen.
Table 2.1: Data collection statistics.
Wavelength (Å) 0.9334
Space group P31
Resolution (Å) 2.92 (3.08-2.92)a
No. measured reflections 610127 (49472)
No. unique reflections 119918 (15498)
Completeness (%) 97.8 (86.4)
Multiplicity 5.1 (3.2)
Mean I/σ(I) 4.9 (1.1)
Rmerge 0.369 (1.108)
Rpim 0.181 (0.708)










2.3. RESULTS AND DISCUSSION
centration was found to be 5–7 % and crystals grown in this condition grew to 0.5
by 0.07 by 0.07 mm and diffracted to around 3 Å (Figure 2.2). Silver stained gels of
washed crystals confirmed that the crystals contained both DDB1 and CSA.
Processing of the diffraction data showed that the crystals belonged to space
group P6222 or P6422 according to Pointless (Evans, 2006) with unit cell param-
eters a=b=142.03 Å, c= 250.19 Å. However, the L and H twinning tests output by
CTRUNCATE (Padilla & Yeates, 2003) indicated that the crystal was twinned. Many
crystals were tested and all were perfectly twinned. The correct space group will be
determined through molecular replacement and refinement by testing all possible
subgroups and enantiomorphs of P31 (see Table 2.1 for data collection statistics for
the crystal in the lowest possible subgroup P31).
The diffraction was anisotropic (Figure 2.3) and the anisotropic diffraction
server (Strong et al., 2006) indeed showed that F/σ>3 at 2.9 Å in the direction of
c*, but 3.3 Å in a* and b*. We chose a diffraction cutoff of 2.92 Å for our data, be-
cause data in this region is still useful though its I/σ is low owing to the anisotropy.
It should be noted that the data can be better than the I/σ suggests, because the pos-
sible non-crystallographic symmetry (NCS) increases the signal to noise ratio. For
example, the I/σ of the data merged in P6422 is 1.9 in the highest resolution shell
of 3.08-2.92 Å. The calculated Matthews coefficient is 2.08 Å3Da−1 assuming four





















Crystal structure of Cockayne
syndrome protein A
Cockayne syndrome protein A (CSA) is a key component of Transcription-Coupled
Nucleotide Excision Repair (TC-NER), a DNA repair pathway that specifically re-
moves transcription-blocking DNA lesions, and a part of an E3-ubiquitin ligase
complex. Mutations in CSA lead to the human recessive disorder Cockayne Syn-
drome. Here we report the crystal structure of CSA in complex with its interact-
ing partner, DNA Damage Binding protein 1 (DDB1). The overall structure of the
WD40-repeat domain protein CSA is a seven-bladed β-propeller. Like the related
complex of DDB1 with DNA damage binding protein 2 (DDB2), CSA interacts with
DDB1 via a helix-loop-helix motif that inserts between the BPA and BPC domain of
DDB1. The top of the WD40 domain of CSA contains a positively charged centre,
which we propose as a substrate-binding site. The structure also shows the location
of the mutations in CSA that cause Cockayne Syndrome and provides explanations
for their detrimental effect, namely disrupted local or global folding that probably
interferes with proper substrate-binding for most of the mutations.
E.M. Meulenbroek, M.G. Vrouwe, L.H.F. Mullenders, N.S. Pannu, Insights into











3. CRYSTAL STRUCTURE OF COCKAYNE SYNDROME PROTEIN A
3.1 Introduction
The human genome is constantly subject to damaging agents, both endogenous
factors such as reactive oxygen species from cellular metabolism and environmen-
tal factors such as UV-irradiation. To prevent cell death or mutagenesis, several
DNA repair pathways have evolved. A major DNA repair pathway is Nucleotide
Excision Repair (NER). This highly conserved pathway removes a wide variety of
helix-distorting lesions by dual incision and by subsequent excision of a stretch of
DNA containing the damage. The remaining gap is filled by DNA repair patch
synthesis using the undamaged strand as a template (Nouspikel, 2009).
As described in Chapter 1, the broad substrate recognition of NER is achieved
by two distinct sub-pathways of NER: Global Genome NER (GG-NER) and
Transcription-Coupled NER (TC-NER), that are triggered by DNA damage medi-
ated structural alterations in the genome. TC-NER specifically repairs DNA lesions
that block transcription by elongating RNA polymerase II resulting in a faster re-
moval of some lesions compared to those in the overall genome (Bohr et al., 1985
and Mellon et al., 1987). TC-NER has many factors in common with GG-NER, but
two factors are unique for TC-NER: Cockayne syndrome protein A (CSA) and B
(CSB) (Fousteri & Mullenders, 2008). CSB is required for recruitment of the core
NER factors, chromatin remodelers and CSA to the site of the lesion. CSA resides
in a complex with DDB1, Cul4A and Roc1 forming an E3 ubiquitin ligase complex
that is inactive for ubiquitin ligase activity upon recruitment. CSA is a WD40 re-
peat protein that presumably functions as the substrate-recruiting subunit of the
E3 ubiquitin ligase complex.
Mutations in CSA or CSB lead to Cockayne syndrome, a recessive human dis-
order that is characterized by poor growth and neurologic abnormalities (Nance &
Berry, 1992). To date, 18 different mutations have been reported in CSA that lead to
Cockayne syndrome (Laugel et al., 2009). How these mutations lead to the disease
remains elusive. Here, we report the crystal structure of human CSA in complex
with its interacting partner human DDB1 solved at 2.9 Å.
3.2 Materials and methods
3.2.1 Protein overproduction, purification and crystallization
We expressed, purified and crystallized the CSA-DDB1 complex as described in
chapter 2 of this thesis. Briefly, CSA with a C-terminal 10x His-tag and DDB1
with a N-terminal 6x His-tag were co-expressed in Sf9 insect cells and purified
as a complex with His-trap affinity chromatography, Q-column ion exchange and
Superdex200 size exclusion and concentrated to 5-8 mg/ml with a 10kDa MWCO
centrifugal filter unit (Millipore) in 20mM HEPES pH 7.2, 200 mM NaCl and 5 mM
DTT. The protein was crystallized in 0.1 M Bis-Tris propane pH 8, 0.2 M sodium










3.2. MATERIALS AND METHODS
3.2.2 Data collection and processing
Data was collected on beam-line ID14-1 at the European Synchrotron Radiation
Facility at a wavelength of 0.933 Å. Reflections were indexed and integrated with
iMosflm (Leslie, 1999). Scaling and merging was performed with SCALA (Evans,
2006) from the CCP4 suite (Winn et al., 2011). Visual inspection of the images indi-
cated anisotropic diffraction. This observation was confirmed with the anisotropic
diffraction server (Strong et al., 2006) that showed F/σ > 3 at 2.9 Å in the direc-
tion of c*, but 4 Å in a* and b*. Thus, in one direction of reciprocal space, useful
diffraction information was available to 2.9 Å and applying an anisotropic correc-
tion in the refinement procedure to down-weight the weaker reflections in the a*
and b* directions allowed us to use all data to 2.9 Å. The data were processed with
an apparent space group of either P6422 or P6222. However, the L and H twinning
tests output by CTRUNCATE (Padilla & Yeates, 2003) indicated that the crystal was
nearly perfectly twinned and that the true space group should be a subgroup that
would allow twinning.
3.2.3 Structure solution and refinement
A combination of twinning, anisotropy and a large solvent content made molecular
replacement challenging. Initially, the structure of DDB1 was solved by molecular
replacement using the structure of DDB1 in complex with a H-box motif peptide (Li
et al., 2010) as a starting model in MOLREP (Vagin & Teplyakov, 2000) from CCP4. A
clear solution to the rotation and translation function was obtained in space group
P6422. The structure of CSA was solved by molecular replacement using Rack1 as
a starting model (Rabl et al., 2011) in MOLREP and fixing the model of DDB1. This
CSA-DDB1 solution was refined in REFMAC in P6422 to an R-free of 40.4%.
To determine the space group, the starting model was refined with the diffrac-
tion data reprocessed in space groups P64, P3121, P3112 and P31. The refinement
was performed with strict non-crystallographic symmetry for spacegroups P3121,
P3112 and P31 to insure that the observation to parameter ratio would be the same
for all space groups. Significantly better R-frees were obtained with the data pro-
cessed in P31, indicating that the crystal might consist of 4 twin domains and 4
non-crystallographically related DDB1-CSA complexes.
The complex structure of DDB1 and CSA was rebuilt with Buccaneer (Cowtan,
2006) and manual adjustments to the model were done with COOT (Emsley & Cow-
tan, 2004). Refinement without modeling twinning resulted in an R-free of 34.7%
in REFMAC (Murshudov et al., 1997) using constrained non-crystallographic sym-
metry (NCS) refinement. After the completion of model building, twinning was
modeled in REFMAC with constrained NCS leading to a final R-factor of 27.1%
and an R-free of 28.2%. This model showed a strong interaction of CSA with the
BPB domain of DDB1 (∆G = -15.8 kcal/mol according to PISA, Krissinel & Henrick,
2007).
However, comparison with the structure of Nicolas Thomä (Fischer et al., 2011)
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a,b,c (Å) 141.89, 141.89, 250.10
α, β, γ (◦) 90.00, 90.00, 120.00




Completeness (%) 98.6 (90.5)
Redundancy 9.7 (6.0)
Refinement
Resolution (Å) 2.92 - 62.53
No. reflections 59838










Bond lengths (Å) 0.008
Bond angles (◦) 1.16
a Values in parentheses are for the highest resolution shell
the DDB1 and CSA models from different twins had been modeled into one model
due to an unfortunate combination of twinning and crystallographic symmetry.
The structure was then re-refined using a CSA-DDB1 model with CSA binding to
the BPA and BPC domains as input (kindly provided by Nicolas Thomä). This final
model had an R-factor of 23.7 and an R-free of 25.7 % (statistics shown in Table 3.1)
and was virtually identical to our initial model except for the CSA-DDB1 interface.
3.2.4 Superpositions
Most of the superpositions were done with Theseus (Theobald & Wuttke, 2006):
superposition of DDB1 with DDB1s from other structures for calculating the rms
deviation of the Cα atoms, and of CSA with other WD40 proteins for calculating











peptides. Other superpositions were done with the ssm function in COOT (Emsley
& Cowtan, 2004). For modeling of the E2 enzyme UbcH5A (2C4P), we superposed
c-Cbl of the c-Cbl-UbcH7 structure 1FBV on Roc1 and subsequently superposed
UbcH5A onto UbcH7.
3.2.5 Complementation assays
The CSA construct with the C-terminal thrombin cleavage site and 10xHis-tag and
the same construct with the sequence for the first 30 amino acids deleted were
cloned into the vector pDONR221 (Invitrogen) and verified by sequencing. Sub-
sequently, they were put into the pLenti6.3 vector (Invitrogen) via the Gateway LR
recombination reaction. The resulting plasmids were transfected to 293FT cells for
virus production and the resulting virus was used to infect CS3BE-SV CS-A cells.
After selection with blasticidin, the UV resistance of these cells and of a negative
control (untransfected CS3BE-SV cells) and a positive control (VH10-SV) was de-
termined by irradiating the cells with 0, 2, 4, 6 and 8 J/m2 and determining their
colony-forming ability after two weeks.
3.2.6 Protein solubility assays
pFastbac Dual vectors (Invitrogen) were constructed with the sequences for DDB1
and CSA, in which the sequence for the first 30 amino acids of CSA were deleted
(CSAdeltaN)or with the mutation W361C (CSA-W361C),but which were otherwise
identical to the vector for DDB1-CSAwt expression. Virus was made and amplified
following our protocol for DDB1-CSAwt. 20 ml Sf9 cells were infected with this
virus or with DDB1-CSAwt virus and cells were harvested 66 hours after infection.
Small-scale native purifications were performed on Ni-NTA material (Qiagen) in
conditions in which free DDB1 did not bind to the column material, but CSA-DDB1
complexes do bind. Eluted fractions were run on 10% SDS PAGE gels. Three inde-
pendent virus productions and Ni column purifications were performed for each
test and these gave virtually identical results.
3.3 Results
3.3.1 Overall structure
To ensure that the C-terminal His-tag in our construct of CSA does not interfere
with the function of CSA and hence to confirm that we crystallized a biologically
relevant complex, we performed a complementation assay with the construct. Our
construct could confer UV resistance to a CS-A deficient cell line (Figure 3.1) to the
level of cells expressing wildtype CSA, hence it is active and the His-tag does not
affect the UV damage response of CSA.
As discussed in the Methods section, the complex structure of CSA-DDB1 was
solved via molecular replacement from a twinned crystal that diffracted anisotrop-
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Figure 3.1: Complementation assay with CSA-His
Survival after UV irradiation of VH10-SV cells (blue), CS3BE-SV cells (red) and CS3BE-SV
cells transfected with the CSA construct used for crystallization (green), showing that this
construct can complement UV-sensitivity of CSA− cells.
3.1. Figure 3.2(a) shows a representative part of the structure with electron density
map, indicating the quality of the map. No density was found for the C-terminal
thirty amino acids of CSA nor its His-tag, probably because they are disordered.
As shown in Figure 3.2, the overall structure of CSA in the CSA-DDB1 complex
consists of a seven-bladed β-propeller like most other WD40 repeat proteins such
as TrCP1 (Wu et al., 2003), DDB2 (Scrima et al., 2008), WDR5 (Schuetz et al., 2006)
and Rack1 (Rabl et al., 2011). From these structures, it is most similar to WDR5: the
root-mean-square deviation of Cα atoms between CSA and WDR5 is 2.4 Å (using all
Cα atoms that are present in both models), while the root-mean-square deviation
of Cα atoms with DDB2 is 3.0 Å. The structures of different WD40 domain proteins
are seen to differ mostly with CSA and with each other in the loop regions.
A number of structures of DDB1 are already known and these structures are
seen to have roughly one of three possible conformations, differing in the rota-
tion of the BPA and BPC domains versus the BPB domain. The structures of 2hye,
2b5m and 3ei4 are representative examples of these three conformations. The over-
all structure of DDB1 in our CSA-DDB1 complex (Figure 3.2) shows three WD40
β-propellers in a conformation similar to the structure of DDB1 in complex with
the Cul4A ubiquitin ligase machinery (2hye; Angers et al., 2006) with a root-mean-
square deviation of Cα atoms of only 0.57 Å versus 5.6 Å and 3.3 Å for 2b5m and
3ei4 respectively.
3.3.2 Interaction of CSA and DDB1
DDB1 has been proposed to function as an adaptor protein between the Cul4A-
Roc1 ubiquitination machinery and a large range of substrate receptor proteins
called DDB1-Cul4A Associated Factors (DCAFs) like CSA (Iovine et al., 2011). One
complex structure of DDB1 with a DCAF is already known, namely the struc-
ture of DDB1 in complex with DDB2, a substrate receptor protein that functions











Figure 3.2: Overall fold of CSA and DDB1
(a) Representative part of the structure with electron density map (in CSA).
(b) Overall fold of CSA showing a seven-bladed β-propeller (one molecule of CSA shown; top
view) with numbering of the blades of CSA.
(c) Overall fold of DDB1 showing three β-propellers (one molecule of DDB1 shown). The
BPA domain is shown in magenta, the BPB domain in cyan and the BPC domain in yellow.
quently ubiquitinates XPC, DDB2 and histones surrounding the damage (Scrima
et al., 2011). In the structure of DDB1-DDB2 it was shown that DDB2 binds via
an N-terminal helix-loop-helix motif and the bottom side of the WD40 domain of
DDB2 to the interface between the BPA and BPC domain of DDB1 (Figure 3.3(a);
Scrima et al., 2008). Two years later, it was found that helix-loop-helix motifs from
a variety of DCAFs bind to the exact same place as the helix-loop-helix motif of
DDB2 in the DDB1-DDB2 structure (Li et al., 2010) and it was then proposed that
this is a general mode of binding to DDB1 for DCAFs. CSA, another DCAF, was
therefore predicted to adopt the same binding mode.
The CSA-DDB1 complex structure indeed confirms that CSA binds via its bot-
tom face and a 30 amino acid N-terminal helix-loop-helix motif to the interface of
the BPA and BPC domain of DDB1 (Figure 3.3(b)). 57 residues in CSA and 69 in
DDB1 are involved in this interaction, with 19 hydrogen bonds and 2 salt bridges
formed and a buried surface area of 2183.7 Å2 (which is 13.1% of CSA’s surface and
4.5% of DDB1’s surface). A large contribution comes from the first thirty amino
acids in CSA: 21 of the 57 interfacing residues of CSA involved in complex forma-
tion are from this 30 amino acid N-terminal helix-loop-helix (and 7 out of 15 hydro-
gen bonding residues and 1 out of 2 salt bridge-forming residues). PISA (Krissinel
& Henrick, 2007) shows that the interaction between CSA and DDB1 is strong (∆G
= -13.2 kcal/mol) and concludes that the interface plays an essential role in complex
formation and is stable in solution.
To verify the importance of CSA’s N-terminal helix-loop-helix in complex forma-
tion, we investigated its role biochemically. Firstly, DDB1 was overexpressed with
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Figure 3.3: Interaction of CSA with DDB1 goes via a general binding mode for DCAFs to
DDB1.
(a) Crystal structure of DDB2 (blue) and DDB1 (yellow to green) showing that DDB2 binds
DDB1 via a N-terminal helix-loop-helix motif inserted between DDB1’s BPA and BPC domain
(Scrima et al., 2008).
(b) Complex of CSA and DDB1 as found in our crystal structure with CSA in blue to purple
and DDB1 in yellow to green. The interface of CSA with DDB1 with the helix-loop-helix of
CSA inserting between the BPA and BPC domain of DDB1 is shown in detail in the box.
type CSA to see whether binding of DDB1 and CSA∆N can occur in vitro. Nickel
column elutions from this overexpression can be seen in Figure 3.4(a) (using the
C-terminal 10xHis-tag on CSA). The amount of DDB1-CSA∆N complex was seen
to be severely reduced (around ten times), suggesting that CSA’s N-terminal helix-
loop-helix indeed plays an important role in stability. To confirm the importance of
the N-terminus, we performed a complementation assay with the same construct
of CSA∆N30: no complementation of a CS-A cell-line was observed (Figure 3.4(b)),
showing that the helix-loop-helix motif of CSA is vital for its function. The reduced
stability and lack of complementation of CSA∆N30 can very well be caused by re-
duced interaction with DDB1.
3.3.3 Substrate binding site of CSA
In TC-NER, CSA gets recruited to the stalled polymerase as part of an E3-ubiquitin
ligase complex that is inactive at the time of recruitment. CSA is thought to be the
substrate-recognizing protein, but exactly which protein(s) it binds to is not known.
One of the probable candidates is Cockayne syndrome protein B (CSB), which has
been shown to be ubiquitinated by the Cul4A-Roc1-DDB1-CSA complex in vitro
(Groisman et al., 2006).
To find a probable substrate-binding site for CSA, its structure was superposi-











Figure 3.4: Importance of the N-terminal 30 amino acids of CSA.
(a) SDS PAGE gel showing the result of a small-scale Ni column purification with DDB1-
CSA∆N (lanes 1 and 2) compared to DDB1-CSAwt (lanes 3 and 4) showing that complex
formation is severely reduced in the absence of the N-terminal 30 amino acids, though not
completely abolished. Results of two independent virus productions are shown to illustrate the
reproducibility.
(b) Survival after UV irradiation of VH10-SV cells (blue), CS3BE-SV cells (red) and CS3BE-SV
cells transfected with the CSA∆N construct (green), showing that an N-terminally truncated
CSA cannot complement UV-sensitivity of CSA- cells.
tides. Some observed binding sites were clearly not possible for CSA, because the
expected shape of the entire E3-ubiquitin ligase complex excludes e.g. peptide
binding at or too close to the DDB1-CSA interface (Figure 3.5(a)). Considering the
shape of the E3-ubiquiting ligase complex, the peptides bound to the top surface
of the WD40 domain gave the most probable outcomes as models for a substrate of
CSA. The centre of the top face is also the most frequently occurring site for sub-
strate binding to WD40 proteins (Xu & Min, 2011; Stirnimann et al., 2010).
A charge surface plot of the structure of CSA showed a small, positively charged
hole in the centre of the top face that we propose as the most likely substrate bind-
ing position (Figure 3.5(b)). This hole is similar to, though slightly smaller than, the
one observed in TrCP1 (Wu et al., 2003) where a phosphorylated protein binds. It
is unlike DDB2, which has a large positive groove where DNA binds. CSA’s small
positively charged hole also differs from the binding pocket of WDR5 (Schuetz et
al., 2006), which has an extensive negative charge where methylated histone tails
bind. Since the substrate-binding interface looks most like the interface of TrCP1,
and other WD40 proteins that bind phosphorylated proteins, we propose that the
part of the substrate that CSA recognizes is a stretch of a phosphorylated protein,
though a negatively charged stretch of a non-phosphorylated protein is also an op-
tion.
From the comparison of the CSA structure to structures of WD40 proteins in
complex with substrate peptides, we suggest that the residues of CSA involved
in substrate-binding include Glu103, Phe120, Lys122, Arg164, Lys247, Lys292 and
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Figure 3.5: The proposed substrate-binding site of CSA.
(a) Model of the CSA-DDB1 structure (CSA in magenta and DDB1 in green) as part of the
E3-ubiquitin ligase complex with Cul4A (red), Roc1 (cyan) and UbcH5A (orange). The arrow
indicates the proposed substrate-binding site of CSA.
(b) Electrostatic surface representation of CSA with blue representing positive charge and red
negative charge. The circle indicates the proposed substrate-binding site.
(c) The structure of CSA showing the proposed substrate-binding residues in magenta and the











Figure 3.6: Alignment of CSA from different species. Arrows point at proposed substrate-
binding residues and dots mark residues mutated in Cockayne syndrome. Red indicates identical
residues, blue partially conserved residues and grey unaligned residues.
proposed substrate-binding site and are close to important parts of substrate pep-
tides in the superposition of CSA with WD40-peptide co-crystals. Especially the
loop around residues 290-296 is notable, because it is in the middle of the pro-
posed substrate-binding site, it contains four charged residues close to each other
(of which three are lysines) and it is notably different from the loops of other WD40
proteins at this location. The proposed substrate-binding residues are also rather
conserved in CSA in different species (see Figure 3.6).
3.3.4 Disease-causing mutations
Mutations in CSA can lead to the recessive human disorder Cockayne syndrome
(CS). So far 18 different mutations in CSA causing CS are known of which there are
8 distinct missense mutations (Laugel et al., 2009). All eight missense mutations
are located in the seven WD40 repeats and consist of changes in residues that are
conserved in the orthologs of CSA (Figures 3.6 and 3.7(a)).
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Figure 3.7: Disease-causing mutations in CSA.
(a) Schematic overview of the eight point mutations in CSA that cause Cockayne syndrome,
shown on the primary structure. The boxes indicated the seven WD40 repeats of CSA.
(b) Disease-causing mutations shown as magenta balls on a cartoon representation of the
structure of CSA.
3.2(b)). The mutation to proline in the disease-causing mutations Q106P and A205P
probably disrupts the β-strands’ proper conformation due to the rigidity of the
proline (see Figure 3.7(b)). Disruption of these β-strands – and potentially their
neighboring strand(s) – will put residues near the proposed substrate-binding site
(e.g. Glu103 and Lys247) out of their normal position and hence disturb substrate
binding. The disruption of the beta-strands may also have a more global, negative
influence on the overall folding and thus the stability of CSA.
Mutations A160T, W194C, L202S and T204K, though separated from each other
in the primary structure of CSA, were found to be surprisingly close to each other in
the three-dimensional structure of CSA (Figure 3.8(a)). These four residues are in
β-strands in blades 3 (A160T) and 4 (W194C, L202S and T204K) and besides being
conserved in CSA orthologs (see Figure 3.6) they are also fairly conserved in other
WD40 repeat proteins. At the corresponding position of A160 usually a small to
medium hydrophobic residue is found (G, V, M) in WD40 domain proteins. At the
position of W194 usually a medium to large hydrophobic residue can be found (like
W, Y, F, I, L). At the position of L202 there is usually a medium to large hydrophobic
residue (like L, V, I, F). The position of T204 is usually occupied by a relatively small,
uncharged residue (A, S, T, G). It seems that the side-chains of the residues A160,
W194 and L202 form a small hydrophobic pocket that is important for the stability
of the fold and that a substitution to a hydrophilic residue might disrupt this pocket.
Substitution of the small threonine at position 204 for lysine will result in a positive
charge very near this pocket – when taking into account the length of a lysine side-
chain compared to a threonine – and thus will also result in a disruption around











Figure 3.8: Close-up of disease causing mutations.
(a) Side-view of CSA and close-up showing that mutations A160T (green), W194C (magenta),
L202S (cyan) and T204K (cyan/ blue) are close together in the three dimensional structure.
(b) Close-up of CSA showing the hydrogen bonding of residue D266 (in green), which is
mutated to glycine in some patients.
(c) Side-view of CSA and close-up showing the environment of residue W361 (in green) involved
in mutation W361C.
blades and thus make that the proposed substrate-binding residues at the end of
these strands (R164 and K247) are positioned incorrectly for binding or this may
affect the overall folding and hence reduce the stability of the protein.
Residue D266, which is mutated in some CS patients to a glycine, is located
in blade 5 close to CSA’s proposed substrate-binding site. This residue is one of
the most conserved residues in WD40 motifs and is expected to be important for
proper folding via side-chain interaction with H244, which is also conserved in
WD40 proteins. Indeed, the side-chain of D266 can be seen in the CSA structure
to form a hydrogen bond with the side-chain of H244, as well as with the amide
nitrogen of N245 (Figure 3.8(b)). These important interactions will be lost in the
mutant D266G. Since this residue is very close to the predicted substrate-binding
site, disrupted folding at this position can affect the substrate-binding and/ or the
global structure of CSA.
The last point-mutation causing disease, W361C (in blade 7), has an interesting
phenotype: this mutant has been reported to confer hypersensitivity to UV radia-
tion but less to inducers of oxidative damage that are usually harmful to cells from
CS patients (Nardo et al., 2009). This finding suggests that the mutation does not
affect the overall fold substantially, otherwise all the functions of CSA would have
been completely lost. It also shows that CSA acts differently in the removal of DNA
lesions that are target to TC-NER and in the removal of oxidative lesions (Nardo
et al., 2009). This mutation changes tryptophan 361 from the last WD motif and
hence it alters a conserved residue that is important for beta-strand stability. In
the CSA structure, it is surrounded by medium sized hydrophobic side chains and
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Figure 3.9: Effect of the W361C mutation on CSA in vitro.
(a) SDS PAGE gel of CSA-W361C versus CSA wt after small-scale Ni-columns showing the
reduced production of CSA-W361C versus wildtype CSA. Two independent W361C overproduc-
tions are shown to illustrate the reproducibility. (b) SDS PAGE gel showing different amounts
of (concentrated) CSA-W361C after a full purification scale purification compared to wildtype
after a small-scale purification. A difference in the ratio of DDB1 to CSA can be seen between
CSAwt and CSA-W361C.
3.8(c)). Mutation of the large and hydrophobic amino acid tryptophan to cysteine
might disturb this hydrophobic pocket. W361 is located very close to DDB1 – L30
and L32 in Figure 3.8(c) are located at the end of the helix-loop-helix through which
CSA binds to DDB1 – and thus the disturbance might affect the stability of the CSA-
DDB1 interaction.
However, the patient phenotype of this mutant shows that it leads to a subtle
change that takes out only part of the function of CSA. To investigate this further
we overproduced the mutant CSA-W361C in insect cells together with DDB1 and
performed small-scale Ni-column purifications of the complex (using the 10xHis-
tag on CSA). This showed that the overproduction of DDB1-CSA-W361C was very
much reduced compared to DDB1-CSA-wt (Figure 3.9(a)). A large-scale purifica-
tion was then performed following the same protocol as wildtype (chapter 2). The
mutant behaved identical to wildtype in the Ni-column and Q-column, but eluted
slightly later on the gel filtration. The yield of DDB1-CSA-W361C complex was
again considerably lower than with DDB1-CSAwt (approximately tenfold), though
the amount of free DDB1 was slightly higher than wildtype, showing that the virus
production had been successful. Moreover, the DDB1 to CSA ratio of the mutant
seemed to be higher than wildtype (around 3 to 1 instead of 1 to 1) at the end of
the purification procedure (Figure 3.9(b)), though all free DDB1 had been removed
during the first stage of the purification, suggesting that CSA is lost during the
purification procedure (around 18 hours in total). These results indicate that the
CSA-DDB1 interaction in the mutant W361C is partially disturbed and hence some
complexes lose CSA over time, which then precipitates since, as described in Chap-
ter 2, CSA is insoluble on its own. The patient phenotype of CSA-W361C might then
be explained by assuming a lower stability and hence a lower amount of CSA in the











pair but not for repair of UV lesions. Since information on CSA protein levels in
patient cells is currently unavailable, we cannot verify or falsify this hypothesis.
Another possibility is that the interaction of CSA with DDB1 is changed in such a
way (e.g. more flexible and hence more likely to dissociate in vitro) that CSA can-
not position its substrate in TCR correctly, but that it can still function in repair of
oxidative damage.
Besides these missense mutations, nonsense mutations and deletion/ insertion
mutations have been reported (Laugel et al., 2010). All of these lead to a severely
truncated protein or lead to a deletion in at least one WD-motif, hence all of these
mutations can be expected to have a profound negative influence on the overall
structure and therefore on the function of CSA.
3.4 Discussion
Cockayne Syndrome protein A is a crucial player in TC-NER and has a high biolog-
ical importance: mutations in this protein cause the serious human disease Cock-
ayne Syndrome. The structure has the expected fold, a seven-bladed β-propeller,
but now that the crystal structure is available the disease-causing mutations can
be mapped onto this structure and it can be explained how they cause the disease.
We found that these mutations most probably interfere with the proper folding of
the β-strands or interactions between β-strands, and hence disrupt local folding of
CSA, interfering with substrate-binding mostly, or with DDB1-interaction, or they
affect more global folding of CSA. This type of errors is very difficult to correct
for and hence, unfortunately, our structure cannot aid in overcoming the problems
caused by these errors that lead to disease.
The structure does, however, yield a more general insight into the function of
this protein and the process of TC-NER. One insight is that the interaction of CSA
and DDB1 is similar to the complex of DDB1 with the substrate receptor DDB2 that
functions in GG-NER and which, like CSA, binds to the interface of the BPA and
BPC domain of DDB1 via an N-terminal helix-loop-helix motif and the bottom face
of its WD40 domain of DDB2. The biological importance of this binding motif was
clear from our in vitro and in vivo studies. Several other DDB1-CUL4-associated
factors (DCAFs) were also proposed to use such a motif to bind to DDB1, because
they contain a similar helix-loop-helix N-terminal to the WD40 domain and these
helical motifs were shown to bind to DDB1 in a similar position (Li et al., 2010).
Furthermore, the V protein of simian virus 5 has been shown to interact with DDB1
via the BPC domain and it also uses a similar helical motif to bind to DDB1. This
helical motif is not predicted for all DCAFs, hence not all DCAFs necessarily have
an identical binding mode, but the fact that our structure shows the exact same
binding mode to DDB1 as DDB2, is a strong confirmation that it is a general feature
of DCAFs and most probably occurs widely.
Moreover, our structure gives insight into the currently unknown substrate(s)
of CSA. Its most probable substrate-binding site has a positive hole that resembles
that seen in other WD40 proteins that bind phosphorylated parts of other proteins.
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in transcription, signal transduction and cell cycle progression, use an F-box con-
taining protein as substrate-presenting unit. These proteins use their C-terminal
WD40 domain for recognizing phosphorylated substrate proteins and thus medi-
ate their ubiquitination (Xu et al., 2011). Phosphorylation of the substrate of CSA
could present a way of regulation in order to ensure the proper timing of ubiquina-
tion of CSA’s substrate(s) in the process of TC-NER.
Based on the structure we cannot predict CSA’s substrate, although we can con-
firm CSB to be a proper candidate. CSA might either recognize a phosphorylated
stretch or a negatively charged stretch on CSB. Notably, CSB contains a negatively
charged acidic domain in its N-terminal end, but has also been reported to be sub-
ject to phosphorylation (Christiansen et al., 2003 and Imam et al., 2007). However,
further research is required to confirm the substrate of CSA and the regulation and














Cockayne Syndrome protein A (CSA) is one of the main players in mammalian
Transcription-Coupled Nucleotide Excision Repair and mutations in this protein
lead to the serious human disorder Cockayne Syndrome. CSA is thought to be
the substrate adaptor protein of an E3-ubiquitin ligase complex, but its exact sub-
strate is still a matter of debate. To get more insight into the function of CSA in
Transcription-Coupled repair, we performed in vitro and in vivo experiments for
determining its substrate. In this chapter we describe the results that show that
CSA probably does not bind DNA, while the related protein DDB2 does, but that
a more likely substrate is a negative stretch of a protein such as encountered in
Cockayne Syndrome protein B.
E.M. Meulenbroek, M.G. Vrouwe, L.H.F. Mullenders, N.S. Pannu, Insights into











4. SUBSTRATE-BINDING BY COCKAYNE SYNDROME PROTEIN A
4.1 Introduction
To repair DNA lesions blocking transcription, the DNA repair pathway of
Transcription-Coupled Nucleotide Excision Repair (TC-NER) has evolved. In mam-
mals, most of the proteins involved are shared with the Global Genome Nucleotide
Excision Repair (GG-NER) pathway, but two factors are unique for TC-NER: Cock-
ayne Syndrome protein A and B (CSA and CSB) (reviewed in a.o. Tornaletti, 2009).
Their function in TC-NER is suggested to be as follows (reviewed in Fousteri &
Mullenders, 2008). CSB is thought to interact dynamically with RNA polymerase
II during transcription. Upon encountering a lesion past which RNA polymerase
II cannot transcribe, it gets stalled on the lesion and this stabilizes its interaction
with CSB. CSB recruits NER factors and chromatin remodelers to the lesion as well
as CSA in an E3 ubiquitin ligase complex (constituted of CSA, DDB1, Cul4A and
Roc1) inactive at the time of recruitment. The function of CSB might be to make
space for the repair with its DNA-dependent ATPase activity. The CSA complex
has been suggested to protect TC-NER factors from degradation in early stages of
repair and/ or direct proteins for degradation at later stages of repair to prevent
them from obstructing transcription (Groisman et al., 2006). The repair is even-
tually done by excision of the fragment containing the lesion by the NER factors.
The biological importance of CSA and CSB is demonstrated by mutations in either
CSA or CSB, that have been reported to cause the serious human recessive disor-
der Cockayne syndrome, which is characterized by a.o. dwarfism and premature
aging (Nance & Berry, 1992).
The crystal structure of CSA has recently been solved (see Chapter 3). In the
crystal structure, CSA was seen to form a complex with DDB1 that is similar to
the DDB1-DDB2 complex, which is involved in initial detection of UV-lesions in
GG-NER (Scrima et al., 2008). Like CSA, DDB2 also forms an E3-ubiquitin ligase
complex with Cul4A, Roc1 and DDB1. DDB2 binds to lesions in the DNA and there
it promotes ubiquitination of the nearby XPC and itself, leading to the handover of
the damage from DDB2 to XPC (Sugasawa et al., 2005).
In the structure of CSA it could be seen that the most likely substrate-binding
site is positively charged and small, as is also observed in proteins that bind e.g.
phosphorylated stretches of other proteins. This site was considerably smaller than
the large positive groove that the DNA-binding protein DDB2 has. Therefore, it
was suggested that CSA binds to a phosphorylated or otherwise negative stretch
of another protein, but its substrate could not yet be identified from these results.
In this chapter we describe experiments to get more insight into the substrate for
CSA.
4.2 Material and methods
4.2.1 Protein overproduction and purification
Overproduction and purification of the CSA-DDB1 complex has been reported
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expressed in Sf9 insect cells with N-terminally 6x-His tagged DDB1. The complex
was co-purified to near homogeneity with Ni-column affinity chromatography, ion
exchange and gel filtration.
4.2.2 Bandshift assay
The oligos containing CPD or 6-4PP were synthesized as described in Iwai, 2006, all
the other oligos were bought at Eurogentec, Belgium. The top strands of the DNA
substrates were 5’ radioactively labelled using polynucleotide kinase as reported
previously (Verhoeven et al., 2002). Labelled DNA substrates were incubated for 10
min at 30 ◦C with up to 0.62µM CSA-DDB1 in 20 mM Tris pH 6.5 and 100 mM NaCl
in a reaction mix of 10 µl. Samples were then loaded on a 3.5 % native Tris-acetate
gel at pH 7.2, which was run at 4 ◦C in 1x TAE pH 7.2. The gel was dried and the
result was visualized by irradiation of a photographic film.
4.2.3 Construction of CSA mutants
CSA mutants were created by PCR and cloned into the pDONR221 vector (Invit-
rogen) with a C-terminal 10x-His-tag as was CSAwt. The presence of the desired
mutation was verified by sequencing analysis (Baseclear, the Netherlands). The
gene with mutation and tag was then transferred to the pLenti4 vector (Invitrogen)
via the Gateway LR recombination reaction. The resulting vector was transfected
to 293FT cells for virus production and this virus was then used to infect CS3BE-
sv cells. After selection with Zeocin, 250 cells of these mutant cell lines or of the
positive control (VH10 cells) or the negative control (untransfected CS3BE-sv) were
seeded on a 90 mm petridish and were irradiated with 0, 2, 4, 6, and 8 J/m2. After
two weeks, the colony-forming ability was assessed. All experiments were executed
four to eight times.
4.2.4 CSA interaction studies
Around 30 * 106 human cells were harvested by trypsination. After inactivation of
the trypsin, centrifugation and washing with 1x PBS, the cells were frozen at -80
◦C until use. The cell lines used were: VH10 cells or CS3BE-sv cells as negative
controls (both gave similar results, hence only one negative control is shown in the
remainder of the chapter), and CS3BE-sv cells into which the gene coding for CSA-
His was transfected as described above.
Cells were resuspended in 1 ml lysis buffer (50 mM Tris pH 8, 200 mM NaCl,
0.1% Triton-X-100, 5 mM β-mercaptoethanol and Complete mini EDTA-free pro-
tease inhibitor cocktail (Roche)) and lysed by sonification. Cells were spun down
at 13.000 rpm in an Eppendorf table-top centrifuge for 10 min at 4 ◦C and the
soluble fraction (lysate) was loaded on 200 µl Ni-NTA column material (Qiagen)
equilibrated in Ni buffer A (20 mM Tris pH 8, 200 mM NaCl, 20 mM imidazol,
5 mM β-mercaptoethanol). The small column was washed with 1.5 ml Ni buffer
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300 µl Ni buffer B (20 mM Tris pH 8, 200 mM NaCl, 330 mM imidazol, 5 mM β-
mercaptoethanol).
Samples of the lysate and the elution fractions were run on 10% SDS PAGE gels
and blotted o/n at 90 mA per gel. The next morning, the blots were washed in
1xTBST and blocked with 5% protifar in TBST for 1 h. The first antibody (GαCSA;
W-16 from Santa Cruz biotechnology or GαCSB; E-18 from Santa Cruz biotechnol-
ogy) was added in 5% protifar in TBST and incubated for 2 h at a 1:200 dilution
(αCSA), 1: 250 (αCSB) or 1:10,000 (αHis). After washing 3 times 15 min with 1x
TBST, the secondary antibody (RαG and GαM HRP) was added in 5% protifar in
TBST and incubated for 1 h. After washing 3 times 15 min with 1x TBST, the blots
were developed using a luminol - enhancer - hydrogen peroxide mixture.
4.3 Results
4.3.1 Verification of CSA’s substrate binding site
From the crystal structure of CSA, several residues have been identified as poten-
tial substrate-interacting residues (see Chapter 3): Glu103, Phe120, Lys122, Arg164,
Lys247, Lys292, Lys293, Arg354 (Figure 4.1(a)). These residues were selected using
the following three criteria: the side-chains should be probable candidates for in-
teraction (e.g. charged or big hydrophobic side-chains), the side-chains should be
interacting with or otherwise be very near substrate peptides in a superposition
of CSA with co-crystal structures of WD40 proteins with peptides, and the side-
chains should not be involved in any interaction that is likely to be important for
the stability of the structure of the protein itself.
To verify the importance of these residues for the function of CSA, complemen-
tation studies were performed with these residues changed to alanine. As can be
seen in Figure 4.1(b), cells with most of the mutants are only marginally more UV-
sensitive than cells with wildtype CSA (VH10 and CSAwt), but one mutant shows
a clear UV-sensitivity (Figure 4.1(c)). This is the only double mutant of the set of
mutants (K292A + K293A), of which the mutations are located exactly in the centre
of the proposed substrate-binding site in a positively charged loop that is unique
to CSA (blue in Figure 4.1(a)). The phenotype of this mutant confirms that the top
face of WD40 domain of CSA is important for CSA function and hence reinforces the
idea that this face is a likely site for substrates to bind to CSA. However, it should be
noted that the sensitivity is only partial, though one might have predicted a more
severe sensitivity for a double mutant.
4.3.2 Determination of CSA’s binding capacity to DNA
Since the structurally related DDB1-DDB2 complex binds strongly and specifically
to damaged DNA (Wittschieben et al., 2005), we decided to test whether DDB1-
CSA also binds to DNA. To this end bandshift assays were performed in many
different conditions. The only conditions in which binding of CSA to DNA was











Figure 4.1: Verification of CSA’s proposed binding site.
(a) Cartoon representation of the CSA structure with the residues potentially involved in
substrate-binding indicated in magenta. The loop 290-296 is indicated in blue.
(b) Results of complementation assays with CSA’s substrate-binding mutants, showing that
most mutants only have a marginal effect on UV-sensitivity, but that the double mutant K292A
+ K293A has a larger effect. The positive controls are in red (CSA-His construct) and blue
(VH10; cell line with wt CSA) and the negative control is in green (CS3BEsv).
(c) Result of Figure 4.1(b) showing only the controls and the double mutant K292A + K293A










4. SUBSTRATE-BINDING BY COCKAYNE SYNDROME PROTEIN A
Figure 4.2: DNA-binding by CSA
Representative bandshift assay with CSA showing that CSA only binds DNA at very high protein
concentrations in a non-damage-specific way. Below the lanes is indicated what concentration
of protein was used, whether the CSA-DDB1 complex (denoted: CSA) was used or only DDB1
(denoted: DDB1) and which DNA damage was used (no: no damage, 8-Ox: 8-oxoguanine,
Fl: fluorescein). The bands were verified not to be in the slots of the gel.
TAE at pH 7.2. High concentrations of protein had to be used (0.5 µM) with DNA
concentrations up to 1.8 nM to see a significant binding (Figure 4.2). Hardly any
binding could be observed at lower protein concentrations, even not at 2x lower
protein concentration (Figure 4.2 lanes 8-15). No discrimination between damaged
and undamaged DNA was observed (Figure 4.2 lanes 2-4 show some representa-
tive examples; a wide range of lesions ranging from 8-oxoguanine to fluorescein to
UV lesions as well as different DNA lengths were attempted; not all results shown).
The bandshift was CSA-dependent as samples with only DDB1 did not show band-
shift (Figure 4.2 lanes 5-7). Filter-binding assays (results not shown) confirmed the
above results.
Binding of CSA to DNA could only be observed at high protein excess (250-
fold or more molar excess) with no discrimination between different DNA sub-
strates in the large range of conditions tested, while DDB1-DDB2 shows bandshifts
at equimolar DNA-protein concentrations and an up to 80x higher affinity for dam-
aged DNA (Wittschieben et al., 2005). Therefore, we are unsure of the biological
relevance of the observed binding and should keep in mind that the binding we
observed might be an artefact. The fact that we don’t see any shift in more bio-
logically relevant ratios while many conditions were tested, shows that it is very











Figure 4.3: CSB as potential substrate for CSA
Western-blot with αCSA (a) or αCSB (b) antibodies on the elutions of small-scale Ni-affinity
purifications with cell lines expressing wildtype CSA (VH10) or overexpressed CSA with a C-
terminal His-tag (CSA-His). For the CSB Western-blot (b), also the lysates are shown to
be able to assess the amount of CSB in the total soluble fraction. The arrows indicate the
specific band for CSA or CSB and the orange star indicates the CSB-PiggyBac fusion protein,
a splice-variant of CSB. Brightness and contrast of the left panel of (b) have been adapted by
computer to improve the image quality and the right panel is taken from the same blot with a
shorter exposure time of the film.
4.3.3 CSB is a possible substrate for CSA
The substrate for CSA in TC-NER is still uncertain, but one of the most likely op-
tions is CSB, since CSA has been reported to ubiquitinate CSB in vitro and a CSA-
dependent degradation of CSB after UV-irradation has been observed (Groisman et
al., 2006). However, this matter has remained controversial due to contradicting re-
sults in literature, for example on the degradation of CSB after UV-irradiation and
on the physical interaction between CSA and CSB in cells (see for a discussion Licht
et al., 2003). To get more insight into the possibility of CSB as substrate for CSA, we
performed pull-down analysis using the 10x His-tag on our CSA construct in com-
plemented CS3BE-sv cells.
In Figure 4.3(a) it can be seen that small-scale Ni-column purification leads to
a high enrichment of CSA in the samples from the cell-line with CSA-His overex-
pressed, as expected, showing that the experimental setup is correct. As can be
seen in Figure 4.3(b), less CSB is present in the lysate of the cell line where CSA is
overexpressed. This suggests that CSA is indeed involved in vivo in ubiquitination
and degradation of CSB. Moreover, when these samples are partially purified with
Ni column affinity chromatography (using the His-tag of the overexpressed CSA),
there is considerably more CSB in the Ni elution fraction of the sample with CSA-
His overexpressed than in the negative control (Figure 4.3(b)), in which no tagged
CSA is present. This shows that CSB co-purifies with CSA. This indeed suggests
that there is a (direct or indirect) interaction between CSA and CSB. Similar exper-
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4.4 Discussion
For understanding the function of CSA in TC-NER and how defects in CSA cause
the disease phenotype, it is vital to know how CSA recognizes its substrate and
what this substrate is. In this chapter site-directed mutagenesis results are reported
that suggest that the top face of the WD40 domain of CSA is indeed the substrate-
binding site, considering the effect a double mutation in the centre of the proposed
site had. Single mutations in this site did not have a clear effect. It is possible that
the affinity for the substrate is not strongly affected by mutation of only one residue
and that the high expression of CSA in the WD40 top-face mutant cell lines might
compensate for slight decreases in efficiency. A double mutation then perhaps has
a too strong influence to be compensated for by a larger amount of CSA. Therefore,
for the double mutation an effect is observed. Together with the fact that it is the
most used substrate-binding site in WD40 proteins and that it is accessible in a
model of CSA in the E3-ubiquitin ligase complex, the UV-sensitivity of the double
mutant provides evidence pointing toward this being the substrate binding site.
Next, we investigated the identity of the substrate for CSA by looking at the
two most likely options. The first option, CSA binds DNA like DDB2 does, is very
unlikely based on our results, since binding to DNA could only be observed in one
condition of salt and pH with a very large excess of protein (250 times or more)
and no discrimination between different substrates was observed. This binding
therefore most likely only represents aspecific binding of CSA to the DNA, e.g. to
the negatively charged phosphate groups. Moreover, CSA was reported not to co-
purify with nucleosomes after UV-irradiation unlike DDB1-DDB2 (Groisman et al.,
2003), which agrees with our results.
Our findings indicate that the second option, CSA binds CSB leading to its ubiq-
uitination, is more likely, since less CSB was shown to be present in cell lines over-
expressing CSA than in cell lines with no or normal amounts of CSA. Moreover,
CSB could be pulled down using the His-tag on CSA. The results in literature on
this matter contradict each other. A physical interaction between CSA and CSB was
found with in vitro translated proteins and with the yeast-two hybrid system (Hen-
ning et al., 1995), but not in cells using gel filtration, co-immunoprecipitation or
immunofluorescence (discussed in Licht et al., 2003). An explanation for this con-
troversy can be that the amount of CSA in cells normally is so low that very sensitive
methods and optimized experimental conditions are required to pick up a CSA-
CSB interaction. Different methods have been used in literature and perhaps not
all are sensitive enough to allow detection of weakly interacting, rare complexes.
Our method, however, has the advantage in this regard that CSA-His is overex-
pressed, so it allows easier detection of CSA-interactions, though its disadvantage
is that overexpression is less close to the normal condition of the cell. Moreover,
our method does not prove that the observed interaction is direct or whether it
is mediated via another protein, hence further research is needed to identify with












carboxylated lysine in UV
damage endonuclease
UV damage endonuclease is a DNA repair enzyme that can both recognize DNA
damage such as UV lesions, and introduce a nick directly 5’ to them. Recently,
the crystal structure of the enzyme from Thermus thermophilus was solved. In the
electron density map of this structure, unexplained density near the active site was
observed at the tip of Lys229. Based on this finding, it was proposed that Lys229 is
post-translationally modified. In this chapter, we give evidence that this modifica-
tion is a carboxyl group. By combining activity assays and X-ray crystallography on
several point mutants, we show that the carboxyl group assists in metal-binding re-
quired for catalysis by donating negative charge to the metal-coordinating residue
His231. Moreover, functional and structural analysis of the K229R mutant reveals
that if His231 shifts away, an increased activity results on both damaged and un-
damaged DNA. Taken together, the results show that T. thermophilus UVDE is car-
boxylated and the modified lysine is required for proper catalysis and preventing
increased incision of undamaged DNA.
published in: E.M. Meulenbroek, K. Paspaleva, E.A. Thomassen, J.P. Abrahams, N.
Goosen, N.S. Pannu, Involvement of a carboxylated lysine in UV damage endonuclease.,










5. INVOLVEMENT OF A CARBOXYLATED LYSINE IN UV DAMAGE ENDONUCLEASE
5.1 Introduction
Repairing damage in DNA is essential for maintaining genomic integrity. There-
fore, several protein systems have evolved in order to remove DNA lesions. One of
them is the ultraviolet damage endonuclease (UVDE) repair system, initially found
in the yeast Schizosaccharomyces pombe, and described as an alternative repair sys-
tem for UV-induced lesions (Sidik et al., 1992). The UVDE enzyme was shown to
introduce a nick 5’ to both of the main UV-induced lesions: cyclobutane pyrimidine
dimers (CPD) and 6-4 photoproducts (6-4PP) (Bowman et al.,1994). Later studies
showed, however, that UVDE from S. pombe has a much broader substrate speci-
ficity than originally thought – recognizing and nicking DNA lesions significantly
different from UV induced damage such as abasic sites and small loops (Avery et
al., 1999). UVDE enzymes have been found in both eukaryotes (e.g. S. pombe, Neu-
rospora crassa) and in prokaryotes (e.g. Thermus thermophilus, Bacillus subtilis).
The crystal structure of the T. thermophilus UVDE has recently been solved to
1.55 Å resolution (Paspaleva, Thomassen et al., 2007). This structure shows UVDE
to be a single domain TIM-barrel with extensive positive charges positioned on
both sides of a 29 Å groove, which was proposed to be the DNA-binding site. At
the bottom of the groove, a cluster of three metal ions was found. Furthermore,
a protein pocket was identified in UVDE near Tyr6 and Asn10, into which UVDE
might flip damaged base(s).
Unexplained electron density at the tip of Lys229 was observed and it was sug-
gested that Lys229 is post-translationally modified. Here, we investigate the iden-
tity of this modification by X-ray crystallography and conclude that it is a carboxyl
group. Carboxylated lysines have been observed in several proteins (Abendroth et
al., 2002; Cha & Mobashery, 2007; Golema-Kotra et al., 2003; Golemi et al., 2001; Li et
al. 2005; Thoden et al., 2001, 2003). Most often, the carboxyl group has a structural
role (e.g. bridging two active site zinc atoms), but a more direct role in reaction
mechanisms has also been reported (Cha & Mobashery, 2007). In addition to iden-
tifying this modification, we study, by means of X-ray crystallography and activity
assays on several point mutants, why the protein uses a carboxylated lysine instead
of a standard amino acid.
5.2 Materials and methods
5.2.1 Proteins
The T.thermophilus UVDE protein used in this study was expressed and purified as
described before (Paspaleva, Thomassen et al., 2007). Mutants K229A, K229L and
K229R were constructed by site-directed mutagenesis using PCR and purified in










5.2. MATERIALS AND METHODS
5.2.2 DNA substrates
DNA substrates used in all activity assays are 30-bp DNA containing either a
CPD or a 6-4PP in the following sequence: 5’ CTCGTCAGCATCTTCATCAT-
ACAGTCAGTG 3’ with TT representing the position of the UV lesion. In case of the
abasic site the same DNA sequence has been used: 5’ CTCGTCAGCATCXTCAT-
CATACAGTCAGTG 3’, with X representing the position of the abasic site. The
oligonucleotides containing CPD or 6-4PP lesions were synthesised as described
(Iwai, 2006). The 30 bp substrate containing an abasic site lesion has been obtained
commercially (Eurogentec, Belgium).
5.2.3 Incision assay
The DNA substrates were labelled at the 5’ side of the top strand using polynu-
cleotide kinase as described (Verhoeven et al., 2002). The DNA substrates (0.2 nM)
were incubated with 5 nM UVDE in 20 µl reaction mix (20 mM HEPES pH 6.5,
100 mM NaCl, 1 mM MnCl2). After 15 minutes incubation at 55 ◦C the reaction
was terminated by adding 3 µl EDTA/SDS (0.33 M EDTA, 3.3 % SDS) and 2.4 µl
glycogen (4 mg/ml) followed by ethanol precipitation. The incision products were
loaded on a 15 % denaturing polyacrylamide gel and visualized by irradiation of a
photographic film after which they were quantified.
5.2.4 Incision of supercoiled plasmid DNA
Supercoiled plasmids pUC18 (2686 bp; 5 ng/µl; UV-irradiated at 300 J/m2 or not
UV-irradiated) and pNP228 (4686 bp; 5 ng/µl) were incubated with 10 nM UVDE
(unless stated otherwise) in a 10 µl reaction mix (20 mM HEPES pH 6.5, 100 mM
NaCl, 1 mM MnCl2). After 15 min incubation at 55 ◦C the reactions were termi-
nated by addition of 3 µl Ficoll/dyes/SDS/EDTA (0.05 M EDTA, 3 % SDS). Samples
were loaded on a 0.7 % agarose gel and visualised by staining with ethidiumbro-
mide.
5.2.5 Filter binding assay
The filter binding assays were conducted in 10 µl samples containing 0.1 µM UVDE
and 8 nM of 32P-labeled DNA in a reaction buffer containing 20 mM Tris pH 6.5,
100 mM NaCl, 1 mM MnCl2. Samples were incubated for 10 min at 55 ◦C. At the
end of the incubation time 0.5 mL reaction buffer (preheated at 55 ◦C) was added.
The mixture was poured over a nitrocellulose filter and the incubation vial was
rinsed with 0.5 mL of the preheated reaction buffer. Finally the filters were washed
with 0.5 mL incubation buffer. Each sample was corrected for the amount of DNA
retained on a filter in the absence of protein. Binding is expressed as the percentage










5. INVOLVEMENT OF A CARBOXYLATED LYSINE IN UV DAMAGE ENDONUCLEASE
5.2.6 Mass-spectrometry
TthUVDE was precipitated in 10% trichloroacetic acid (TCA) and subsequently
washed with acetone. After drying, it was resuspended in 8 M urea and 0.4 M
NH4HCO3. After 15 min incubation with dithiothreitol at 50 ◦C and addition of
iodoacetamide, trypsin digestion was carried out for 24 h at 37 ◦C. The trypsinated
sample was loaded on an LTQ-orbitrap mass-spectrometer and MS and MSMS was
run.
5.2.7 Crystallization
The purified protein was dialysed against 1x PBS (25 mM Phosphate, 150 mM NaCl,
pH 7.4) and concentrated to 3-5 mg/ml by centrifugation using an Ultrafree Filter
Device (Millipore). Crystals were grown by sitting-drop vapour diffusion at 22 ◦C
using as precipitant: 0.1 M sodium acetate buffer pH 4.4, 2 M sodium formate and
1 mM MnCl2 (UVDE pH 4.4; 1 µl protein and 1 µl precipitant) or 0.5 M (NH4)2SO4,
0.1 M sodium acetate buffer pH 6.0, 1 M Li2SO4 (UVDE K229L and UVDE E175A;
1 µl protein and 0.5 µl precipitant) or 0.1 M sodium acetate buffer pH 5.6, 1 M
sodium formate (UVDE K229R; 1 µl protein and 1 µl precipitant). The crystals grew
like diamonds (40 to 100 µm) in 1-2 days. Crystals were transferred to precipitant
solution with 10 % glycerol prior to data collection.
5.2.8 Data collection and processing
Datasets were collected on beam-line ID14-2 at the European Synchrotron Radia-
tion Facility at a wavelength of 0.933 Å. The crystals were flash-frozen and kept at
100 K during data collection. Data collection strategy was determined with the pro-
gram BEST (Popov & Bourenkov, 2003). Reflections were indexed and integrated
with iMosflm (Leslie, 1999). Scaling and merging was performed with SCALA from
the CCP4 (CCP4, 1994) suite. For data statistics, see Table 5.1.
5.2.9 Structure solution and refinement
Structure solution was performed by molecular replacement with as search model
the structure of TthUVDE wild type (pdb-code: 2j6v) with an unmodified lysine
using MOLREP (Vagin & Teplyakov, 1997) from the CCP4 suite, though for K229R,
the structure of UVDE pH 4.4 was used as input directly into refinement. Manual
adjustments to the model were done with COOT (Emsley & Cowtan, 2004). Re-
finement was done using REFMAC (Murshudov et al., 1997) and water molecules
were added using ARP/wARP (Perrakis et al., 1999) and COOT. TLS refinement was
used in refinement for structures UVDE pH 4.4, UVDE K229L and UVDE E175A.











Figure 5.1: Detail of the original structure of TthUVDE wild type with electron density map
(contoured at 1.5 σ) showing a carboxyl group modeled into the additional density at the tip
of Lys229 (Kcx229). Carbons are depicted in green, oxygens in red, nitrogens in blue and the
metal ion in grey. Distances between the oxygen atoms of the carboxyl group and neighboring
residues, and the distance of His231 to Mn1 are indicated.
5.3 Results
5.3.1 Identity of the modification
The unexplained electron density observed at the tip of Lys229 is situated between
Arg58, Ser99 and His231. His231 was shown to coordinate one of the metal ions
(Mn1). By comparing the metal ion cluster of TthUVDE to that of endonuclease
IV (Hosfield et al., 1999), Mn1 is probably one of the two metal ions that together
activate the water molecule (bridging Mn1 and Mn2) that serves as a nucleophile
to attack the DNA phosphodiester backbone.
Several options are possible for the unexplained electron density at the tip of
Lys229 among which are an acetyl group or a carboxyl group. Considering the
potential hydrogen bonding to the neighboring residues (Arg58, Ser99 and His231),
a carboxyl group is the more likely option (Figure 5.1). Moreover, if an acetyl group
is modeled into the density, its methyl group’s B-factor is 13.94 Å2 while the Nζ and
Cǫ of the lysine and the carbonyl of the acetyl group all have B-factors between 20
and 22 Å2. If a carboxyl group is modeled into the density, all atoms of the carboxyl
group and the Nζ and Cǫ of the lysine have B-factors between 18 and 21 Å2.
To begin the investigation on the modification’s identity we performed mass-
spectrometry on trypsinated UVDE. In the resulting mass-spectrum, however, only
a peptide fragment with an unmodified Lys229 was found. Considering the prepa-
ration of the sample (TCA precipitation and trypsin digestion), an acetyl group
probably would have been observed if it had been present. In contrast, a carboxyl
group on a lysine residue can be expected to fall off during the sample preparation,
since at low pH the ζ-nitrogen of the lysine is protonated, which results in a loss of
the carboxyl group as carbon dioxide.
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Figure 5.2: Structure of UVDE pH 4.4.
(a) Model and map (contoured at 1.7 σ) of UVDE pH 4.4, showing an unmodified Lys229.
Carbons are depicted in green, oxygens in red and nitrogens in blue. Hydrogen network with
Ser99, Lys229 and His231 is indicated.
(b) Detail of the superposition of the original structure of UVDE (green) and UVDE pH 4.4
(purple). Shifts of residues Arg58, Ser99, Glu175, Lys229 and His231 and of Mn1 compared
to the water in UVDE pH 4.4 are indicated at the atoms where the shift was measured.
that the carboxylation will not be present, due to the acid liability of the carboxy-
lation). For this, TthUVDE was crystallized in 0.1 M acetate buffer pH 4.4, 2 M
sodium formate and 1 mM MnCl2 (UVDE pH 4.4) and crystallized in a different
space group (P6122) with different packing than the wild type structure (P1) (See
Table 5.1 for the crystallographic statistics). In this structure Lys229 is indeed not
modified (Figure 5.2). Two waters are at the place where the modified lysine orig-
inally was. His231 seems to have moved inwards (over 0.96 Å) in order to form
hydrogen bonds with one of these waters. This shift seems to have cause a 1.36 Å
shift to Glu175. In the structure of UVDE pH 4.4, no metal ions were found, proba-
bly because of protonation of the metal-coordinating histidines due to the low pH.
A water molecule was found near the site (0.81 Å distance) where originally Mn1
was located.
In order to check that the above result is caused by the low pH of the crystalliza-
tion condition and not due to the different space group (P6122) of the previously
published structure (P1), we also solved a structure of TthUVDE in P6122 that was
crystallized at a higher pH (0.5 M (NH4)2SO4, 0.1 M sodium acetate buffer pH 5.6,
1 M Li2SO4, 1 mM MnCl2; results not shown). In this crystal structure, Lys229 was




















Table 5.1: Data collection and refinement statistics.
UVDE pH 4.4 UVDE K229L UVDE K229R UVDE E175A
Data collection
Beam line ESRF ID14-2 ESRF ID14-2 ESRF ID14-2 ESRF ID14-2
Detector MAR225 CCD MAR225 CCD MAR225 CCD MAR225 CCD
Resolution range (Å) 28.78-1.91 (2.01-1.91)a 37.11-2.30 (2.42-2.30) 46.37-3.15 (3.32-3.15) 40.46-2.74 (2.89-2.74)
Multiplicity 6.4 (6.5) 11.3 (11.5) 10.7 (11.0) 4.4 (4.4)
Completeness (%) 99.2 (100) 99.2 (99.8) 95.3 (96.2) 99.3 (99.8)
Rmergeb 0.048 (0.282) 0.078 (0.367) 0.134 (0.366) 0.087 (0.364)
Rpimc 0.020 (0.113) 0.025 (0.122) 0.043 (0.117) 0.048 (0.203)
I/σ 10.2 (2.0) 8.3 (2.0) 5.4 (2.0) 8.0 (2.0)
Space group P6122 P6122 P6122 P6122
N◦ of molecules in ASU 1 1 1 1
Unit cell parameters a, b, c (Å) 107.14x107.14x90.83 113.39x113.39x89.39 107.11x107.11x91.12 113.38x113.38x89.08
Crystallization conditions 0.1 M Ac pH 4.4, 0.5 M (NH4)2SO4, 0.1 M Ac pH 5.6, 0.5 M (NH4)2SO4,
2 M Naformate, 0.1 M Ac pH 6, 1 M Naformate 0.1 M Ac pH 6,
1 mM MnCl2 1 M Li2SO4 1 M Li2SO4
Refinement
N◦ reflections used 22835 14615 5122 8773
Resolution range (Å) 28.71-1.91 (1.96-1.91) 34.28-2.30 (2.36-2.30) 46.18-3.15 (3.23-3.15) 35.03-2.74 (2.81-2.74)
Rfactor 0.196 (0.286) 0.188 (0.198) 0.195 (0.232) 0.198 (0.295)
Rfreed 0.244 (0.363) 0.244 (0.278) 0.249 (0.360) 0.245 (0.363)
Ramachandran statisticse (%) 91.1/7.6/0.8/0.4 89.8/8.9/0.4/0.8 91.5/7.7/0.0/0.9 91.9/6.8/0.9/0.4
R.m.s. dev. (bonds, Å/ angle, ◦) 0.019/ 1.689 0.014/ 1.545 0.006/ 0.945 0.009/ 1.320
Average atomic B-factor
protein 25.4 30.6 32.6 22.8
Mn NA 65.2 NA 74.3
solvent atoms 33.0 30.6 32.4 11.0
Wilson plot B-factor 25.0 35.9 54.4 47.3
a Values in parentheses are for the highest resolution shell
b Rmerge=Σ|I-<I>|/Σ|I|
c Weiss & Hilgenfeld, 1997; Diederichs & Karplus, 1997
d About 5% of the reflections were used for the cross-validation set. These reflections were randomly chosen.
e According to the program PROCHECK (Laskowski et al., 1993). The percentages are indicated of residues in the most
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Figure 5.3: Activity of wild type and mutant UVDE proteins.
Activity assay with terminally labelled 30 bp DNA substrates containing a CPD (a), 6-4PP
lesion (b), abasic site (c). The incision product is indicated with an arrow. Below the lanes is
indicated which protein is used and the concentration of protein used (in nM).
5.3.2 Functional studies of Lys229 mutants
To investigate the role of the carboxylated lysine in the activity of UVDE, we mu-
tated this residue into an alanine (UVDE K229A) and a leucine (UVDE K229L).
UVDE K229A showed an extremely reduced catalytic activity on all tested DNA
substrates (Figure 5.3). The K229L mutant showed severely reduced catalytic ac-
tivity on the CPD (10%) and the abasic site lesion (less than 1%). On the 6-4PP the
incision efficiency of this mutant is slightly reduced compared to that of the wild
type (Figure 5.3). These results indicate that Lys229 has an important role in the
function of TthUVDE. Experiments attempting to decarboxylate UVDE (by lower-
ing the pH) and then carboxylate it again by addition of HCO3− were unsuccessful,
probably due to loss of activity of the protein (also in the neutral pH controls) in
the many dialysis steps that were necessary in the procedure (amongst others to
remove the HCO3− to prevent interference in the activity assay).
To investigate if the observed reduction in the incision efficiency is due to an ef-
fect on the formation of protein - DNA complexes, we tested the binding properties
of UVDE K229A and UVDE K229L in a filter binding assay. As can be seen in Table
5.2 the binding capacity of both mutants is similar to the wild type. This indicates
that the reduced incision activity is not due to changes in the enzymes ability to
bind DNA, but an impairment in catalysis. Moreover, DNA-binding is similar ei-











Table 5.2: DNA binding by TthUVDE wildtype and mutants.
DNA lesion UVDE % binding, no Mn2+ % binding, 1 mM Mn2+
CPD Wildtype 34 ± 2 33 ± 1.7
CPD K229L 31 ± 0.7 31 ± 0.7
CPD K229R 31 ± 0.5 32 ± 0.2
6-4PP Wildtype 19 ± 3.7 20 ± 1
6-4PP K229L 20 ± 0.5 21 ± 1.8
6-4PP K229R 17 ± 2.8 19 ± 0.7
Abasic site Wildtype 20 ± 2 23 ± 0.7
Abasic site K229L 21 ± 0.7 21 ± 1.4
Abasic site K229R 21 ± 2 21 ± 0.7
No damage Wildtype 2.5 ± 0.1 2.8 ± 0.4
No damage K229L 3.7 ± 0.2 3.8 ± 0.4
No damage K229R 7.6 ± 0.7 5.8 ± 1
Mn2+ does not influence DNA binding.
To gain a more detailed insight into the function of the carboxylated lysine,
a mutant was constructed in which Lys229 was changed to an arginine (UVDE
K229R). An arginine has a positive charge like a lysine, but an arginine cannot be
carboxylated. The positive side-chain of an arginine can therefore not be turned
into a negative group by carboxylation.
Surprisingly, the K229R mutant was found to be active and shows very high ac-
tivity on CPD (Figure 5.3(a)) and 6-4PP (Figure 5.3(b)) lesions, even higher than that
of wild type. Also abasic site, which is not an optimal substrate for the TthUVDE
wild type (20 % incision), is cleaved by the K229R mutant with high efficiency (80
%, Figure 5.3(c)).
We also tested the activity of K229R on UV-damaged DNA in a supercoiled inci-
sion assay (Figure 5.4(a); plasmid I). In the lanes with UVDE K229R (lane 6-8), much
more relaxed and even linear plasmid DNA as a result of damage-specific incision
can be seen compared to the lanes with UVDE wild type (lanes 2-4). This confirms
that UVDE K229R is much more active on UV damage sites than the wild type pro-
tein. UVDE K229R also has incision activity on the undamaged supercoiled plas-
mid DNA present in the assay (Figure 5.4(a), plasmid II, lane 8), though this activity
is very small compared to the activity on UV-damaged supercoiled plasmid DNA.
To investigate this activity on undamaged DNA more closely, we performed an as-
say with only undamaged supercoiled plasmid DNA (Figure 5.4(b)). In this assay
we could see that, surprisingly, UVDE wild type has some activity on undamaged
plasmid DNA (lane 2). The activity of K229R on undamaged DNA, however, was
again significantly higher (lane 4).
Filter-binding assays (Table 5.2) showed that K229R has similar DNA binding
properties to wild type UVDE. Thus, the higher activity of this mutant on both
damaged and undamaged DNA is not caused by a change to DNA binding, but by
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Figure 5.4: Activity of UVDE wild type and K229R on UV-irradiated and non-irradiated
plasmid DNA.
(a) A mixture of UV-irradiated supercoiled DNA of pUC18 (I, 2686 bp) and non-irradiated
pNP228 (II, 4686 bp) was incubated with different concentrations (as indicated) UVDE wild
type and K229R mutant for 15 min. The positions of the supercoiled (sc), open circle (oc)
and linear (lin) forms of the plasmids are indicated.
(b) A mixture of undamaged supercoiled DNA of pUC18 (I, 2686 bp) and pNP228 (II, 4686 bp)
was incubated with 10 nM UVDE wild type and mutant proteins as indicated. The positions
of the supercoiled (sc) and open circle (oc) forms of the plasmids are indicated.
5.3.3 Structural studies of the Lys229 mutants
To obtain a structural basis for the above results, the mutants K229L, K229R and
E175A were crystallized and their structures were solved by molecular replacement
(see Table 5.1 for statistics). In all three mutants, the overall structure is the same
as wild type.
In the structure of K229L, a water molecule is present at the place of the car-
boxylated lysine (Figure 5.5). Only one of the three metal ions is present: Mn3.
This is the metal ion near residues His244 and His203 and it corresponds to Zn3 in
endonuclease IV (Hosfield et al., 1999). The two metal ions (Mn1 and Mn2) that are
proposed to activate the catalytic water molecule (based on comparison to EndoIV)
are absent. These results suggest a correlation between the presence of the metal
ions and the carboxyl group.
To study whether the carboxyl group can still be present if there are no metal
ions, the previously constructed mutant (Paspaleva et al., 2007) E175A was studied
in detail. Glu175 bridges Mn1 and Mn2. The mutant E175A was previously found
to have no observable activity on DNA containing CPD and a severely reduced
activity on DNA containing 6-4PP (5 % activity left). In the structure of this mutant,











Figure 5.5: Structure of UVDE K229L.
(a) Detail of the model and the map of UVDE K229L showing the environment of Leu229.
Carbons are depicted in green, oxygens in red and nitrogens in blue. Distances of the water
molecule to neighboring residues are indicated.
(b) Detail of a superposition of UVDE K229L (in purple) with the original structure of UVDE
(in green). The slight shifts of residues Arg58, Ser99 and His231 are indicated.
water molecule (Figure 5.6). The metal ion near His244 and His203, Mn3, is present.
Most importantly, the modification on Lys229 was still observed. This result shows
that the modification can be present in the absence of the Mn1 and Mn2.
Together, the above results suggest that the carboxyl group can be present on
Lys229 in absence of Mn1 (as in E175A), but that perhaps this metal ion cannot bind
stably in the absence of the carboxyl group (as in structure K229L).
In K229R, Arg229 has moved compared to the carboxylated lysine (Figure 5.7(a)
and (b)). A water molecule was found at the place where the tip of the carboxylated
lysine originally was. Significant shifts are seen for the side-chains of His231 (2.5
Å) and Glu269 (3.2 Å), which have moved outwards away from Arg229. Indeed,
His231 moves away from the positive charge of Arg229 and Glu269 moves accord-
ingly. It should be noted that UVDE K229R is actually a double mutant (K229R
L133I) due to a misincorporation during the PCR reaction. No influence of the sec-
ond mutation on the structure of the protein could be seen (The shift of the Cα
of residue 133 is only 0.34 Å). Furthermore, Leu133 is a non-conserved residue far
away from the DNA binding site, leucine is very similar to isoleucine, and, in fact,
some bacterial UVDE have isoleucine in this position. Thus, the mutation L133I is
likely to have no impact on the behavior of K229R.
Metal ions were not observed in the K229R structure, which is probably caused
by the low pH of the crystallization condition (below the pKa of histidine side-
chains). Although two of the metal-coordinating residues have shifted consider-










5. INVOLVEMENT OF A CARBOXYLATED LYSINE IN UV DAMAGE ENDONUCLEASE
Figure 5.6: Structure of UVDE E175A.
(a) Detail of the map (contoured at 1.25 σ) and the model of UVDE E175A showing the
environment of Ala175 and the presence of a carboxylated lysine. Carbons are depicted in
green, oxygens in red and nitrogens in blue. Distance between an oxygen atom of Kcx229 and
His231 is indicated as well as the distances to the water taking the place of Mn1 and Mn2 to
neighboring residues.
(b) Detail of the superposition of the original structure of UVDE (in green) and UVDE E175A
(in purple) showing the surroundings of residue Glu175/ Ala175.
vironments for the three metal ions seem to be intact. Thus, the metals probably
can bind stably in all three sites (as the activity also suggests) if the pH permits it,
although Mn1 would have to shift over about 1 Å to get into a proper coordination
environment.
To get insight into the possible influence of the shifts of His231 and Glu269 on
the activity of UVDE K229R, DNA was modeled into K229R based on the crystal
structure of endonuclease IV with DNA (Hosfield et al., 1999). In this model, it can
be seen that the observed shifts are near the part of the DNA where the damage is
expected to be located. In contrast to wild type, in K229R the shifted Glu269 clashes
with the abasic site (damaged site) of this model (see Figure 5.7(c)), suggesting that
the part of DNA near the damage might have to bind slightly different in UVDE
K229R compared to wild type.
5.4 Discussion
The results from mass-spectrometry and crystallization at low pH showed that the
modification we initially observed on Lys229 is (acid) labile. Together with the
observed hydrogen bonding pattern of the modification in the original structure,











Figure 5.7: Structure of UVDE K229R and model with DNA.
(a) Model and map (contoured at 1.5 σ) of UVDE K229R. Carbons are depicted in green,
oxygens in red and nitrogens in blue. Distances between a water molecule and Arg58 and
Ser99 are indicated.
(b) Detail of the superposition of the original structure of UVDE (in green) and UVDE K229R
(in purple) showing the position of Arg229 compared to the carboxylated lysine and the large
shift in the position of His231. Also the shifts in the position of Arg58 and Ser99 are indicated.
(c) Detail of superposition of the original structure of UVDE (in green) and the structure of
UVDE K229R (in purple) in which DNA with an abasic site was modeled (orange) based on a
comparison to the structure of endonuclease IV with damaged DNA. Arg229/ Kcx229, His231
and Glu269 are depicted in cylinder representation, the abasic site of the DNA is depicted in
ball-and-stick representation while the rest of the protein and the DNA is depicted in ribbon
representation.
been observed before in prokaryotic proteins and carboxylation of a lysine does not
require an enzyme, but can happen in solution at a suitable position in a protein
due to dissolved carbon dioxide (Li et al., 2005). Therefore, it is a likely possibility
for a protein (TthUVDE) overexpressed in a foreign host (E. coli). With activity
assays and structural analysis on mutants, we conclude the carboxyl group might
be involved in the stable binding of Mn1 by donating some of its negative charge
to the His231. Reduced stability of metal binding explains the reduced activity of
K229A and K229L. For K229L, this reduction in activity is stronger on CPD than on
6-4PP, possibly because the presence of DNA with a 6-4PP might facilitate metal-
binding and thus allow activity on 6-4PP. Notably, also UVDE E175A (in which also
reduced binding of Mn1 is involved) has a more severe phenotype on CPD than on
6-4PP (Paspaleva et al., 2007).
The mutant K229R, however, does not have a negative charge near His231. Quite
the contrary: the protein has a positive charge at position 229 (an arginine). Still,
the mutant is active on CPD, 6-4PP and abasic sites with a higher incision efficiency
than wild type on these substrates. This increased activity of K229R might be ex-
plained by considering a potential mechanism for UVDE where, the protein first
recognizes a general distortion in the DNA and binds to it (proposed previously
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performs this step similar to UVDE wild type, since overall DNA binding was seen
not to be affected by the mutation. Then, the DNA gets into the right conformation
for incision and the incision takes place. This step is performed more efficiently in
K229R than wild type. Structural changes were observed in the active site of K229R
and the induced changes block the previously proposed damage-binding pocket.
However, the structure of UVDE in complex with DNA is needed to clarify the rel-
evance of the latter observation. The structural changes in the active site of K229R
may cause the portion of the DNA near the damage to bind slightly different in the
active site, perhaps in a conformation more favorable for incision.
The results on mutant UVDE K229R raise an interesting question. Why did T.
thermophilus not use an arginine at position 229 if this protein is more efficient than
wild type? An answer to this may be found in the activity of UVDE K229R on un-
damaged DNA. Both UVDE wild type and K229R were found to incise undamaged
DNA, which has not been reported for UVDE from S. pombe. Apparently, TthUVDE
has more difficulties in discriminating damaged and undamaged DNA. The high
temperature used for incision assays with this thermophile, might play a role in
the incision of undamaged DNA, since the DNA can be more readily distorted at
higher temperature. Interestingly, we found that the activity on undamaged DNA
was much higher for K229R than for UVDE wild type. Perhaps Arg229 is not favor-
able for T. thermophilus because the incision on undamaged DNA in the cell might
be too high.
UVDE is present in several organisms, both prokaryotic and eukaryotic. Is car-
boxylation a general phenomenon in all these proteins? Two of the residues near
the carboxylated lysine, Arg58 and His231, are fully conserved in all UVDE pro-
teins (Golemi et al., 2001). In eukaryotic UVDEs, Lys229 itself is also conserved and
these proteins have a threonine instead of a serine at the position corresponding to
Ser99. Thus, these proteins might have a similar site at this position and therefore,
they might be carboxylated like TthUVDE.
In the prokaryotic UVDEs, however, Lys229 is only partially conserved. Most
UVDE proteins have a lysine at this position as well as a serine at the position cor-
responding to Ser99 and thus might be carboxylated like TthUVDE. A few UVDEs,
however, have a leucine, isoleucine, methionine, glutamic acid, threonine or a va-
line at the position corresponding to Lys229. Thus, these UVDE homologues can-
not have the same modification.
We have shown here that a leucine at position 229 results in an inactive enzyme
for TthUVDE while some of the other UVDEs do have a leucine at that position,
such as Desulfotelea psychrophila UVDE (Goosen & Moolenaar, 2008). Perhaps in
these UVDEs the environment near His231 is such that a negative charge is pro-
vided to His231 by other residues nearby so that stable metal-binding is assured in
these proteins as well. Indeed, the UVDEs with a leucine at position 229 all have a
glutamic acid or an aspartic acid at the position of Met267, which is spatially close to
His231 (the side chain of glutamic acid is 2.5 Å away from the side-chain of His231
if glutamic acid is modeled at this position in the structure of TthUVDE). Such a
negatively charged residue is not present in the UVDEs that do have a lysine at po-











UVDEs that do not have a lysine at the position of Lys229, also have a glutamic acid
near or at position 229. Thus, also these UVDEs might have a negative charge near
His231 for assuring proper metal binding, though no definite conclusions can be
made in absence of structural data on these proteins.
In conclusion, we think that UVDE from T.thermophilus is carboxylated at
Lys229. The carboxyl group might be required for stable metal-binding and
perhaps also for preventing an unfavorably high incision of undamaged DNA.
Note
Coordinates and structure factor amplitudes have been deposited in the Protein
Data Bank under ID code 3bzg for UVDE pH 4.4, 3bzj for UVDE K229L, 3c0l for






















ability to recognize and incise
different types of damaged
DNA
UV damage endonuclease (UVDE) is a DNA repair enzyme that can recognize and
incise a diverse set of DNA lesions including UV-induced DNA damage and DNA
containing abasic sites. In this chapter, we present the structure of UVDE from
Sulfolobus acidocaldarius (SacUVDE) and a pre-catalytic structure of SacUVDE in
complex with DNA containing a 6-4 photoproduct. These structures show that
UVDE has an intriguing "dual flip" mechanism: the two purines opposite to the
damaged pyrimidine bases are flipped into a dipurine-specific pocket, whilst the
damaged bases are also flipped into a pocket. In contrast to UVDEs from other
species, SacUVDE shows a marked preference for DNA substrates containing 6-4
photoproducts compared to cyclobutane pyrimidine dimers: biochemical assays
and mutagenic studies show that the flexibility of the damage binding pocket and
positive charges on both sides of the substrate binding groove are main contributors
to the broad substrate specificity for UVDE in general.
E.M. Meulenbroek, C. Peron Cane, I. Jala, S. Iwai, G.F. Moolenaar, N. Goosen, N.S.
Pannu, UV damage endonuclease employs a novel dual-dinucleotide flipping mechanism










6. UNRAVELLING UVDE’S UNCANNY ABILITY TO RECOGNIZE AND INCISE DIFFERENT TYPES OF
DAMAGED DNA
6.1 Introduction
The UV damage endonuclease (UVDE) repair pathway, present in some prokary-
otes and lower eukaryotes, was first identified in S. pombe where Nucleotide Exci-
sion Repair deletion mutants were seen to be only moderately UV-sensitive (Mc-
Cready et al., 1993). Its central enzyme, UVDE, was found to be a DNA endonucle-
ase that not only recognizes and incises DNA 5’ to cyclobutane pyrimidine dimers
(CPDs) and 6-4 photoproducts (6-4PPs) (Bowman et al., 1994), but also non-UV-
induced DNA damage such as abasic sites, nicks and gaps (Avery et al., 1999). The
activity on abasic sites, nicks and gaps was seen to depend on the presence of neigh-
boring pyrimidines, suggesting that UVDE’s active site is most optimal for binding
distorted pyrimidines (Paspaleva et al., 2009). Later, UVDE homologues were dis-
covered in Neurospora crassa and from Bacillus subtilis that incise at least CPD, 6-4PP
and abasic site very efficiently (Kanno et al., 1999; unpublished results) and UVDE
from Thermus thermophilus that efficiently cleaves CPDs and 6-4PPs while incising
abasic sites only with moderate efficiency (Paspaleva, Thomassen et al., 2007).
Insights into the mechanism of UVDE came from the crystal structure of UVDE
from Thermus thermophilus (Paspaleva, Thomassen et al., 2007). TthUVDE has a
TIM-barrel fold with a large groove with positive charges on the edges where DNA
was proposed to bind based on the structural similarity to Endonuclease IV (Hos-
field et al., 1999). The active site containing three metal ions is located on the bottom
of this groove and two conserved residues (Gln and Tyr; together called the ’prob-
ing finger’) were proposed to aid in flipping out the damaged bases from the DNA
helix. Thus, the structure suggested plausible mechanisms for DNA binding and
three-metal-ion catalysis, but could not explain UVDE’s wide substrate specificity.
To explain the broad specificity, we have determined the structures of UVDE
Sulfolobus acidocaldarius (SacUVDE) on its own to 1.5 Å resolution and in a pre-
catalytic complex with DNA containing a 6-4 photoproduct determined to 2.7 Å.
The structures show that UVDE recognizes damaged pyrimidine dimers by flip-
ping the two bases opposite to the damage into a dipurine-specific pocket and by
flipping the damage itself into a flexible damage-binding pocket. Positive charges
on both sides of the DNA binding-groove probably aid in binding different dam-
aged DNA substrates.
6.2 Materials and methods
6.2.1 Cloning
Genomic DNA was isolated from S. acidocaldarius by resuspension of cells in TEN-
buffer (20 mM Tris pH 8, 1 mM EDTA, 100 mM NaCl), followed by lysis in TENST-
buffer (20 mM Tris pH 8, 1 mM EDTA, 100 mM NaCl, 1.6 % sarcosyl, 0.12 % Tri-
ton) and phenol/ chloroform extraction. The gene for UVDE was amplified using
the primers 5’ ATTAATAACATATGAGAGTAGGTTACGTATCCAC 3’ and 5’ TAG-
GATCCATTAATCCAGTTTGTTTAACTCCTTTAAC3’. Subsequently, it was cloned










6.2. MATERIALS AND METHODS
Table 6.1: 30-mer DNA substrates used in this study.
No damage 5’ CTCGTCAGCATCTTCATCATACAGTCAGTG 3’
3’ GAGCAGTCGTAGAAGTAGTATGTCAGTCAC 5’
CPD and 6-4PP 5’ CTCGTCAGCATCTTCATCATACAGTCAGTG 3’
3’ GAGCAGTCGTAGAAGTAGTATGTCAGTCAC 5’
Abasic site 5’ CTCGTCAGCATCXTCATCATACAGTCAGTG 3’
3’ GAGCAGTCGTAGAAGTAGTATGTCAGTCAC 5’
The positions of the CPD (TT), (6-4)PP (TT) and AP site (X) are indicated in bold.
sulting in the gene for SacUVDE with a N-terminal 10x His-tag and factor Xa cleav-
age site. Mutants of SacUVDE were created by PCR and cloned into the same vector
with NdeI and BamHI. All constructs were verified by sequencing.
6.2.2 Expression and purification
The plasmid with the gene for SacUVDE was transformed to E.coli BL21(DE3)-
codon+ and overexpressed for 2 hours at 37◦C after induction by 0.5 mM IPTG.
After harvesting, the pellet was resuspended in Ni buffer A (20 mM Tris pH 7.5, 500
mM NaCl, 50 mM imidazole, 8 mM β-mercaptoethanol and 10 % glycerol) and the
cells were lysed by sonication. The lysate was spun down at 37.000 rpm (100.000 g)
for 30 min and the soluble fraction was loaded on a His-trap column (GE healthcare)
equilibrated with Ni buffer A. The column was washed with 20 column volumes
Ni buffer A and the protein was then eluted with a 60 column volumes gradient
to Ni buffer B (20 mM Tris pH 7.5, 500 mM NaCl, 500 mM imidazole, 8 mM β-
mercaptoethanol and 10 % glycerol). Fractions containing SacUVDE were dialyzed
to 20 mM Tris pH 8 and were then loaded on a HiTrap Q column (GE healthcare)
equilibrated with Q buffer A (20 mM Tris pH 8 and 10 % glycerol). The column was
washed with 10 column volumes Q buffer A and eluted with a 60 column volumes
gradient to Q buffer B (20 mM Tris pH 8, 1 M NaCl and 10 % glycerol).
For crystallization, the purification protocol was adapted: size exclusion (Su-
perdex 200, GE healthcare) was performed in GF buffer (20 mM HEPES 7.2, 200
mM NaCl, 5 mM DTT) after the Ni purification instead of ion exchange. The pro-
tein from either protocol was found to be more than 95 % pure as judged from SDS
PAGE. All purification steps were performed at 4 ◦C.
6.2.3 DNA substrates
The DNA substrates used in this study can be seen in Table 6.1. The oligos contain-
ing CPD or 6-4PP were synthesized as described in Iwai, 2006. The top strands of
the DNA substrates were 5’ radioactively labelled using polynucleotide kinase as
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6.2.4 Incision assays
Labelled DNA substrates (1 nM) were incubated for 15 min at 55 ◦C with the in-
dicated amount of UVDE (in the range 0.05 to 50 nM) in 20 mM HEPES pH 6.5,
100 mM NaCl and 1 mM MnCl2 in a reaction mix of 20 µl. The reaction was then
stopped by adding 3 µl stop mix (0.33 M EDTA, 3.3 % SDS), after which 2.4 µl 4
mg/ml glycogen was added and the DNA was precipitated by ethanol. Samples
were loaded on a 15 % denaturing polyacrylamide gel and visualized by autoradio-
graphy. For kinetics incision assays, a mix was prepared of buffer, cofactor, protein
(25 nM) and DNA and put at 55 ◦C. At the indicated time points, samples were
taken out and the reaction was stopped in these samples.
6.2.5 Bandshift assays
Labelled DNA substrates (0.1 nM) were incubated for 10 min on ice with 660 nM
UVDE in 20 mM Tris pH 6.5, 100 mM NaCl and 1 mM MnCl2 in a reaction mix of
10 µl. Samples were loaded on a 6 % native gel, which was run at 4 ◦C in 1x TBE.
The gel was dried and the result was visualized by autoradiography.
6.2.6 Filter-binding assays
Labelled 50-mer DNA substrates (4 nM) were incubated for 7 min with 50 nM
UVDE at 55 ◦C in a reaction buffer containing 20 mM Tris pH 6.5, 100 mM NaCl
and 1 mM MnCl2 in a reaction mix of 20 µl. After incubation, 0.1 ml reaction buffer
was added and the mixture was poured over a nitrocellulose filter. The filters were
washed with 0.2 ml reaction buffer. The amount of DNA retained on the filter (by
binding to UVDE) was determined using a scintillation counter. Each sample was
corrected for the amount of DNA retained on a filter in the absence of protein. Bind-
ing is expressed as the percentage of the DNA retained on the filter divided by the
input DNA.
6.2.7 Crystallization
SacUVDE was concentrated to 3-5 mg/ml with a 3 kDa MWCO centrifugal fil-
ter unit (Millipore). Crystallization trials were performed using the sitting-drop
vapour diffusion method and the JCSG+ and PACT (Qiagen) screens. SacUVDE
crystals were obtained in 20 % PEG3350 with 0.2 M NH4Cl or 0.2 M NaI. The con-
ditions were optimized by a systematic screen around these conditions and the
largest crystals were grown in 14 to 28 % PEG3350 with 0.15 to 0.3 M NH4Cl.
The damaged strand of the oligo containing 6-4PP for crystallization was
synthesized as previously described (Iwai, 2006) while the undamaged strand
was purchased from Eurogentec, Belgium. The sequence of the oligo was: 5’
GCGTCCTTGACGACG 3’ with the site of the damage printed in bold. The two
strands were hybridized by heating to 80 ◦C for two minutes in 20 mM Tris pH 7
and then allowed to slowly cool down to room temperature. For co-crystallization,
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after which sitting-drop vapour diffusion experiments were set up in the NucPro
screen (Jena Biosciences). Damaged DNA:protein complex crystals appeared after
several days in 30 % PEG2000-MME, 100 mM acetate buffer pH 4.6, and 200 mM
(NH4)2SO4.
6.2.8 Data collection
Crystals were caught with SPINE sample loops and put in cryoprotectant solution
(precipitant solution with 10-15 % glycerol) and flash-frozen. Data were collected at
the European Synchrotron Radiation Facility (Grenoble, France). 180 images were
collected with an oscillation angle of 1.0◦ with transmission of 13 % and exposure
time of 0.5 s per frame at 0.9393 Å at 100 K on beamline ID14-4 for the apoprotein
crystals. For the DNA:protein complex crystals, 150 images were collected with an
oscillation angle of 1.0◦ and an exposure time of 25 s per frame at 0.934 Å at 100 K on
beamline ID14-1. The images were processed with iMosflm (Leslie, 2011). Scaling
and merging were done with SCALA (Evans, 2006) from the CCP4 suite (Winn et
al., 2011). For the apoprotein structure, two datasets (from two different crystals)
were merged to yield the final dataset used for determining the structure. Data
collection statistics are shown in Table 6.2.
6.2.9 Structure solution and refinement
The phase problem for the apoprotein was solved by molecular replacement us-
ing the structure of TthUVDE (PDB entry 2j6v) as a search model. The model was
automatically rebuilt using ArpWarp (Perrakis et al., 1999) and refined with Refmac
(Murshudov et al., 2011). Manual fitting was performed using Coot (Emsley et al.,
2010). For the DNA:protein complex, the phase problem was solved by molecular
replacement using the structure of SacUVDE as a search model. Clear difference
density was visible for the DNA (Figure 6.1(e)) and the DNA was built in man-
ually in Coot. The model was refined with Refmac and further manual fitting was
also performed using Coot. The final R-factor and Rfree for uncomplexed SacUVDE
were 0.177 and 0.214 respectively and 0.201 and 0.271 for SacUVDE in complex with
DNA. Refinement statistics are shown in Table 6.2.
Superpositions were done with the ssm function in Coot. Root-mean-square de-
viation calculations were done using Theseus (Theobald & Wuttke, 2006). Structure-
based sequence alignment was performed using the program VAST (Thompson
et al., 2009). Atomic coordinates and structure factors have been deposited in the
RCSB Protein Data Bank (accession code 3tc3 for the apoprotein and 4gle for the
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6.3 Results
6.3.1 Overall structure of SacUVDE with and without damaged DNA
To gain insight into UVDE’s damage recognition and incision mechanism, a co-
crystal structure of UVDE with damaged DNA is needed. Crystallization of
TthUVDE and BsuUVDE with different damage-containing oligos (abasic site,
CPD, different lengths and ends of oligos) was unsuccessful: only crystals of either
protein or DNA alone were obtained. This is probably due to the relatively low
affinity of UVDE for damaged DNA and the high propensity of TthUVDE to crys-
tallize on its own. Luckily, we found a UVDE homologue that more strongly inter-
acts with DNA: UVDE from Sulfolobus acidocaldarius, an aerobic thermoacidophilic
crenarchaeon. This homologue is more specific for 6-4PPs and also binds slightly
stronger to this damage than TthUVDE (see section 6.3.3). Crystallization of this
protein with and without DNA were successful: a crystal of SacUVDE diffracted to
1.5 Å and a crystal of SacUVDE in complex with DNA containing 6-4 photoproduct,
diffracted to 2.7 Å (statistics are shown in Table 6.2). The quality of the map of both
structures is shown in Figure 6.1(a) and (c). Clear difference density for DNA was
seen in the complex after molecular replacement with the apoprotein, into which
the damaged DNA could be built manually. An OMIT map for the DNA can be seen
in Figure 6.1(e). For uncomplexed SacUVDE, two very similar chains are present in
the asymmetric unit (root mean square deviation of the Cα atoms is 0.064 Å), while
the DNA:protein complex crystals contain only one chain in the asymmetric unit.
SacUVDE has a TIM-barrel fold (Figure 6.1(b)) and the SacUVDE backbone
structure is very similar to TthUVDE: the root mean square deviation of the Cα
atoms is only 0.651 Å. The sequence identity between these two proteins is 38 %.
Figure 6.2 shows a structure-based sequence alignment. Density is only present for
one metal in the SacUVDE structure; this ion is located near (0.42 Å) the position of
metal ion Mn1 in TthUVDE (the most stably bound metal ion). During refinement,
the occupancy for this metal ion was set to unity, but the B-factor of this ion refined
to a relatively high value (50.78), suggesting either high mobility or low occupancy.
The metal coordinating residues in SacUVDE are at similar positions as those of
all three metal ions in TthUVDE. Addition of manganese is needed for activity in
incision assays and therefore it is very likely that active SacUVDE also uses a three-
metal ion catalysis. Another notable difference between the structures of SacUVDE
and TthUVDE, is that SacUVDE has one extra α-helix (α8; Figure 6.1(b)) at its C-
terminus. Thus, SacUVDE does have a complete α8β8 TIM-barrel, like the majority
of UVDEs, in contrast to TthUVDE.
The overall fold of SacUVDE in the complex structure with DNA containing a
6-4 photoproduct is very similar to that of the apoprotein; the root mean square
deviation of the Cα atoms is only 0.11 Å and thus hardly any changes occur upon
DNA binding (Figure 6.1(d)). In the DNA:protein complex structure, the DNA is
bound in the previously predicted DNA-binding groove. The DNA makes a bend
of around 90 ◦ (Figure 6.1(f)), like in the related structure of Endonuclease IV with











Table 6.2: Data collection and refinement statistics.
Data collection
SacUVDE SacUVDE with 6-4PP
Space group P1 C2221
Cell dimensions
a, b, c (Å) 42.08 x 53.59 x 77.39 57.20 x 112.51 x 153.85
α, β, γ (◦) 102.09, 93.02, 111.76 90.00, 90.00, 90.00
Resolution (Å) 46.05-1.50 (1.58-1.50)a 52.83-2.70 (2.85-2.70)a
Wilson plot B-factor 17.5 64.7
Rmerge 0.099 (0.520) 0.121 (0.832)
I/σI 9.3 (1.9) 11.1 (1.9)
Completeness (%) 97.3 (94.0) 99.9 (99.2)
Redundancy 3.4 (2.4) 5.9 (5.2)
Total n◦ observations 317749 82168
N◦ unique reflections 94666 14041
Refinement
Resolution (Å) 46.05-1.50 52.89-2.70
N◦ reflections 89933 13316
N◦ molecules in ASU 2 1
Rwork/ Rfree 0.177/ 0.214 0.191/ 0.262
N◦ atoms
Protein 4706 2353
Metal ions 2 0
Water 579 4
DNA 0 609
Other ions 0 10
B-factors
Protein 20.37 55.28
Metal ions 50.78 NA
Water 31.93 34.14
DNA NA 67.83
Other ions NA 60.77
R.m.s. deviations
Bond lengths (Å) 0.026 0.011
Bond angles (◦) 2.21 1.57
N◦ TLS bodies 2 NA
Ramachandran favoredb 96.87 % 92.8 %
Ramachandran outliersb 0.00 % 0.69 %
Rotamer outliersb 1.48 % 2.95 %
aValues in parentheses are for the highest resolution shell.
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Figure 6.1: Overall structure of SacUVDE with and without DNA.
(a) Representative part of the electron density map of SacUVDE.
(b) Overall fold of SacUVDE, which has a TIM-barrel fold. The metal ion is shown in magenta.
(c) Representative part of the electron density map of SacUVDE in complex with DNA.
(d) Superposition of SacUVDE with (magenta) and without (yellow) DNA (blue and cyan),
showing that the two structures are very similar.
(e) Omit map of the SacUVDE cocrystal with DNA showing clear positive difference density
for the DNA (contoured at 3 σ).











Figure 6.2: Structure-based sequence alignment of SacUVDE and TthUVDE.
Secondary structure elements are indicated with cylinders and arrows for α-helices and β-
strands respectively. Identical residues are in red, variable residues in blue, and unaligned
residues in grey.
chains or backbone amides of the protein mostly with the DNA phosphates (and
some with the base or the deoxyribose ring) hold the DNA in the DNA binding
groove (Figure 6.3). The residues responsible for these interactions are partially or
fully conserved in UVDE from different organisms, hence our structure is of general
relevance for the understanding of the mode of action of the entire UVDE family.
In the structure of SacUVDE in complex with damaged DNA, no metal ions can
be seen and thus the DNA is not incised and the complex is in a pre-incision state.
The absence of metals in the structure is probably an effect of the crystallization
condition. The position of the metal ions can be estimated by superposition with
the crystal structure of TthUVDE that contains all three metals. In the DNA:protein
complex structure, the scissile P-O bond is still several Å away from the correct
position for cleavage, but the positive charge of the metal ions is likely required
to draw the scissile bond inwards to the correct position, allowing incision to take
place.
6.3.2 Recognition of pyrimidine-dimer lesions by UVDE
Strikingly, the two bases opposite to the damage (nucleotides A8 and A9) are
flipped from the DNA helix into a "undamaged-bases-binding" pocket of UVDE










6. UNRAVELLING UVDE’S UNCANNY ABILITY TO RECOGNIZE AND INCISE DIFFERENT TYPES OF
DAMAGED DNA
Figure 6.3: Schematic representation of UVDE-DNA interactions with the undamaged DNA
strand in blue, the damaged strand in cyan and the protein in magenta. In three dimensions,
the damaged bases T7 and T8 and the undamaged bases A8 and A9 are actually below the
plane of the figure and the residues Q103 and Y104 are inserting in the helix.
ger forms stacking interactions with the base of A9. Leu65 aids in creating a hy-
drophobic environment on the other side of this pocket near A8. In other UVDEs,
usually a leucine or phenylalanine is found at this position and in a superposition
of TthUVDE with the DNA:protein complex structure, this phenylalanine indeed
forms stacking interaction with the base of A8. A hydrogen bond between the con-
served Ser67 and the N1 of the A8 base is present that would be lost if a pyrim-
idine was present in this position due to its smaller size. The size of the pocket
together with these stacking and hydrogen bond interactions make that the pocket
is customized to fit two purines. Such a specific pocket for two bases of the un-
damaged DNA strand seems to be a novel property for a DNA repair enzyme. The
existence of this pocket is a ingenious, useful feature for an enzyme that needs to
recognize UV-damaged DNA, since dipyrimidines always have two purines oppo-
site the lesion. It also gives an explanation for the strong preference of UVDE for











Figure 6.4: Detailed view of the pockets for the undamaged bases (a) and the damaged bases
(b), showing their environment in the pockets. Hydrogen bonds are indicated with dashed
lines.
paleva et al., 2009), since the abasic sites flanked by a pyrimidine used in (Paspaleva
et al., 2009) had two purines opposite the damage. The importance of the pocket
for the enzyme’s function has been previously shown, since the mutation of the
Tyr104 residue to alanine in TthUVDE abolishes its incision activity (Paspaleva,
Thomassen et al., 2007). Moreover, flipping of the bases opposite to the damage
into a pocket concurs with the previously reported fluorescence studies (Paspaleva
et al., 2009). In that study, it was noticed that the bases opposite to the damage are
flipped from the helix into a partially to not solvent-exposed area, which agrees
with bases flipped into a pocket.
Not only are the undamaged bases flipped, but the damage itself is also flipped
into a protein pocket. A hydrogen bond by the probing finger residue Gln103 to the
base just 5’ to the damage probably helps in stabilizing this flipped conformation
(Figure 6.3). The damage pocket is lined with several residues capable of making
hydrogen bonds to the damage (shown in Figure 6.3 and Figure 6.4(b)) and is close
to the active site responsible for the enzyme’s catalytic function. The pocket is tight
around the 6-4PP, but the shape does allow a CPD to fit and be stabilized, while
purines would be excluded from the pocket due to their larger size. To enter the
pocket, the DNA backbone must deform substantially. The loss of base-pairing and
amount of deformation that an undamaged DNA substrate would have to undergo
is probably too energetically unfavorable to allow an undamaged DNA substrate
to enter the pocket. This explains the broad specificity of the enzyme for many
damaged types of DNA, while not cutting undamaged DNA.
6.3.3 SacUVDE has a preference for 6-4 photoproduct over CPD damaged DNA
Although the structure of the apoprotein shows a high structural similarity to










6. UNRAVELLING UVDE’S UNCANNY ABILITY TO RECOGNIZE AND INCISE DIFFERENT TYPES OF
DAMAGED DNA
Figure 6.5: Activity of SacUVDE versus TthUVDE.
Incision assay with SacUVDE or TthUVDE (indicated below the lanes) showing that SacUVDE
has a strong preference for incising 6-4PP compared to CPD in contrast to TthUVDE. The
incision product is indicated with an arrow. The assay was carried out at 55 ◦C for both
proteins.
Table 6.3: DNA binding by SacUVDE wildtype.
DNA lesion % binding
CPD 8.6 ± 4
6-4PP 42.9 ± 2
Abasic site 8.1 ± 1
No damage 8.3 ± 7
cision activity for the 6-4PP, even higher than that of TthUVDE, but it is low for
CPD and virtually absent for abasic sites (Figure 6.5 lanes 4 to 9). This is in con-
trast to TthUVDE that has a high incision activity for both CPD and 6-4PP and a
lower incision activity for abasic sites (Figure 6.5 lanes 10 to 15). We set out to com-
pare the structure and function of these two homologues to explain this difference
and, by extending this explanation, to get insight into the generally broad substrate
specificity of UVDE.
We tested whether the different substrate specificity is caused by experimental
conditions, such as DNA length, pH, metal cofactor and temperature (results not
shown). Much higher incision on 6-4PP than on CPD has been confirmed on 50-
mer DNA substrates at both 55 ◦C (the standard temperature for our thermophilic
incision assays) and 80 ◦C. The optimum activity is at pH 5.5 to 6.5 (range of 3.5 to
8.5 attempted), which is not surprising since the cellular pH is 6.5 in S. acidocaldarius
(Moll & Schaefer, 1988). The optimal cofactor is manganese or cobalt; absence of
metal ions, calcium, zinc and nickel gives little to no activity, and the addition of
magnesium lowers the activity slightly. At all pHs and with all cofactors tested,
the activity is always much higher for the 6-4PP than for the CPD, confirming that
our result is a genuine characteristic of the protein and is not an artifact caused by
experimental conditions.
Bandshift assays were performed on 6-4PP and CPD substrates to determine if











Figure 6.8 lanes 3 and 4, binding to 6-4PP seems stronger than to the CPD. Both
for CPD and 6-4PP the amount of free DNA can be seen to decrease, so the protein
binds to both, but only on 6-4PP it gives a complex that is stable and specific enough
to see a tight band on the gel. To confirm the results of the bandshift (stronger
binding to 6-4PP than CPD), filter-binding assays were performed. As can be seen
in Table 6.3, the filter-binding assays show that SacUVDE indeed binds stronger to
6-4PP than to CPD. We therefore conclude that the difference in activity is caused
by a difference in binding to the damage.
6.3.4 Structure-based mutagenesis explains SacUVDE’s substrate specificity
To explain SacUVDE’s preference for binding and incising 6-4PP, we took a closer
look at the structural differences between SacUVDE and TthUVDE. In contrast to
TthUVDE, SacUVDE has an extra helix (α8) at its C-terminus. There is a shift of
around 2 Å in the neighboring α-helix of residues 248 to 260 (α7) and a shift of
up to 3.3 Å in the loop of residues 235 to 242 (see Figure 6.6(a)). This latter loop
is positively charged in TthUVDE and is close to the DNA groove in the UVDE-
DNA structure (Figure 6.9(b)), hence a shift of this loop might cause differences in
DNA binding. To test the function of the α8-helix, we made a C-terminal truncation
(SacUVDE 1-275). Hardly any overexpression of soluble protein was detected for
this construct, indicating that the α8-helix is important for stability in SacUVDE.
Moreover, other UVDEs like SpUVDE and BsUVDE have this additional helix as
well, yet they can recognize both CPD and 6-4PP. It is therefore unlikely that this
helix is the main reason for the difference.
Another reason for the different phenotypes could be that the the damage-
binding pockets differ (see Figure 6.6(b)). However, the damage-binding pockets
of both enzymes are very similar. The most prominent side-chain difference in the
pocket is the Tyr10 in SacUVDE (versus leucine in TthUVDE and valine, methio-
nine or threonine in most other UVDEs). A tyrosine at this position might favor
binding of 6-4PP over CPD, because it might have some specific interactions with
6-4PP (the oxygen atom in the deoxyribose ring of base 8 will come into hydrogen
bonding distance of the hydroxyl group of Tyr10 when metal ions pull down the
lesions deeper into pocket). To test this, we mutated Tyr10 to alanine and tested its
activity. As can be seen in Figure 6.7, the activity of the SacUVDE Y10A mutant is
very similar to wildtype, with high incision at the 6-4PP and hardly any incision
at the CPD and abasic site (compare lanes 4-6 to lanes 11-13). The binding to ei-
ther substrate is also comparable to wildtype (Figure 6.8). Hence we conclude that
the different phenotype is most probably not due to side-chain differences in the
damage-binding pocket.
Another remarkable difference between the structures SacUVDE and TthUVDE
is a backbone shift (up to 2.8 Å) of residues 10-18 in SacUVDE (Figure 6.6(c)), which
is located near the damage-binding pocket. This shift is most probably caused
by the disulfide bridge between C14 and C40 in SacUVDE that is not present in
TthUVDE nor most other UVDEs. To study the importance of the disulfide bridge,










6. UNRAVELLING UVDE’S UNCANNY ABILITY TO RECOGNIZE AND INCISE DIFFERENT TYPES OF
DAMAGED DNA
Figure 6.6: Most notable differences between structures of SacUVDE and TthUVDE. Super-
position is shown with SacUVDE depicted in magenta, TthUVDE in green, the metal ions in
grey, undamaged DNA in blue and damaged DNA in cyan. The following features can be seen.
(a) The presence of α8-helix in SacUVDE causes a shift of the α7-helix and the 235-242 loop.
(b) The substrate-binding pocket with residue Tyr10 in SacUVDE and Leu11 in TthUVDE.
(c) The disulfide bridge C14-C40 causes a shift of residues 10-18 near the damage binding
pocket.
(d)The probing finger loop of UVDE starting at Pro101 and ending at Leu107. The probing
finger itself (Gln103 and Tyr104) is also indicated. The numbering of SacUVDE is used.
mercaptoethanol or DTT; results not shown). No difference in activity could be
observed even at the highest reducing agent concentration. Since there is 5 mM
DTT present in the crystallization buffer and still the disulfide bridge was seen in
the crystal structure, it is likely that the disulfide bridge is not easily broken. During
the assay in presence of reducing agents this might also have been the case.
To disrupt the disulfide bridge with certainty and hence be able to verify its im-
portance, we mutated C14 to alanine and tested its activity. Figure 6.7 shows that
SacUVDE C14A (lanes 14-16) has a strongly reduced activity compared to SacUVDE
wt (lanes 4-6). This can be seen more clearly in an assay with reduced concentra-
tions of protein, which shows a much lower incision activity of SacUVDE C14A
(lanes 20-26) compared to wildtype (lanes 4-10). At all temperatures tested (35
◦C, 45 ◦C and 55 ◦C), the relative difference between mutant and wildtype stays
the same (results not shown). The solubility of the mutant during purification is











Figure 6.7: Activity of mutants of SacUVDE.
Lanes 1-10: Incision activity of SacUVDE wt at concentrations of 0.05 to 5 nM showing a
strong preference for incision on 6-4PP. The incision product is indicated with an arrow.
Lanes 11-19: Incision activity of SacUVDE mutants showing that mutants Y10A and L107P
have a similar activity to SacUVDE wt and that SacUVDE C14A has a strongly reduced activity.
Lanes 20-26: Incision activity of SacUVDE C14A in more detail confirming the strongly reduced
activity of this mutant.
duced activity is not caused by reduced stability during the time of the assay, but by
a genuine defect in the protein’s function. We tested DNA binding of this mutant by
a bandshift assay (Figure 6.8), which also shows a reduced affinity, suggesting that
mutant C14A has a defect in binding to damaged DNA. This result was confirmed
by filter-binding assays (results not shown). It is possible that the rigidity caused
by the disulfide bridge prevents SacUVDE to incise efficiently both CPD and 6-4PP,
but that removing this disulfide bridge leads to a pocket that is too flexible to cut
anything efficiently.
An important factor for DNA recognition and binding is the probing finger of
the residues Gln103 and Tyr104 in SacUVDE (Gln104 and Tyr105 in TthUVDE; Fig-
ure 6.6(d)), which helps in flipping out the damaged bases and the opposite bases
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DAMAGED DNA
Figure 6.8: Bandshift assay of SacUVDE wt and mutants Y10A, C14A and L107P, showing
all proteins have a strong preference of binding 6-4PP to CPD and reduced binding of mutant
C14A. Protein and DNA substrates used are indicated below the lane.
rigid, since it has a proline at the beginning and the end of it (Pro102 and Pro108),
while SacUVDE only has one proline at the corresponding positions (Pro101 and
Leu107). A more rigid finger loop might be more suited to flip out less distorted
DNA substrates and hence a protein with such a rigid finger might have a broader
substrate range. To test this hypothesis, we mutated Leu107 in SacUVDE to a pro-
line. The resulting protein was poorly soluble (most of the protein was in the pellet
after lysis and centrifugation), but the soluble part could still be purified to near
homogeneity. As can be seen in Figure 6.7 the mutant protein (lanes 17-19) has
an incision activity and substrate specificity comparable to wildtype (lanes 4-6):
it only incises 6-4PP efficiently. Also binding studies show the same pattern (see
Figure 6.8), with a large preference for 6-4PP over CPD. The binding efficiency of
L107P looks slightly higher than wildtype, but this is probably due to inaccurate
concentration determination of the mutant due to its low concentration caused by
problems in its solubility. Taken together the above results, we deem it unlikely
that the difference in rigidity of the probing finger causes the different phenotypes
of SacUVDE and other UVDEs.
A charge surface plot of both SacUVDE and TthUVDE (Figure 6.9) shows a dif-
ference in the positive charges on the end of the DNA-binding groove that insert
into the DNA helix, which have previously been hypothesized to be involved in
DNA binding (Paspaleva et al., 2007). For TthUVDE there is a stretch of three pos-
itively charged residues (Lys238, Lys239 and Arg240) and another lysine close by
(Lys179) on one side of the groove, while SacUVDE only has two (Lys178, Lys239).
On the other side of the groove, TthUVDE also has more positive charges: four
(Arg22, His25, Arg30, Lys34), while SacUVDE has only two (Lys21, Arg29). Hav-
ing a prominent positive charge on both sides of the groove likely helps in fixing
and bending the DNA and might explain the different phenotype of SacUVDE and
TthUVDE. To verify the importance of this positive charge at both sides of the DNA-
binding groove, we mutated residues Gly237 and Glu238 to lysine in SacUVDE. To
test its activity in detail, we performed a kinetics incision assay (shown in Figure











Figure 6.9: Charge surface representations of SacUVDE and TthUVDE with positive charge
in blue and negative charge in red. DNA is depicted in cyan (damaged strand) and blue
(undamaged strand).
(a) SacUVDE; regions corresponding to that with more positive charge in TthUVDE are shown
in circles with one residue number for orientation.
(b) TthUDVE; regions which have more positive charge shown in circles.
6-4PP has become smaller in the G237K + E238K mutant. This can be explained by
assuming a combination of the two following effects. First, the overall activity of
the protein goes down, as can be seen with the 6-4PP, due to addition of non-natural
charge for this homologue that might put the DNA slightly in the wrong position.
Secondly, the CPD goes up relatively to the 6-4PP, potentially due to the easier bend-
ing of the DNA. Together, these two effects can cause the result we observed: a
smaller difference in the activity between the two substrates. Thus, the positive
charge on both sides of the groove can be indeed an important factor in SacUVDE
substrate preference and explains at least in part its difference with UVDEs from
other organisms.
6.4 Discussion
The pre-incision complex structure has provided confirmation of previously pro-
posed elements of the mechanism of UVDE, such as the DNA binding groove and
the 90◦ bend in the DNA. It also presents a novel mechanism for recognizing dam-
aged dipyrimidines by a dual flipping mechanism. UVDE flips the undamaged
bases opposite to the damage (always two purines, since the damage consists of
a dipyrimidine) in a dipurine-specific pocket. Not only the undamaged bases are
flipped, but also the damaged ones are flipped in a protein pocket. This combina-
tion represents an elegant mechanism for recognizing and verifying the presence
of the lesion. First, the flipping probably can only occur in damaged DNA, since
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DAMAGED DNA
Figure 6.10: Activity of SacUVDE wt and SacUVDE G237K E238K.
(a) Kinetics incision assay with SacUVDE wildtype, showing a strong difference between incision
on CPD and 6-4PP.
(b) Kinetics incision assay with SacUVDE G237K E238K, showing a smaller difference between
incision on CPD and 6-4PP.
gen bonding). It is therefore highly likely that flipping is easier in damaged DNA.
Second, dipurines are stabilized in the undamaged-DNA-binding pocket, provid-
ing a mechanism for preferentially repairing distorted dipyrimidines. Thirdly, the
damaged bases are flipped into a pocket that can accommodate damaged dipyrim-
idines very well, but will exclude larger lesions. Smaller lesions such as abasic sites
can be incised by UVDE, albeit with a lower efficiency, perhaps because the lesion
is too small to be held stably in the damage pocket. And last, the DNA backbone
is rather distorted at the point where the damaged bases are flipped, which likely
helps in discriminating between damaged and undamaged DNA: for undamaged
DNA such a distortion would be energetically quite unfavorable.
To gain more insight into the broad specificity of UVDE, we have compared
the phenotype and structure of the more general TthUVDE to the more specific
SacUVDE. The latter only efficiently incises 6-4PPs, the UV-lesion that causes se-
vere distortion in the DNA backbone (a 44◦ kink; Kim & Choi, 1995). Surprisingly,
SacUVDE’s structure was found to be very similar to the structure of TthUVDE,
which also incises CPDs well and abasic sites moderately well. We demonstrated
that the different phenotype is not caused by a more specific damage-binding
pocket nor by less rigidity of the probing finger. However, the disulfide bridge
in SacUVDE might have a role in this. Removing this disulfide bridge in SacUVDE
has a detrimental effect on the protein’s ability to bind and incise damaged DNA.
This could be explained as follows. Rigidity around the binding pocket potentially
caused by the disulfide bridge in SacUVDE might prevent the protein from bind-
ing to both CPD and 6-4PP. This non-flexible pocket might be shaped to only fit
well, selectively, 6-4PP. Removing the disulfide bridge might then result in a pro-











our biochemical assays. The disulfide bridge might have arisen in evolution to yield
a more thermoresistant protein for this thermophilic organism, which has a 10 to
15 ◦C higher optimum growth temperature than Thermus thermophilus). Perhaps as
trade-off for the extra stability, it had to give up the broader substrate specificity
typical for UVDE. Potentially it could do this, because the organism already has a
photolyase for repairing CPDs. This scenario is feasible, since a homologous pro-
tein to the potential ORF for S. acidocaldarius photolyase has been shown to reverse
CPDs in vitro (Fujihashi et al., 2007).
Less positive charge on both sides of the DNA binding groove might also make
binding a broad range of DNA substrates more difficult for SacUVDE, since this
charge likely assists in bending the DNA; a 90◦ bend in the DNA is needed for
optimal binding. The 6-4PP is already distorted more than the CPD in solution,
explaining why the protein can bind 6-4PP without the charge on both sides of
the groove. Indeed, addition of this charge in SacUVDE decreases the difference in
incision efficiency between CPD and 6-4PP. This could be taken as a confirmation of
this hypothesis. In conclusion, we think that the difference in substrate specificity
between TthUVDE and SacUVDE is caused by a combination of effects, such as the
rigidity caused by the disulfide bridge and more difficulty in bending DNA caused
by having less positive charges on both sides of the groove.
Comparison of the very specific SacUVDE to the more broad TthUVDE gives
insight into the relatively broad substrate specificity of UVDE in general. It seems
that flexibility around the binding pocket and capacity of bending the DNA are im-
portant factors for UVDE’s capacity to recognize and incise different DNA lesions.
SacUVDE might have given up these features to obtain a more stable protein for liv-
ing at extraordinarily high temperatures. Though SacUVDE perhaps plays a lesser
role in DNA repair in S. acidocaldarius, it may be useful for biochemical assays to
distinguish between CPD and 6-4PP, since it is, to the authors’ knowledge, the most
specific enzyme for incision only next to 6-4PPs.
Taking together the above results, we can make the following model for UVDE
activity. First, UVDE recognizes a distortion in the DNA, such as a kink and/ or loss
of hydrogen bonding, and binds to it. The residues of the probing finger (Gln103
and Tyr104) flip the damaged bases as well as the opposite bases out of the helix
into their respective pockets. Only if the opposite bases are two purines (so they fit
well in their pocket) and if the damaged bases fit in the damage pocket, does the
enzyme bind stably to the damage. The positive charge of the metal ions then draws
in the scissile phosphodiester bond and incision by a hydroxyl ion takes place using


























The Potato Serine Protease Inhibitor (PSPI) constitutes about 22% of the total
amount of proteins in potato tubers (cv. Elkana) making it the plant’s most abun-
dant protease inhibitor. PSPI is a heterodimeric, double-headed Kunitz-type serine
protease inhibitor that can tightly and simultaneously bind two serine proteases by
mimicking the enzyme’s substrate with its reactive site loops. We report the crystal
structure of PSPI, representing the first heterodimeric double-headed Kunitz-type
serine protease inhibitor structure determined. PSPI has a β-trefoil fold and based
on the structure, we have identified two reactive site loops bearing residues Phe75
and Lys95.
published in: E.M. Meulenbroek, E.A.J. Thomassen, L. Pouvreau, J.P. Abrahams, H.
Gruppen, N.S. Pannu, Structure of a post-translationally processed heterodimeric double-











7. CRYSTAL STRUCTURE OF A HETERODIMERIC, DOUBLE-HEADED KUNITZ-TYPE SERINE
PROTEASE INHIBITOR FROM POTATO.
7.1 Introduction
Protease inhibitors are abundantly present in plant seeds and tubers. In the tubers
of the potato cultivar Elkana, for example, circa 50 % (w/w) of the total amount
of soluble proteins are protease inhibitors (Pouvreau et al., 2001). Plant protease
inhibitors prevent pathogens or predators feeding on the plant by inhibiting their
proteases. Protease inhibitors are, therefore, also expressed in response to wound-
ing of the plant (reviewed in Valueva & Mosolov, 2004). In addition to their im-
portance in plant physiology, protease inhibitors are also reported to show anti-
carcinogenic effects: they were shown to prevent carcinogenesis in many different
model systems and are effective at very low concentrations (reviewed in Kennedy,
1998).
Kunitz-type protease inhibitors can bind and inhibit serine, cysteine and aspar-
tic proteases (Oliva et al., 2010). Plant Kunitz-type protease inhibitors are small 20
kDa proteins that usually have two disulfide bonds and a single reactive site (single-
headed), though two reactive site (double-headed) Kunitz-type inhibitors have also
been described (e.g. Dattagupta et al., 1999 and Azarkan et al., 2011). The proteins
inhibit proteases by binding tightly to the enzyme’s active site via their reactive site
loops in a substrate-like manner.
Potato serine protease inhibitor (PSPI) is the most abundant protease inhibitor
group in potato tubers and constitutes 42 % of the protease inhibitors present in
potato juice (Pouvreau et al., 2003). This group of Kunitz-type serine protease in-
hibitors is composed of seven different isoforms, differing slightly in their pI’s. PSPI
is reported to inhibit the serine proteases trypsin, chymotrypsin and human leuko-
cyte elastase (Valueva et al., 2000). It is expressed as a single polypeptide, but six
amino acids are deleted during post-translational processing to yield a protein con-
sisting of a large (16.2 kDa) and small (4.2 kDa) subunit that are held together by
a disulfide bridge and non-covalent interactions (Pouvreau et al., 2003); literature
on Kunitz-type protease inhibitors refers to this multimeric complex as a "dimer",
but for clarity, we refer to the complex as a heterodimer. PSPI is proposed to be a
double-headed protease inhibitor, i.e. having two independent reactive site loops,
since it can form a ternary complex with both trypsin and chymotrypsin (Valueva
et al., 2000). These two loops, however, have never been identified. To be able to de-
termine the location and residues involved in the reactive site loops and thus gain
insight into the mechanism of PSPI and since no three-dimensional atomic struc-
ture of a heterodimeric double-headed Kunitz-type protease inhibitor is known,
we set out to determine the crystal structure of this protein. Here we present the
high resolution structure of PSPI. The structure shows a β-trefoil fold with large
protruding loops and based on the structure, we identified the two reactive loops
as being centered on Phe75 and on Lys95.
7.2 Methods
Protein purification, crystallization and data collection have been reported previ-










7.3. RESULTS AND DISCUSSION
pleteness at this resolution is very low, with only 18.4 % completeness in the high-
est resolution shell (1.69 - 1.60 Å). Although incomplete, we included this high-
resolution data in refinement. The resolution of the data corresponding to a 100
% complete dataset, as calculated by SFTOOLS (Bart Hazes, unpublished) is 1.80
Å. The phase problem was solved by molecular replacement using BALBES (Long
et al., 2008) with the structure of soybean trypsin inhibitor (Song & Suh, 1998)
as a search model. The molecular replacement solution was then rebuilt with
ARP/wARP (Perrakis et al., 1999) resulting in a model that was 87 % complete. Re-
finement was performed with REFMAC using TLS (Murshudov et al., 2011) and
manual fitting was performed using COOT (Emsley et al., 2010). Data and refine-
ment statistics are shown in Table 7.1. In the analysis of the structure, superpo-
sitions with other Kunitz-type serine proteases and root-mean-square deviation
calculations were done by THESEUS (Theobald & Wuttke, 2006). Structure-based
sequence alignment was done with VAST (Thompson et al., 2009). Atomic coor-
dinates and structure factors have been deposited in the RCSB Protein Data Bank
(accession code 3tc2). Figures were made with CCP4mg (Potterton et al., 2004).
7.3 Results and Discussion
7.3.1 Overall structure
The structure of PSPI was determined to high resolution and contains three
molecules in the asymmetric unit. These three molecules are very similar with the
root-mean-square deviations of the Cα-backbone being 0.23 Å between chains A
and B, 0.33 Å between A and C and 0.28 Å between B and C.
The quality of the electron density map is excellent for nearly all of the structure
(Figure 7.1(a)). The map is poor around the loop of amino acids 42-46 in chains B
and C and around amino acids 72-77 in chains A and B. Nevertheless, for each
of these loops, an NCS-related chain with moderate to good density (chain A for
loop 42-46 and chain C for loop 72-77) was available to build a complete model.
The electron density being well defined only in A for 42-46 and only in C for 72-77
could not be attributed to any obvious interface interactions in the crystal.
The overall structure of PSPI shows a β-trefoil fold (Figure 7.1(b)). It consists
of twelve anti-parallel β-strands, which form six two-stranded β-hairpins. Three
of these hairpins form a small β-barrel, while the other three hairpins close off the
barrel in a triangular fashion. The β-strands are connected by long, protruding
loops. Two disulfide bridges are present: between Cys48 and Cys97 and between
Cys146 and Cys157. This fold is usually observed for Kunitz-type serine protease
inhibitors (e.g. Soybean Trypsin Inhibitor, (Song & Suh, 1998)) and the reactive sites
are commonly found in the protruding loops. The β-sheets provide a stable core
that can hold together the structure even if incision by the protease takes place, both
by the covalent interaction of the disulfide bridges and the numerous non-covalent
interactions.
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a, b, c (Å) 54.82 x 93.92 x 55.44
α, β, γ (◦) 90.00, 100.69, 90.00
Resolution (Å) 54.23–1.60 (1.69-1.60)a
Resolution of a 100 % complete data set (Å) 1.80b
Wilson plot B-factor 20.1
Rmergec 0.044 (0.370)
I/σI 14.0 (1.8)
Completeness (%)b 70.0 (18.4)
Redundancy 2.1 (1.8)
Total n◦. observations 104501
N◦ unique reflections 50787




N◦ molecules in ASU 3










Bond lengths (Å) 0.030
Bond angles (◦) 2.25
No. TLS bodies 3
Ramachandran favoredd 95.23 %
Ramachandran outliersd 0.38 %
Rotamer outliersd 0.88 %
aValues in parentheses are for highest-resolution shell.
bData is complete to 1.80 Å.
cMultiplicity weighted R-merge, (Diederichs & Karplus, 1997; Weiss & Hilgenfeld,
1997)










7.3. RESULTS AND DISCUSSION
Figure 7.1: Overall structure of PSPI.
(a) Representative part of the electron density map of PSPI with a short stretch of the model
(map clipped to show only this part of the model), demonstrating excellent electron density to
a high resolution. Map is contoured at 1.5 σ.
(b) Ribbon diagram of one molecule of PSPI with β-sheets indicated, showing a β-trefoil fold.
The N- and C-terminus are labelled as well as the two disulfide bridges (in yellow).
mined previously. The structures most similar to PSPI in terms of amino acid se-
quence are a miraculin-like protein with 32.7% identity (PDB entry 3iir, Gahloth et
al., 2010), a Kunitz-type inhibitor from Delonix Regia seeds with 31.7% identity (PDB
entry 1r8n, Krauchenco et al., 2003), a winged-bean chymotrypsin inhibitor with
27.9% identity (PDB entry 2wbc, Dattagupta et al., 1999) and a soybean trypsin in-
hibitor with 27.4% identity (PDB entry 1avx, Song & Suh, 1998). A structure-based
sequence alignment of PSPI with other similar proteins (Figure 7.2) shows that the
sequences are most similar in the β-strand regions, which form the scaffold of the
structure, compared with that of protruding loops, which determine the specificity
of the inhibitors.
Structural superposition gives a similar pattern. The overall root-mean-square
deviations of the Cα-backbone of PSPI with these four structures are (calculated
with subunit A of PSPI): 1.47 Å for the miraculin-like protein, 1.22 Å for the Kunitz-
type inhibitor from Delonix regia seeds, 1.21 Å for a winged-bean chymotrypsin
inhibitor, and 1.35 Å for a soybean trypsin inhibitor. This indicates that the struc-
tures are indeed similar, but as expected, the similarity is mostly in the β-sheet core,
whilst the protruding loops differ substantially.
An important difference between PSPI and the previously determined struc-
tures of Kunitz-type serine protease inhibitors is that, to the best of our knowl-










7. CRYSTAL STRUCTURE OF A HETERODIMERIC, DOUBLE-HEADED KUNITZ-TYPE SERINE
PROTEASE INHIBITOR FROM POTATO.
Figure 7.2: Structure-based sequence alignment.
Alignment of PSPI with other previously structurally characterized Kunitz-type serine protease
inhibitors. β-strands are indicated with blue arrows and the yellow box shows where six residues
are post-translationally deleted from PSPI.
double-headed protease inhibitor. Only crystal structures of monomeric Kunitz-
type double-headed serine protease inhibitors are known, such as winged bean
α-chymotrypsin inhibitor (Dattagupta et al., 1999).
PSPI is expressed as a single polypeptide chain, but in a post-translational pro-
cess around six residues after Thr150 are removed. Thus, there is no loop between
Thr150 and Ser151 and despite the consecutive numbering of the amino acids,
there is also no peptide bond between Thr150 and Ser151, because of the deletion.
The residues just before the site of the deletion (Thr149 and Thr150) and just after
(Ser151, Ser152 and Asp153) are not modelled in our structure due to poor density
probably caused by structural flexibility. Despite being (hetero)dimeric, the confor-
mation of the whole molecule including the region close to the deleted loop is very
similar to other, monomeric, Kunitz-type serine protease inhibitors. The structure
seems to be held together in this very similar conformation by the disulfide bridge
Cys146-Cys157 close to the beginning and the end of the deleted loop, since only
the residues between these two cysteines show a different backbone direction from
monomeric Kunitz-type serine protease inhibitors. Apparently, the presence of the
extra loop and the post-translational deletion of the loop has not affected the over-
all structure of the inhibitor. It is possible that the loop functions as a shield for an










7.3. RESULTS AND DISCUSSION
activated upon cleavage. The range in which the excised loop can be is indicated in
Figure 7.3(a).
7.3.2 Identification of reactive site loops
The reactive site loops for PSPI have not yet been identified. Previous predictions
based on sequence alignment with other Kunitz-type inhibitors located the reac-
tive site loops around Arg67-Phe68 (with Arg67 being the P1 position) and around
Met115-Leu116 (with Met115 occupying the P1 position; Valueva et al., 2000). How-
ever, both these proposed sites are located on the inside of the structure and not in
protruding loops. Indeed, Arg67 is in the middle of a β-strand in the protein’s core
and hence cannot be the P1 residue of the reactive site loop. Similarly, there would
also be a considerable amount of steric hindrance for a protease to bind if Met115
was a P1 amino acid.
To find more likely reactive site loops, we compared the PSPI structure to other
Kunitz-type serine protease inhibitors with previously determined and verified re-
active site loops. Five possibilities for reactive side loops arose. Based on compari-
son with double-headed arrowhead protease inhibitor, the reactive loops could be
located around Asn50 and around Leu84 of PSPI (Xie et al., 1997). However, in the
PSPI structure these residues are also not in protruding loops, but at sterically more
inaccessible positions, and thus ruling out these sites.
Another possibility for a reactive site loop is near Asp45-Asn50 in PSPI (see Fig-
ure 7.3(a) and (b)). This loop corresponds to the Asn38-Leu43 loop that has been
proposed to be one of the reactive site loops for winged-bean α-chymotrypsin in-
hibitor (Dattagupta et al., 1999) based on structural similarity to its other verified
reactive site. The Asp45-Asn50 loop in PSPI looks similar in structure and partially
similar in sequence to the winged-bean α-chymotrypsin inhibitor reactive loop.
The P1 residue in this loop is proline (Pro47 in PSPI) for both proteins. In PSPI
this loop is partially disordered in chains B and C and has higher than average B-
factors for chain A. This is a typical property of substrate loops that probably aids
in binding the protease. The reactive site loops adopt a more rigid conformation
upon protease binding (Song & Suh, 1998).
The most common reactive site loop for monomeric Kunitz-type serine protease
inhibitors is the loop starting at Ser71 to Phe80 with Phe75 being the P1 residue in
PSPI. This sequence was proposed to be the reactive site loop of other serine pro-
tease inhibitors including miraculin-like protein (Gahloth et al., 2010), for a mutant
trypsin inhibitor based on a co-crystal with trypsin (PDB entry 3i29), for double-
headed winged bean chymotrypsin inhibitor based on biochemical evidence (Shi-
bata et al., 1988) and, finally, for soybean trypsin inhibitor based on a co-crystal with
trypsin (Song & Suh, 1998). In PSPI this loop has poor density in chains A and B
and has high B-factors in chain C, indicating flexibility. As can be seen in Figure
7.3(a), Phe75 sticks out into the solvent in chain C (the only NCS-related molecule
for which there is moderately good electron density; see Figure 7.3(c) for an OMIT
map), which would facilitate its recognition by a target protease.










7. CRYSTAL STRUCTURE OF A HETERODIMERIC, DOUBLE-HEADED KUNITZ-TYPE SERINE
PROTEASE INHIBITOR FROM POTATO.
Figure 7.3: Reactive site loops of PSPI.
(a) P1 residues of the three most probable candidates for reactive site loops of PSPI highlighted
on the structure of PSPI, showing their position to be in loops and showing how they stick out
into the solvent. Disulfide bridges are indicated in yellow. The orange circle shows the range
in which the excised loop can be (on the right side of the protein in this view) and the last and
first ordered residue in the structure at the beginning and end of the excised loop are indicated
(V148 and D154).
(b) Omit map of putative reactive site loop of Asp45-Asn50 (yellow).
(c) Omit map of putative reactive site loop of Ser71-Phe80 (yellow).
(d) Omit map of putative reactive site loop of Ser92-Ser99 (yellow).
The electron difference density maps are calculated based on phases from the model without
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corresponding loop was identified to be a reactive site loop in both double-
headed arrowhead protease inhibitor (PDB entry 3e8l) based on mutagenesis
studies and a co-crystal with two trypsins (Bao et al., 2009) and also in bar-
ley α-amylase/subtilisin inhibitor based on a co-crystal with subtilisin savinase
(Micheelsen et al., 2008). The latter inhibitor is identified as fifth structurally most
related protein to PSPI by the VAST program. The loop around Lys95 has a simi-
lar conformation to the loop from the double-headed arrowhead protease inhibitor
and protrudes from the structure with Lys95 sticking out to the solvent as can be
expected for a P1 reactive site residue (Figure 7.3(a) and (d)).
As stated above, the loops around Pro47, Phe75 and Lys95 are the three most
likely candidates for reactive site loops. Since in the trypsin active site a large
positively charged amino acid fits best (to make contacts with Asp189), we pro-
pose that the Lys95 is the trypsin interacting loop. Chymotrypsin is specific for
sequences with bulky hydrophobic amino acids; hence it is plausible that chy-
motrypsin binds to the Phe75 loop. Moreover, these two reactive site loops have
been confirmed by co-crystallization in other Kunitz-type serine protease inhibitors
providing stronger evidence for its potential biological function than structural
similarity of a loop in an uncomplexed structure, as is the case with Pro47. The
Phe75 reactive site loop might be hidden before the post-translational processing
of the loop between Thr150 and Ser151 (Figure 7.3(a)).
It has been reported that one molecule of PSPI can bind a trypsin and a chy-
motrypsin molecule at the same time (Valueva et al., 2000). To verify whether this
is indeed possible with the suggested reactive site loops, we modelled two pro-
teases on the reactive site loops based on co-crystal structures in which a trypsin
is bound to one of these loops (Song & Suh, 1998 and Bao et al., 2009) using the
secondary-structure matching (SSM) function in COOT. As can be seen in Figure
7.4, it is possible for the two proteases to simultaneously bind PSPI.
It has also been reported that PSPI inhibits human leukocyte elastase (Valueva
et al., 2000). Since elastase is specific for a small neutral amino acid, we are unsure
whether it can act on either of the loops proposed for trypsin or chymotrypsin.
Thus, it might need another binding site such as the Pro47 loop. Unfortunately, no
elastase structure with bound Kunitz-type serine protease inhibitor is available for
comparison.
7.3.3 Interfaces for aggregation
The PISA (Protein Interfaces, Surfaces and Assemblies) server (Krissinel & Hen-
rick, 2007) was used to investigate potential interfaces for interaction in the PSPI
crystal structure. The surface including residues 107, 127 and 148 with the plane
formed by residues 30, 58 and 169 was predicted to be a strong interface and have
a high probability to occur in solution. Since PSPI was reported to exist as a single
molecule in solution (Pouvreau et al., 2005), this interface is apparently not seen un-
der ambient conditions. However, it has been reported that PSPI aggregates upon
heating into a product with four molecules of PSPI (Pouvreau et al., 2005). The
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PROTEASE INHIBITOR FROM POTATO.
Figure 7.4: Model of PSPI with two proteases.
Model of PSPI (magenta) with two proteases (green) on it, showing that it is possible for two
proteases to bind simultaneously at the reactive sites F75 and K95 to one molecule of PSPI. In
this picture two trypsins were modelled, but the picture will be equivalent for one chymotrypsin
and one trypsin, due to the structural similarity of trypsin and chymotrypsin.
tion when the conditions for solubility are changed, as happens in a crystallization
experiment with increasingly high concentrations, after which two seeding two-
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DNA carries our genetic information and hence its integrity is of the utmost impor-
tance. However, there are many influences from inside the cell, like free oxygen rad-
icals produced during metabolism, and from outside the cell, like UV-irradiation,
that result in damage in the DNA. If left unrepaired, these lesions can lead to cell
death and mutations, the latter potentially resulting in cancer. To prevent these
deleterious effects of DNA damage, several DNA repair pathways have evolved.
The major pathways are described in Chapter 1, where insights into these path-
ways gained from structural biology are emphasized. In this thesis, research into
components of Transcription-Coupled Nucleotide Excision Repair (TC-NER) and
UV Damage Endonuclease repair (UVDE) are described, with the most important
findings listed below.
TC-NER is a conserved DNA repair pathway that removes DNA damages from
the transcribed strand of actively transcribed genes. It is a subpathway of Nu-
cleotide Excision Repair (NER) that removes DNA lesions by excising a 25-30 nu-
cleotide DNA fragment containing the lesion and filling up the gap. Most proteins
involved in TC-NER come from this more global pathway of NER, but two proteins
are unique in humans: Cockayne Syndrome protein A and B (CSA and CSB). CSA is
the substrate-adaptor protein in an E3-ubiquitin ligase complex and CSB is a pro-
tein with DNA-dependent ATPase activity that probably assists in making space
for repair around the site of the damage. Mutations in either CSA and CSB lead
to the severe human disorder Cockayne Syndrome. This disease is characterized
by, amongst others, premature aging and neurodevelopmental abnormalities. This
shows that CSA and CSB are biologically important, but their exact function is not
clear.
To gain more insight into the function of CSA and into how mutations cause
disease, a detailed picture of the protein is useful. Structural prediction tools in-
dicated that CSA probably has a seven-bladed β-propeller fold, since it has seven
WD40 repeats. Hence the general shape was known, but what was not known was
the exact structure with the conformation of all the loops and the position of all
the side-chains that makes CSA different from other WD40 proteins. Exactly that
information is needed to be able to explain the disease. Therefore, we decided to
solve its crystal structure by X-ray crystallography, which is a technique that yields
a picture of a protein to atomic detail.











crystallizing it. In Chapter 2 we describe the expression of CSA in complex with
its interaction partner DNA Damage Binding protein 1 (DDB1), since CSA was not
soluble on its own. The complex was then purified in a three-step procedure and
crystallized. The crystals diffracted anisotropically to 2.9 Å.
Chapter 3 describes the crystal structure of CSA in complex with DDB1. As
expected, the overall structure of CSA showed a β-propeller fold. CSA was found
to interact with DDB1 using its N-terminal helix-loop-helix motif. The disease-
causing mutations could be mapped onto the structure. It was found that the mu-
tations mostly disrupt local or global folding and probably lead to problems in ei-
ther binding to CSA’s substrate or binding to CSA’s interaction partner DDB1. This
kind of errors are, unfortunately, difficult to counteract. The most likely substrate-
binding site for CSA was found to be the centre of the top face of its WD40 do-
main. This was seen to have a small, positively charged centre, much like substrate-
binding sites for phosphorylated proteins. This suggested that CSA might recog-
nize a phosphorylated protein or an otherwise negatively charged stretch on an-
other protein.
The crystal structure of CSA suggested a potential substrate-binding site and
residues involved in substrate binding, but this had to be verified biochemically. Ex-
periments performed to this end are described in Chapter 4. Mutation of two pos-
itively charged residues (K292 and K293) in the centre of the proposed substrate-
binding site resulted in a protein that could not complement for UV-sensitivity in
a CS-A cell line, showing that this site is indeed important for CSA’s function. The
two most likely options for CSA to bind to, DNA and CSB, were then tested. CSA
was found not to bind DNA at biologically significant protein-DNA ratios, virtu-
ally excluding DNA as binding partner of CSA. Pull-down experiments using a
His-tagged CSA overexpressed in a CS-A cell line showed CSB being pulled-down
by CSA. Moreover, in cell lines overexpressing CSA, less CSB was detected com-
pared to cell lines without CSA. This suggests that CSB might be the substrate that
CSA targets for ubiquitination.
Bacteria and lower eukaryotes have another pathway for the repair of UV-
lesions: the UV Damage Endonuclease (UVDE) repair pathway. UVDE is an en-
zyme that can both recognize and make a 5’ incision in a number of different DNA
lesions, such as the UV-photoproducts Cyclobutane Pyrimidine Dimer (CPD) and
6-4 Photoproduct (6-4PP), but also abasic sites and other lesions. After the 5’ inci-
sion, other enzymes complete the repair. The fact that one enzyme both recognizes
different damages and incises them is rather unique, and it makes UVDE a nice,
simplified model system for DNA repair.
The crystal structure of UVDE from Thermus thermophilus was solved in Leiden
some years ago. In this structure, a post-translational modification was seen on a ly-
sine residue near the active site. This is uncommon for a bacterial protein expressed
in a foreign host and therefore we investigate the identity of the modification and
its function in Chapter 5. With mass-spectrometry and X-ray crystallography, the
modification was shown to be a carboxylation of a lysine residue. Site-directed
mutagenesis in combination with activity assays and crystallography was used to










ing the metal ions required for the activity of UVDE. Moreover, it was seen that a
positive charge at this position in the protein is actually dangerous, since it leads to
rearrangements in the structure near the site where the damage in the DNA has to
bind and this leads to increased incision of undamaged DNA.
Another open question was how can UVDE, as a single enzyme, recognize dif-
ferent DNA damages. To answer this question, we cocrystallized UVDE with 6-
4PP containing DNA. In the crystal structure (described in Chapter 6), we saw that
UVDE has a unique mechanism for recognizing UV-damaged DNA: double two-
nucleotide flipping. Not only the damage flipped is into a pocket that excludes
larger damages, but also the two opposite bases are flipped into a dipurine-specific
pocket, hence providing extra specificity for distorted dipyrimidines. The DNA has
to be bent around 90 ◦ to fit into the protein; this is probably energetically rather
unfavourable for undamaged DNA, hence providing extra specificity for damaged
DNA where e.g. already part of the hydrogen bonding is lost. To investigate fur-
ther why most UVDEs can both incise CPD and 6-4PP efficiently, we compared the
UVDE homologues TthUVDE (incises CPD, 6-4PP and abasic site) and SacUVDE
(only incises 6-4PP efficiently) both in activity and it structure. Rigidity around
the damage-binding pocket in SacUVDE due to a disulfide bridge, combined with
the lack of positive charges on opposite sides of the DNA-binding groove that are
needed to bend the DNA, probably are the causes for the narrow substrate speci-
ficity of this homologue. These hypotheses were confirmed by site-directed muta-
genesis and activity assays. These results suggest that the relatively broad substrate
specificity of the other UVDEs is caused by their ability to bend the damaged (hence
flexible) DNA correctly in its DNA binding groove combined with a moderately
flexible DNA binding pocket.
The last chapter of this thesis (Chapter 7) describes the crystal structure of
an unrelated protein, Potato Serine Protease Inhibitor (PSPI), to show the general
applicability of X-ray crystallography for gaining insight into biological systems.
PSPI is a protein involved in the defense mechanism of the plant. It inhibits ser-
ine proteases such as trypsin and chymotrypsin and thus prevents predators and
pathogens to feed on the plant. It was found to have a β-trefoil fold, which has
a very stable core with protruding loops. The reactive site loops are commonly
found in these protruding loops. The protein inhibits proteases by trapping them
on these loops, because the core of the protein is too stable to fall apart. With our
structure, we could determine the reactive site loops of PSPI based on comparison
to other protease inhibitor structures. PSPI is special in that it is a heterodimeric,
double-headed protease inhibitor: in a post-translational process six amino acids
in a loop are deleted. Our structure provided a possible reason for this: it might be
involved in activating the inhibitor, since taking away of this loop uncovers one of
the reactive site loops.
Concluding remark
This thesis gives some examples of how X-ray crystallography can give insight into











helps in explaining the function of the protein from its overall fold and from what
residues are found at what positions. With the wealth of structural information
already present in the Protein Data Bank, any new structure can be interpreted by
comparing it to other known structures of proteins with known function. However,
the interesting bits and pieces of a protein are usually found exactly in the parts of
the protein that differ from the previous structures. Interpretation of those differ-
ences is subjective and needs verification. Biochemical techniques like site-directed
mutagenesis and activity assays are very well suited for this: they form a comple-
mentary source of information to structural information. As is also demonstrated
in the chapters on CSA and UVDE in this thesis, not only structural biology, but












DNA is de drager van ons genetisch materiaal. Het is daarom belangrijk dat de
informatie in het DNA correct blijft. Door allerlei oorzaken kan er echter schade
ontstaan in het DNA. Dat gebeurt zowel door processen in onze cellen, zoals door
vrije zuurstofradicalen die ontstaan tijdens het metabolisme in de cel, als door in-
vloeden van buitenaf, zoals UV-straling. Als de schade niet wordt hersteld, kan
dat tot celdood en mutaties leiden. Dat laatste kan kanker tot gevolg hebben.
Om deze negatieve gevolgen van DNA-schade te voorkomen, zijn er in de evolutie
verschillende DNA-herstelmechanismen ontstaan. In Hoofdstuk 1 van dit proef-
schrift staan de belangrijkste DNA-herstelmechanismen samengevat. De nadruk
wordt hier gelegd op inzichten die zijn verkregen door middel van structuurbiolo-
gie. Het onderzoek beschreven in dit proefschrift, gaat over de herstelmecha-
nismen Transcriptie-gekoppelde Nucleotide Excisie Reparatie (TC-NER) en UV-
schade endonuclease herstel (UVDE). De belangrijkste resultaten van dit promotie-
onderzoek staan hieronder samengevat.
TC-NER is een geconserveerd DNA-herstelmechanisme dat schades herstelt in
de DNA-regio’s waar actieve transcriptie plaatsvindt. Het is een submechanisme
van Nucleotide Excisie Reparatie (NER), waarbij DNA-schade wordt hersteld door
het uitknippen van een stuk DNA van 25-30 nucleotiden met de schade erin en
door het vervolgens opvullen van het gat. De meeste eiwitten die zijn betrokken
bij TC-NER komen uit het meer algemene mechanisme van NER, maar er zijn twee
eiwitten uniek voor TC-NER: Cockayne Syndroom eiwit A en B (CSA en CSB). CSA
is het substraat-bindende eiwit in een E3-ubiquitine ligase complex en CSB is een
eiwit dat waarschijnlijk met zijn ATPase activiteit ruimte maakt rond de schade om
herstel mogelijk te maken. Mutaties in CSA of CSB leiden tot de ernstige ziekte
Cockayne Syndroom. Patiënten met deze ziekte vertonen o.a. versnelde verouder-
ing. Dit laat zien dat CSA en CSB belangrijk zijn voor de mens, maar hun exacte
functie is nog niet duidelijk.
Om meer inzicht te krijgen in de functie van CSA en om te kunnen verklaren
hoe mutaties erin Cockayne Syndroom veroorzaken, zou een gedetailleerd plaatje
van het eiwit nuttig zijn. Met bioinformatica is de algemene vorm van CSA te
voorspellen. Het heeft een WD40 domein en dergelijke eiwitten hebben meestal
een β-propeller vouwing. Wat niet voorspeld kan worden, is hoe alle lussen zijn
gevouwen en welke zijketens waar zitten. Dat is namelijk het aspect waarin CSA











om de ziekte te kunnen verklaren. Die informatie is alleen te verkrijgen door de
structuur van het eiwit op te lossen. Dat hebben we dan ook gedaan en wel met de
techniek eiwitkristallografie, waarmee een driedimensionaal plaatje van het eiwit
met atomaire resolutie gemaakt kan worden.
De eerste stappen voor het oplossen van een eiwitstructuur bestaan uit het
verkrijgen van het eiwit en de kristallisatie ervan. In Hoofdstuk 2 staat beschreven
hoe we CSA overgeproduceerd hebben in een complex met zijn interactiepart-
ner DNA-schade Bindend eiwit 1 (DDB1), omdat CSA afzonderlijk niet oplosbaar
was. We hebben het complex gezuiverd met drie zuiveringsstappen en vervolgens
gekristalliseerd. De kristallen diffracteerden tot 2.9 Å.
Hoofdstuk 3 gaat verder met de beschrijving van de kristalstructuur van CSA
in een complex met DDB1. Zoals verwacht vormt CSA een β-propeller. CSA bindt
aan DDB1 via een N-terminaal helix-lus-helix motief. In de structuur kunnen we
zien waar de mutaties zitten die Cockayne Syndroom veroorzaken. Deze mutaties
leiden waarschijnlijk vooral tot problemen, doordat ze de lokale of globale vouwing
verstoren. Dit zorgt er dan voor dat CSA niet meer kan binden aan zijn substraat
of aan zijn interactiepartner DDB1. Helaas zijn zulke fouten in een eiwit moeilijk
om te corrigeren met een klassiek medicijn. Verder is gekeken naar wat de meest
waarschijnlijke plek van CSA is waarmee het aan zijn substraat bindt. Dit bleek
het midden van de bovenkant van het WD40 domein te zijn. Daar zit een klein,
positief geladen gat dat lijkt op de substraatbindende plekken voor gefosforyleerde
eiwitten. Dit suggereert dat CSA een gefosforyleerd eiwit herkent of een anderszins
negatief geladen deel van een ander eiwit.
De kristalstructuur van CSA liet zien welke aminozuren betrokken kunnen zijn
bij binding van het substraat. Dit moest wel nog gecontroleerd worden met bio-
chemische experimenten. Dergelijke experimenten staan beschreven in Hoofd-
stuk 4. Een variant van CSA met mutaties middenin de mogelijke substraat-
bindende plek, bleek niet de UV-gevoeligheid van een CS-A cellijn te kunnen com-
plementeren. Dit wijst erop dat het inderdaad een belangrijke plek voor de functie
van het eiwit is. Vervolgens keken we naar de twee meest waarschijnlijke substraten
voor binding door CSA: DNA en CSB. CSA bleek niet aan DNA te binden bij bi-
ologisch relevante eiwit-DNA verhoudingen. Daardoor is het onwaarschijnlijk dat
CSA aan DNA bindt in de cel. In andere experimenten bleek dat CSB meegetrokken
wordt met CSA als CSA met zijn C-terminale His-tag uit menselijke cellen wordt
gehaald. Bovendien zat er minder CSB in cellijnen waar CSA tot overexpressie werd
gebracht. Dit wijst erop dat CSB het daadwerkelijke substraat voor CSA kan zijn.
Bacteriën en lagere eukaryoten hebben nog een andere manier om DNA-
schades te herstellen, namelijk die van UV-schade endonuclease herstel (UVDE).
UVDE is een eiwit dat verschillende schades kan herkennen, waaronder UV-
schades als Cyclobutaan Pyrimidine Dimeer (CPD) en 6-4 fotoproduct (6-4PP). Ver-
volgens kan UVDE ook een knip in het DNA maken aan de 5’ kant van de schade.
Andere enzymen maken het herstel daarna af. Het is bijzonder dat één enkel eiwit
zowel meerdere schades kan herkennen als deze kan knippen. Normaal gesproken











Een aantal jaren geleden is in Leiden de kristalstructuur van UVDE uit Thermus
thermophilus opgelost. Daarin kon gezien worden dat een lysine in de buurt van de
actieve plek van UVDE een post-translationele modificatie heeft. Dit is ongebruike-
lijk voor een bacterieel eiwit dat in een gastheer tot overexpressie wordt gebracht
en daarom hebben we de identiteit en functie van deze modificatie onderzocht in
Hoofdstuk 5. Met massa-spectrometrie en eiwitkristallografie hebben we aange-
toond dat het om een carboxylering gaat. Met functionele en structurele testen van
mutanten van UVDE hebben we de functie van deze carboxylering kunnen aanto-
nen. Het bleek nodig om negatieve lading te geven die helpt bij de binding van de
metaalionen die UVDE gebruikt voor katalyse. Bovendien bleek dat positieve lad-
ing op deze plek erg gevaarlijk is voor het eiwit, omdat dat voor veranderingen in
de structuur zorgt dichtbij de plek waar de schade moet binden en daardoor gaat
het eiwit ook onbeschadigd DNA knippen.
Verder was nog niet duidelijk uit de kristalstructuur van TthUVDE hoe dit ei-
wit verschillende DNA schades kan herkennen en knippen. Om deze vraag te
beantwoorden hebben we de cokristalstructuur van UVDE met beschadigd DNA
(6-4PP) bepaald. In deze structuur (beschreven in Hoofdstuk 6) konden we zien
dat UVDE een uniek mechanisme heeft om UV-schade in het DNA te herkennen.
Niet alleen wordt de schade in een bindingsplek geduwd, ook de basen tegenover
de schade gaan in een inkeping die specifiek is voor twee purines, wat leidt tot ex-
tra specificiteit voor beschadigde dipyrimidines. Het DNA moet over 90◦ buigen
om in de bindingsgroef te passen; dit is waarschijnlijk energetisch ongunstig voor
onbeschadigd DNA, wat leidt tot specificiteit voor beschadigd DNA waar bijvoor-
beeld een deel van de waterstofbruggen al zijn verstoord. Om verder te onder-
zoeken waarom de meeste UVDEs meerdere schades kunnen knippen, hebben we
de UVDE homologen TthUVDE (die CPD, 6-4PP en AP kan knippen) en SacUVDE
(die alleen 6-4PP kan knippen) vergeleken in activiteit en structuur. De plek waar
de schade bindt in het eiwit bleek minder flexibel te zijn in SacUVDE door een
zwavelbrug. Ook bleek SacUVDE geen positieve ladingen te hebben aan beide
kanten van de DNA-bindingsgroef - wat TthUVDE wel heeft - en die ladingen zijn
waarschijnlijk nodig om meerdere DNA substraten correct te kunnen buigen, zodat
ze in de groef kunnen binden. Deze hypotheses hebben we bevestigd met activiteit-
stesten op mutanten van UVDE. De resultaten tonen aan dat de meeste UVDEs juist
veel verschillende substraten kunnen binden, doordat ze goed DNA kunnen buigen
met positieve ladingen aan beide kanten van de bindingsgroef en doordat ze een
relatief flexibele bindingsplek voor schade hebben.
Het laatste hoofdstuk van dit proefschrift (Hoofdstuk 7) gaat over de kristal-
structuur van een ongerelateerd eiwit, Aardappel Serine Protease Remmer (PSPI).
PSPI is een onderdeel van het verdedigingsmechanisme van de plant. Het remt
serine proteases zoals trypsine en chymotrypsine en kan daardoor voorkomen dat
dieren of ziekteverwekkers zich voeden met de plant. PSPI bleek een β-trefoil
vouwing te hebben. Karakteristiek hiervoor is een zeer stabiele kern met lussen die
van daaruit naar buiten steken. De reactieve plekken van het eiwit zitten meestal
in deze lussen. Het eiwit kan proteases remmen door ze vast te laten lopen op











Echter, door de stabiele kern valt de remmer niet uit elkaar na de knip en blijft de
protease op de remmer vastzitten doordat het blijft proberen die kapot te knippen.
Door onze structuur te vergelijken met andere structuren van protease-remmers
konden we bepalen wat de reactieve plekken zijn van PSPI. PSPI is bijzonder, om-
dat het een heterodimere protease-remmer is met twee reactieve plekken. In een
post-translationeel proces zijn er namelijk zes aminozuren uit een lus weggeknipt.
Uit onze structuur bleek een mogelijke functie hiervoor: het is misschien betrokken
bij de activatie van de remmer, want het wegknippen van de lus legt één van de re-
actieve plekken bloot.
Afsluitende opmerking
Dit proefschrift laat zien hoe eiwitkristallografie inzicht kan geven in de functie van
eiwitten. Het geeft voorbeelden van hoe een drie-dimensionaal plaatje van een ei-
wit met atomaire resolutie kan helpen in het verklaren hoe een eiwit werkt; zowel
de globale vouwing als de exacte locaties van bepaalde aminozuren zijn hierbij van
belang. Met de overvloed aan informatie die al beschikbaar is in de Eiwit Data Bank
(PDB) kan bijna elke nieuwe structuur geïnterpreteerd worden door de structuur
te vergelijken met eerder bekende structuren. Echter, de interessantste onderde-
len van een eiwit zijn juist de delen die anders zijn dan in eerdere structuren. De
interpretatie van die verschillen is vaak speculatief en daarom is biochemische ver-
ificatie ervan nodig. Technieken als mutagenese en activiteitstesten zijn hier zeer
geschikt voor: ze vormen een complementaire bron van informatie. Zoals te zien is
in de hoofdstukken over CSA en UVDE in dit proefschrift, is vooral de combinatie
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